| 1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
| A
|
|
|
|
|
Alimentary tract and metabolism
|
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
|
A01AD11
|
Various
|
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
|
Empty
|
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
|
Empty
|
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
|
empty
|
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
|
A03FA06
|
Clebopride
|
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
|
|
A04AA55
|
palonosetron, combinations
|
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
|
A05AA
|
|
Bile acids and derivatives
|
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
|
|
A05AA04
|
obeticholic acid
|
|
|
|
|
|
A05AA05
|
ursodoxicoltaurine
|
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
|
|
|
A05AX04
|
maralixibat chloride
|
|
|
|
|
|
A05AX05
|
odevixibat
|
|
|
|
|
|
A05AX06
|
elafibranor
|
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
|
Empty
|
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
|
|
A06AH03
|
naloxegol
|
|
|
|
|
|
A06AH04
|
naloxone
|
|
|
|
|
|
A06AH05
|
naldemedine
|
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
|
|
|
|
A06AX07
|
plecanatide
|
|
|
|
|
|
A06AX08
|
tenapanor
|
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
|
A07A
|
|
|
Intestinal anti-infectives
|
|
|
|
|
A07AA
|
|
Antibiotics
|
|
|
|
|
|
A07AA01
|
Neomycin
|
|
|
|
|
|
A07AA02
|
Nystatin
|
|
|
|
|
|
A07AA03
|
Natamycin
|
|
|
|
|
|
A07AA04
|
Streptomycin
|
|
|
|
|
|
A07AA05
|
Polymyxin B
|
|
|
|
|
|
A07AA06
|
Paromomycin
|
|
|
|
|
|
A07AA07
|
Amphotericin B
|
|
|
|
|
|
A07AA08
|
Kanamycin
|
|
|
|
|
|
A07AA09
|
Vancomycin
|
|
|
|
|
|
A07AA10
|
Colistin
|
|
|
|
|
|
A07AA11
|
Rifaximin
|
|
|
|
|
|
A07AA12
|
Fidaxomicin
|
|
|
|
|
|
A07AA51
|
Neomycin, combinations
|
|
|
|
|
|
A07AA54
|
Streptomycin, combinations
|
|
|
|
|
A07AB
|
|
Sulfonamides
|
|
|
|
|
|
A07AB02
|
Phthalylsulfathiazole
|
|
|
|
|
|
A07AB03
|
Sulfaguanidine
|
|
|
|
|
|
A07AB04
|
Succinylsulfathiazole
|
|
|
|
|
A07AC
|
|
Imidazole derivatives
|
|
|
|
|
|
A07AC01
|
Miconazole
|
|
|
|
|
A07AX
|
|
Other intestinal anti-infectives
|
|
|
|
|
|
A07AX01
|
Broxyquinoline
|
|
|
|
|
|
A07AX02
|
Acetarsol
|
|
|
|
|
|
A07AX03
|
Nifuroxazide
|
|
|
|
|
|
A07AX04
|
Nifurzide
|
|
|
|
A07B
|
|
|
Intestinal adsorbents
|
|
|
|
|
A07BA
|
|
Charcoal preparations
|
|
|
|
|
|
A07BA01
|
Medicinal charcoal
|
|
|
|
|
|
A07BA51
|
Medicinal charcoal, combinations
|
|
|
|
|
A07BB
|
|
Bismuth preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
A07BC
|
|
Other intestinal adsorbents
|
|
|
|
|
|
A07BC01
|
Pectin
|
|
|
|
|
|
A07BC02
|
Kaolin
|
|
|
|
|
|
A07BC03
|
Crospovidone
|
|
|
|
|
|
A07BC04
|
Attapulgite
|
|
|
|
|
|
A07BC05
|
Diosmectite
|
|
|
|
|
|
A07BC30
|
Combinations
|
|
|
|
|
|
A07BC54
|
Attapulgite, combinations
|
|
|
|
A07C
|
|
|
Electrolytes with carbohydrates
|
|
|
|
|
A07CA
|
|
Oral rehydration salt formulations
|
|
|
|
|
|
|
human ATC classification.
|
|
|
|
A07D
|
|
|
Antipropulsives
|
|
|
|
|
A07DA
|
|
Antipropulsives
|
|
|
|
|
|
A07DA01
|
Diphenoxylate
|
|
|
|
|
|
A07DA02
|
Opium
|
|
|
|
|
|
A07DA03
|
Loperamide
|
|
|
|
|
|
A07DA04
|
Difenoxin
|
|
|
|
|
|
A07DA05
|
Loperamide oxide
|
|
|
|
|
|
A07DA06
|
eluxadoline
|
|
|
|
|
|
A07DA52
|
Morphine, combinations
|
|
|
|
|
|
A07DA53
|
Loperamide, combinations
|
|
|
|
A07E
|
|
|
Intestinal anti-inflammatory agents
|
|
|
|
|
A07EA
|
|
Corticosteroids acting locally
|
|
|
|
|
|
A07EA01
|
Prednisolone
|
|
|
|
|
|
A07EA02
|
Hydrocortisone
|
|
|
|
|
|
A07EA03
|
Prednisone
|
|
|
|
|
|
A07EA04
|
Betamethasone
|
|
|
|
|
|
A07EA05
|
Tixocortol
|
|
|
|
|
|
A07EA06
|
Budesonide
|
|
|
|
|
|
A07EA07
|
Beclometasone
|
|
|
|
|
A07EB
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
A07EB01
|
Cromoglicic acid
|
|
|
|
|
A07EC
|
|
Aminosalicylic acid and similar agents
|
|
|
|
|
|
A07EC01
|
Sulfasalazine
|
|
|
|
|
|
A07EC02
|
Mesalazine
|
|
|
|
|
|
A07EC03
|
Olsalazine
|
|
|
|
|
|
A07EC04
|
Balsalazide
|
|
|
|
A07F
|
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
A07FA
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
|
A07FA01
|
Lactic acid producing organisms
|
|
|
|
|
|
A07FA02
|
Saccharomyces boulardii
|
|
|
|
|
|
A07FA51
|
Lactic acid producing organisms, combinations
|
|
|
|
A07X
|
|
|
Other antidiarrheals
|
|
|
|
|
A07XA
|
|
Other antidiarrheals
|
|
|
|
|
|
A07XA01
|
Albumin tannate
|
|
|
|
|
|
A07XA02
|
Ceratonia
|
|
|
|
|
|
A07XA03
|
Calcium compounds
|
|
|
|
|
|
A07XA04
|
Racecadotril
|
|
|
|
|
|
A07XA51
|
Albumin tannate, combinations
|
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
A08A
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
|
A08AA
|
|
Centrally acting antiobesity products
|
|
|
|
|
|
A08AA01
|
Phentermine
|
|
|
|
|
|
A08AA02
|
Fenfluramine
|
|
|
|
|
|
A08AA03
|
Amfepramone
|
|
|
|
|
|
A08AA04
|
Dexfenfluramine
|
|
|
|
|
|
A08AA05
|
Mazindol
|
|
|
|
|
|
A08AA06
|
Etilamfetamine
|
|
|
|
|
|
A08AA07
|
Cathine
|
|
|
|
|
|
A08AA08
|
Clobenzorex
|
|
|
|
|
|
A08AA09
|
Mefenorex
|
|
|
|
|
|
A08AA10
|
Sibutramine
|
|
|
|
|
|
A08AA11
|
lorcaserin
|
|
|
|
|
|
A08AA12
|
setmelanotide
|
|
|
|
|
|
A08AA51
|
phentermine and topiramate
|
|
|
|
|
|
A08AA56
|
Ephedrine, combinations
|
|
|
|
|
|
A08AA62
|
bupropion and naltrexone
|
|
|
|
|
A08AB
|
|
Peripherally acting antiobesity products
|
|
|
|
|
|
A08AB01
|
Orlistat
|
|
|
|
|
A08AX
|
|
Other antiobesity drugs
|
|
|
|
|
|
A08AX01
|
Rimonabant
|
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
|
A09A
|
|
|
Digestives, including enzymes
|
|
|
|
|
A09AA
|
|
Enzyme preparations
|
|
|
|
|
|
A09AA01
|
Diastase
|
|
|
|
|
|
A09AA02
|
Multienzymes (lipase, protease, etc.)
|
|
|
|
|
|
A09AA03
|
Pepsin
|
|
|
|
|
|
A09AA04
|
Tilactase
|
|
|
|
|
A09AB
|
|
Acid preparations
|
|
|
|
|
|
A09AB01
|
Glutamic acid hydrochloride
|
|
|
|
|
|
A09AB02
|
Betaine hydrochloride
|
|
|
|
|
|
A09AB03
|
Hydrochloric acid
|
|
|
|
|
|
A09AB04
|
Citric acid
|
|
|
|
|
A09AC
|
|
Enzyme and acid preparations, combinations
|
|
|
|
|
|
A09AC01
|
Pepsin and acid preparations
|
|
|
|
|
|
A09AC02
|
Multienzymes and acid preparations
|
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
|
|
A10BD14
|
metformin and repaglinide
|
|
|
|
|
|
A10BD15
|
metformin and dapagliflozin
|
|
|
|
|
|
A10BD16
|
metformin and canagliflozin
|
|
|
|
|
|
A10BD17
|
metformin and acarbose
|
|
|
|
|
|
A10BD18
|
metformin and gemigliptin
|
|
|
|
|
|
A10BD19
|
linagliptin and empagliflozin
|
|
|
|
|
|
A10BD20
|
metformin and empagliflozin
|
|
|
|
|
|
A10BD21
|
saxagliptin and dapagliflozin
|
|
|
|
|
|
A10BD22
|
metformin and evogliptin
|
|
|
|
|
|
A10BD23
|
metformin and ertugliflozin
|
|
|
|
|
|
A10BD24
|
sitagliptin and ertugliflozin
|
|
|
|
|
|
A10BD25
|
metformin, saxagliptin and dapagliflozin
|
|
|
|
|
|
A10BD26
|
metformin and lobeglitazone
|
|
|
|
|
|
A10BD27
|
metformin, linagliptin and empagliflozin
|
|
|
|
|
|
A10BD28
|
metformin and teneligliptin
|
|
|
|
|
|
A10BD29
|
sitagliptin and dapagliflozin
|
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
|
A10BH06
|
gemigliptin
|
|
|
|
|
|
A10BH07
|
evogliptin
|
|
|
|
|
|
A10BH08
|
eneligliptin
|
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
|
|
A10BH52
|
gemigliptin and rosuvastatin
|
|
|
|
|
A10BJ
|
|
Glucagon-like peptide-1 (GLP-1) analogues
|
|
|
|
|
|
A10BJ01
|
exenatide
|
|
|
|
|
|
A10BJ02
|
liraglutide
|
|
|
|
|
|
A10BJ03
|
lixisenatide
|
|
|
|
|
|
A10BJ04
|
albiglutide
|
|
|
|
|
|
A10BJ05
|
dulaglutide
|
|
|
|
|
|
A10BJ06
|
semaglutide
|
|
|
|
|
|
A10BJ07
|
beinaglutide
|
|
|
|
|
A10BK
|
|
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
|
|
|
|
|
|
A10BK01
|
Dapagliflozin
|
|
|
|
|
|
A10BK02
|
Canagliflozin
|
|
|
|
|
|
A10BK03
|
Empagliflozin
|
|
|
|
|
|
A10BK04
|
Ertugliflozin
|
|
|
|
|
|
A10BK05
|
Ipragliflozin
|
|
|
|
|
|
A10BK06
|
Sotagliflozin
|
|
|
|
|
|
A10BK07
|
Luseogliflozin
|
|
|
|
|
|
A10BK08
|
bexagliflozin
|
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
|
A10BX04
|
Exenatide (בוטל, קוד חדש A10BJ01)
|
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
|
A10BX07
|
Liraglutide (בוטל, קוד חדש A10BJ02)
|
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
|
A10BX09
|
Dapagliflozin (בוטל, קוד חדש A10BK01)
|
|
|
|
|
|
A10BX10
|
lixisenatide (בוטל, קוד חדש A10BJ03)
|
|
|
|
|
|
A10BX11
|
canagliflozin (בוטל, קוד חדש A10BK02)
|
|
|
|
|
|
A10BX12
|
empagliflozin (בוטל, קוד חדש A10BK03)
|
|
|
|
|
|
A10BX13
|
albiglutide (בוטל, קוד חדש A10BJ04)
|
|
|
|
|
|
A10BX14
|
dulaglutide (בוטל, קוד חדש A10BJ05)
|
|
|
|
|
|
A10BX15
|
imeglimin
|
|
|
|
|
|
A10BX16
|
tirzepatide
|
|
|
|
|
|
A10BX17
|
carfloglitazar
|
|
|
|
|
|
A10BX18
|
dorzagliatin
|
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
|
A11
|
|
|
|
Vitamins
|
|
|
|
A11A
|
|
|
Multivitamins, combinations
|
|
|
|
|
A11AA
|
|
Multivitamins with minerals
|
|
|
|
|
|
A11AA01
|
Multivitamins and iron
|
|
|
|
|
|
A11AA02
|
Multivitamins and calcium
|
|
|
|
|
|
A11AA03
|
Multivitamins and other minerals, including combinations
|
|
|
|
|
|
A11AA04
|
Multivitamins and trace elements
|
|
|
|
|
A11AB
|
|
Multivitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11B
|
|
|
Multivitamins, plain
|
|
|
|
|
A11BA
|
|
Multivitamins, plain
|
|
|
|
|
|
|
empty
|
|
|
|
A11C
|
|
|
Vitamin A and D, including combinations of the two
|
|
|
|
|
A11CA
|
|
Vitamin A, plain
|
|
|
|
|
|
A11CA01
|
Retinol (vitamin A)
|
|
|
|
|
|
A11CA02
|
Betacarotene
|
|
|
|
|
A11CB
|
|
Vitamin A and D in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11CC
|
|
Vitamin D and analogues
|
|
|
|
|
|
A11CC01
|
Ergocalciferol
|
|
|
|
|
|
A11CC02
|
Dihydrotachysterol
|
|
|
|
|
|
A11CC03
|
Alfacalcidol
|
|
|
|
|
|
A11CC04
|
Calcitriol
|
|
|
|
|
|
A11CC05
|
Colecalciferol
|
|
|
|
|
|
A11CC06
|
Calcifediol
|
|
|
|
|
|
A11CC07
|
paricalcitol (בוטל, קוד חדש H05BX02)
|
|
|
|
|
|
A11CC20
|
Combinations
|
|
|
|
A11D
|
|
|
Vitamin B1, plain and in combination with vitamin B6 and B12
|
|
|
|
|
A11DA
|
|
Vitamin B1, plain
|
|
|
|
|
|
A11DA01
|
Thiamine (vitamin B1)
|
|
|
|
|
|
A11DA02
|
Sulbutiamine
|
|
|
|
|
|
A11DA03
|
Benfotiamine
|
|
|
|
|
A11DB
|
|
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
|
|
|
|
|
|
|
empty
|
|
|
|
A11E
|
|
|
Vitamin B-complex, including combinations
|
|
|
|
|
A11EA
|
|
Vitamin B-complex, plain
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EB
|
|
Vitamin B-complex with vitamin C
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EC
|
|
Vitamin B-complex with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11ED
|
|
Vitamin B-complex with anabolic steroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EX
|
|
Vitamin B-complex, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11G
|
|
|
Ascorbic acid (vitamin C), including combinations
|
|
|
|
|
A11GA
|
|
Ascorbic acid (vitamin C), plain
|
|
|
|
|
|
A11GA01
|
Ascorbic acid (vitamin C)
|
|
|
|
|
A11GB
|
|
Ascorbic acid (vitamin C), combinations
|
|
|
|
|
|
A11GB01
|
Ascorbic acid (vitamin C) and calcium
|
|
|
|
A11H
|
|
|
Other plain vitamin preparations
|
|
|
|
|
A11HA
|
|
Other plain vitamin preparations
|
|
|
|
|
|
A11HA01
|
Nicotinamide
|
|
|
|
|
|
A11HA02
|
Pyridoxine (vitamin B6)
|
|
|
|
|
|
A11HA03
|
Tocopherol (vitamin E)
|
|
|
|
|
|
A11HA04
|
Riboflavin (vitamin B2)
|
|
|
|
|
|
A11HA05
|
Biotin
|
|
|
|
|
|
A11HA06
|
Pyridoxal phosphate
|
|
|
|
|
|
A11HA07
|
Inositol
|
|
|
|
|
|
A11HA08
|
Tocofersolan
|
|
|
|
|
|
A11HA30
|
Dexpanthenol
|
|
|
|
|
|
A11HA31
|
Calcium pantothenate
|
|
|
|
|
|
A11HA32
|
Pantethine
|
|
|
|
A11J
|
|
|
Other vitamin products, combinations
|
|
|
|
|
A11JA
|
|
Combinations of vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JB
|
|
Vitamins with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JC
|
|
Vitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
|
A12A
|
|
|
Calcium
|
|
|
|
|
A12AA
|
|
Calcium
|
|
|
|
|
|
A12AA01
|
Calcium phosphate
|
|
|
|
|
|
A12AA02
|
Calcium glubionate
|
|
|
|
|
|
A12AA03
|
Calcium gluconate
|
|
|
|
|
|
A12AA04
|
Calcium carbonate
|
|
|
|
|
|
A12AA05
|
Calcium lactate
|
|
|
|
|
|
A12AA06
|
Calcium lactate gluconate
|
|
|
|
|
|
A12AA07
|
Calcium chloride
|
|
|
|
|
|
A12AA08
|
Calcium glycerylphosphate
|
|
|
|
|
|
A12AA09
|
Calcium citrate lysine complex
|
|
|
|
|
|
A12AA10
|
Calcium glucoheptonate
|
|
|
|
|
|
A12AA11
|
Calcium pangamate
|
|
|
|
|
|
A12AA12
|
Calcium acetate anhydrous (בוטל, קוד חדש V03AE07)
|
|
|
|
|
|
A12AA20
|
Calcium (different salts in combination)
|
|
|
|
|
|
A12AA30
|
Calcium laevulate
|
|
|
|
|
A12AX
|
|
Calcium, combinations with vitamin D and/or other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
|
A12BA
|
|
Potassium
|
|
|
|
|
|
A12BA01
|
Potassium chloride
|
|
|
|
|
|
A12BA02
|
Potassium citrate
|
|
|
|
|
|
A12BA03
|
Potassium hydrogentartrate
|
|
|
|
|
|
A12BA04
|
Potassium hydrogencarbonate
|
|
|
|
|
|
A12BA05
|
Potassium gluconate
|
|
|
|
|
|
A12BA30
|
Combinations
|
|
|
|
|
|
A12BA51
|
Potassium chloride, combinations
|
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
|
A12CA01
|
Sodium chloride
|
|
|
|
|
|
A12CA02
|
Sodium sulfate
|
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
|
A12CB01
|
Zinc sulfate
|
|
|
|
|
|
A12CB02
|
Zinc gluconate
|
|
|
|
|
|
A12CB03
|
Zinc protein complex
|
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
|
A12CC01
|
Magnesium chloride
|
|
|
|
|
|
A12CC02
|
Magnesium sulfate
|
|
|
|
|
|
A12CC03
|
Magnesium gluconate
|
|
|
|
|
|
A12CC04
|
Magnesium citrate
|
|
|
|
|
|
A12CC05
|
Magnesium aspartate
|
|
|
|
|
|
A12CC06
|
Magnesium lactate
|
|
|
|
|
|
A12CC07
|
Magnesium levulinate
|
|
|
|
|
|
A12CC08
|
Magnesium pidolate
|
|
|
|
|
|
A12CC09
|
Magnesium orotate
|
|
|
|
|
|
A12CC10
|
Magnesium oxide
|
|
|
|
|
|
A12CC30
|
Magnesium (different salts in combination)
|
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
|
A12CD01
|
Sodium fluoride
|
|
|
|
|
|
A12CD02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A12CD51
|
Fluoride, combinations
|
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
|
A12CE01
|
Sodium selenate
|
|
|
|
|
|
A12CE02
|
Sodium selenite
|
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
|
empty
|
|
|
A13
|
|
|
|
Tonics
|
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
|
empty
|
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
|
A14A
|
|
|
Anabolic steroids
|
|
|
|
|
A14AA
|
|
Androstan derivatives
|
|
|
|
|
|
A14AA01
|
Androstanolone
|
|
|
|
|
|
A14AA02
|
Stanozolol
|
|
|
|
|
|
A14AA03
|
Metandienone
|
|
|
|
|
|
A14AA04
|
Metenolone
|
|
|
|
|
|
A14AA05
|
Oxymetholone
|
|
|
|
|
|
A14AA06
|
Quinbolone
|
|
|
|
|
|
A14AA07
|
Prasterone
|
|
|
|
|
|
A14AA08
|
Oxandrolone
|
|
|
|
|
|
A14AA09
|
Norethandrolone
|
|
|
|
|
A14AB
|
|
Estren derivatives
|
|
|
|
|
|
A14AB01
|
Nandrolone
|
|
|
|
|
|
A14AB02
|
Ethylestrenol
|
|
|
|
|
|
A14AB03
|
Oxabolone cipionate
|
|
|
|
A14B
|
|
|
Other anabolic agents
|
|
|
|
|
|
|
empty
|
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
|
empty
|
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
A16A
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
|
A16AA
|
|
Amino acids and derivatives
|
|
|
|
|
|
A16AA01
|
Levocarnitine
|
|
|
|
|
|
A16AA02
|
Ademetionine
|
|
|
|
|
|
A16AA03
|
Levoglutamide
|
|
|
|
|
|
A16AA04
|
Mercaptamine
|
|
|
|
|
|
A16AA05
|
Carglumic acid
|
|
|
|
|
|
A16AA06
|
Betaine
|
|
|
|
|
A16AB
|
|
Enzymes
|
|
|
|
|
|
A16AB01
|
Alglucerase
|
|
|
|
|
|
A16AB02
|
Imiglucerase
|
|
|
|
|
|
A16AB03
|
Agalsidase alfa
|
|
|
|
|
|
A16AB04
|
Agalsidase beta
|
|
|
|
|
|
A16AB05
|
Laronidase
|
|
|
|
|
|
A16AB06
|
Sacrosidase
|
|
|
|
|
|
A16AB07
|
Alglucosidase alfa
|
|
|
|
|
|
A16AB08
|
Galsulfase
|
|
|
|
|
|
A16AB09
|
Idursulfase
|
|
|
|
|
|
A16AB10
|
Velaglucerase alfa
|
|
|
|
|
|
A16AB11
|
Taliglucerase alfa
|
|
|
|
|
|
A16AB12
|
elosulfase alfa
|
|
|
|
|
|
A16AB13
|
asfotase alfa
|
|
|
|
|
|
A16AB14
|
sebelipase alfa
|
|
|
|
|
|
A16AB15
|
velmanase alfa
|
|
|
|
|
|
A16AB16
|
idursulfase beta
|
|
|
|
|
|
A16AB17
|
cerliponase alfa
|
|
|
|
|
|
A16AB18
|
vestronidase alfa
|
|
|
|
|
|
A16AB19
|
pegvaliase
|
|
|
|
|
|
A16AB20
|
pegunigalsidase alfa
|
|
|
|
|
|
A16AB21
|
atidarsagene autotemcel
|
|
|
|
|
|
A16AB22
|
avalglucosidase alfa
|
|
|
|
|
|
A16AB23
|
cipaglucosidase alfa
|
|
|
|
|
|
A16AB24
|
pegzilarginase
|
|
|
|
|
|
A16AB25
|
olipudase alfa
|
|
|
|
|
|
A16AB26
|
eladocagene exuparvovec
|
|
|
|
|
|
A16AB27
|
pabinafusp alfa
|
|
|
|
|
A16AX
|
|
Various alimentary tract and metabolism products
|
|
|
|
|
|
A16AX01
|
Thioctic acid
|
|
|
|
|
|
A16AX02
|
Anethole trithione
|
|
|
|
|
|
A16AX03
|
Sodium phenylbutyrate
|
|
|
|
|
|
A16AX04
|
Nitisinone
|
|
|
|
|
|
A16AX05
|
Zinc acetate
|
|
|
|
|
|
A16AX06
|
Miglustat
|
|
|
|
|
|
A16AX07
|
Sapropterin
|
|
|
|
|
|
A16AX08
|
Teduglutide
|
|
|
|
|
|
A16AX09
|
Glycerol phenylbutyrate
|
|
|
|
|
|
A16AX10
|
eliglustat
|
|
|
|
|
|
A16AX11
|
sodium benzoate
|
|
|
|
|
|
A16AX12
|
trientine
|
|
|
|
|
|
A16AX13
|
uridine triacetate
|
|
|
|
|
|
A16AX14
|
migalastat
|
|
|
|
|
|
A16AX15
|
telotristat
|
|
|
|
|
|
A16AX16
|
givosiran
|
|
|
|
|
|
A16AX17
|
triheptanoin
|
|
|
|
|
|
A16AX18
|
lumasiran
|
|
|
|
|
|
A16AX19
|
fosdenopterin
|
|
|
|
|
|
A16AX20
|
lonafarnib
|
|
|
|
|
|
A16AX21
|
elivaldogene autotemcel
|
|
|
|
|
|
A16AX22
|
tiomolibdic acid
|
|
|
|
|
|
A16AX30
|
sodium benzoate and sodium phenylacetate
|
| B
|
|
|
|
|
Blood and blood forming organs
|
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
|
B01AC14
|
anagrelide (בוטל, קוד חדש L01XX35)
|
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
|
|
B01AF03
|
edoxaban
|
|
|
|
|
|
B01AF04
|
betrixaban
|
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
|
|
|
|
B01AX06
|
rivaroxaban (בוטל, קוד חדש B01AF01)
|
|
|
|
|
|
B01AX07
|
caplacizumab
|
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
|
|
B02A
|
|
|
Antifibrinolytics
|
|
|
|
|
B02AA
|
|
Amino acids
|
|
|
|
|
|
B02AA01
|
Aminocaproic acid
|
|
|
|
|
|
B02AA02
|
Tranexamic acid
|
|
|
|
|
|
B02AA03
|
Aminomethylbenzoic acid
|
|
|
|
|
B02AB
|
|
Proteinase inhibitors
|
|
|
|
|
|
B02AB01
|
Aprotinin
|
|
|
|
|
|
B02AB02
|
Alfa1 antitrypsin
|
|
|
|
|
|
B02AB03
|
c1-inhibitor, plasma derived (בוטל, קוד חדש B06AC01)
|
|
|
|
|
|
B02AB04
|
Camostat
|
|
|
|
B02B
|
|
|
Vitamin K and other hemostatics
|
|
|
|
|
B02BA
|
|
Vitamin K
|
|
|
|
|
|
B02BA01
|
Phytomenadione
|
|
|
|
|
|
B02BA02
|
Menadione
|
|
|
|
|
B02BB
|
|
Fibrinogen
|
|
|
|
|
|
B02BB01
|
Human fibrinogen
|
|
|
|
|
B02BC
|
|
Local hemostatics
|
|
|
|
|
|
B02BC01
|
Absorbable gelatin sponge
|
|
|
|
|
|
B02BC02
|
Oxidized cellulose
|
|
|
|
|
|
B02BC03
|
Tetragalacturonic acid hydroxymethylester
|
|
|
|
|
|
B02BC05
|
Adrenalone
|
|
|
|
|
|
B02BC06
|
Thrombin
|
|
|
|
|
|
B02BC07
|
Collagen
|
|
|
|
|
|
B02BC08
|
Calcium alginate
|
|
|
|
|
|
B02BC09
|
Epinephrine
|
|
|
|
|
|
B02BC10
|
Fibrinogen, human (בוטל, קוד חדש B02BC30)
|
|
|
|
|
|
B02BC30
|
Combinations
|
|
|
|
|
B02BD
|
|
Blood coagulation factors
|
|
|
|
|
|
B02BD01
|
Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
|
|
|
|
|
|
B02BD02
|
Coagulation factor VIII
|
|
|
|
|
|
B02BD03
|
Factor VIII inhibitor bypassing activity
|
|
|
|
|
|
B02BD04
|
Coagulation factor IX
|
|
|
|
|
|
B02BD05
|
Coagulation factor VII
|
|
|
|
|
|
B02BD06
|
Von Willebrand factor and coagulation factor VIII in combination
|
|
|
|
|
|
B02BD07
|
Coagulation factor XIII
|
|
|
|
|
|
B02BD08
|
Eptacog alfa (activated)
|
|
|
|
|
|
B02BD09
|
Nonacog alfa (בוטל, קוד חדש B02BD04)
|
|
|
|
|
|
B02BD10
|
von Willebrand factor
|
|
|
|
|
|
B02BD11
|
Catridecacog
|
|
|
|
|
|
B02BD12
|
Trenonacog alfa (בוטל, קוד חדש B02BD04)
|
|
|
|
|
|
B02BD30
|
Thrombin
|
|
|
|
|
B02BX
|
|
Other systemic hemostatics
|
|
|
|
|
|
B02BX01
|
Etamsylate
|
|
|
|
|
|
B02BX02
|
Carbazochrome
|
|
|
|
|
|
B02BX03
|
Batroxobin
|
|
|
|
|
|
B02BX04
|
Romiplostim
|
|
|
|
|
|
B02BX05
|
Eltrombopag
|
|
|
|
|
|
B02BX06
|
emicizumab
|
|
|
|
|
|
B02BX07
|
lusutrombopag
|
|
|
|
|
|
B02BX08
|
avatrombopag
|
|
|
|
|
|
B02BX09
|
fostamatinib
|
|
|
B03
|
|
|
|
Antianemic preparations
|
|
|
|
B03A
|
|
|
Iron preparations
|
|
|
|
|
B03AA
|
|
Iron bivalent, oral preparations
|
|
|
|
|
|
B03AA01
|
Ferrous glycine sulfate
|
|
|
|
|
|
B03AA02
|
Ferrous fumarate
|
|
|
|
|
|
B03AA03
|
Ferrous gluconate
|
|
|
|
|
|
B03AA04
|
Ferrous carbonate
|
|
|
|
|
|
B03AA05
|
Ferrous chloride
|
|
|
|
|
|
B03AA06
|
Ferrous succinate
|
|
|
|
|
|
B03AA07
|
Ferrous sulfate
|
|
|
|
|
|
B03AA08
|
Ferrous tartrate
|
|
|
|
|
|
B03AA09
|
Ferrous aspartate
|
|
|
|
|
|
B03AA10
|
Ferrous ascorbate
|
|
|
|
|
|
B03AA11
|
Ferrous iodine
|
|
|
|
|
B03AB
|
|
Iron trivalent, oral preparations
|
|
|
|
|
|
B03AB01
|
Ferric sodium citrate
|
|
|
|
|
|
B03AB02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AB03
|
Sodium feredetate
|
|
|
|
|
|
B03AB04
|
Ferric hydroxide
|
|
|
|
|
|
B03AB05
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AB06
|
Ferric citrate (בוטל, קוד חדש V03AE08)
|
|
|
|
|
|
B03AB07
|
Chondroitin sulfate-iron complex
|
|
|
|
|
|
B03AB08
|
Ferric acetyl transferrin
|
|
|
|
|
|
B03AB09
|
Ferric proteinsuccinylate
|
|
|
|
|
B03AC
|
|
Iron trivalent, parenteral preparations
|
|
|
|
|
|
B03AC01
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AC02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AC03
|
Iron-sorbitol-citric acid complex
|
|
|
|
|
|
B03AC05
|
Ferric sorbitol gluconic acid complex
|
|
|
|
|
|
B03AC06
|
Ferric oxide dextran complexes
|
|
|
|
|
|
B03AC07
|
Ferric sodium gluconate complex
|
|
|
|
|
B03AD
|
|
Iron in combination with folic acid
|
|
|
|
|
|
B03AD01
|
Ferrous amino acid complex
|
|
|
|
|
|
B03AD02
|
Ferrous fumarate
|
|
|
|
|
|
B03AD03
|
Ferrous sulfate
|
|
|
|
|
|
B03AD04
|
Ferric oxide polymaltose complexes
|
|
|
|
|
B03AE
|
|
Iron in other combinations
|
|
|
|
|
|
B03AE01
|
Iron, vitamin B12 and folic acid
|
|
|
|
|
|
B03AE02
|
Iron, multivitamins and folic acid
|
|
|
|
|
|
B03AE03
|
Iron and multivitamins
|
|
|
|
|
|
B03AE04
|
Iron, multivitamins and minerals
|
|
|
|
|
|
B03AE10
|
Various combinations
|
|
|
|
B03B
|
|
|
Vitamin B12 and folic acid
|
|
|
|
|
B03BA
|
|
Vitamin B12 (cyanocobalamin and analogues)
|
|
|
|
|
|
B03BA01
|
Cyanocobalamin
|
|
|
|
|
|
B03BA02
|
Cyanocobalamin tannin complex
|
|
|
|
|
|
B03BA03
|
Hydroxocobalamin
|
|
|
|
|
|
B03BA04
|
Cobamamide
|
|
|
|
|
|
B03BA05
|
Mecobalamin
|
|
|
|
|
|
B03BA51
|
Cyanocobalamin, combinations
|
|
|
|
|
|
B03BA53
|
Hydroxocobalamin, combinations
|
|
|
|
|
B03BB
|
|
Folic acid and derivatives
|
|
|
|
|
|
B03BB01
|
Folic acid
|
|
|
|
|
|
B03BB51
|
Folic acid, combinations
|
|
|
|
B03X
|
|
|
Other antianemic preparations
|
|
|
|
|
B03XA
|
|
Other antianemic preparations
|
|
|
|
|
|
B03XA01
|
Erythropoietin
|
|
|
|
|
|
B03XA02
|
Darbepoetin alfa
|
|
|
|
|
|
B03XA03
|
Methoxy polyethylene glycol-epoetin beta
|
|
|
|
|
|
B03XA04
|
Peginesatide
|
|
|
|
|
|
B03XA05
|
roxadustat
|
|
|
|
|
|
B03XA06
|
luspatercept
|
|
|
|
|
|
B03XA07
|
daprodustat
|
|
|
|
|
|
B03XA08
|
vadadustat
|
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
|
|
|
|
|
empty
|
|
|
B06
|
|
|
|
Other hematological agents
|
|
|
|
B06A
|
|
|
Other hematological agents
|
|
|
|
|
B06AA
|
|
Enzymes
|
|
|
|
|
|
B06AA02
|
Fibrinolysin and desoxyribonuclease
|
|
|
|
|
|
B06AA03
|
Hyaluronidase
|
|
|
|
|
|
B06AA04
|
Chymotrypsin
|
|
|
|
|
|
B06AA07
|
Trypsin
|
|
|
|
|
|
B06AA10
|
Desoxyribonuclease
|
|
|
|
|
|
B06AA11
|
Bromelain (בוטל, קוד חדש D03BA03)
|
|
|
|
|
|
B06AA55
|
Streptokinase, combinations
|
|
|
|
|
B06AB
|
|
Other hematological products
|
|
|
|
|
|
B06AB01
|
Hematin
|
|
|
|
|
B06AC
|
|
Drugs used in hereditary angioedema
|
|
|
|
|
|
B06AC01
|
C1-inhibitor, plasma derived
|
|
|
|
|
|
B06AC02
|
Icatibant
|
|
|
|
|
|
B06AC03
|
Ecallantide
|
|
|
|
|
|
B06AC04
|
Conestat alfa
|
| C
|
|
|
|
|
Cardiovascular system
|
|
|
C01
|
|
|
|
Cardiac therapy
|
|
|
|
C01A
|
|
|
Cardiac glycosides
|
|
|
|
|
C01AA
|
|
Digitalis glycosides
|
|
|
|
|
|
C01AA01
|
Acetyldigitoxin
|
|
|
|
|
|
C01AA02
|
Acetyldigoxin
|
|
|
|
|
|
C01AA03
|
Digitalis leaves
|
|
|
|
|
|
C01AA04
|
Digitoxin
|
|
|
|
|
|
C01AA05
|
Digoxin
|
|
|
|
|
|
C01AA06
|
Lanatoside C
|
|
|
|
|
|
C01AA07
|
Deslanoside
|
|
|
|
|
|
C01AA08
|
Metildigoxin
|
|
|
|
|
|
C01AA09
|
Gitoformate
|
|
|
|
|
|
C01AA52
|
Acetyldigoxin, combinations
|
|
|
|
|
C01AB
|
|
Scilla glycosides
|
|
|
|
|
|
C01AB01
|
Proscillaridin
|
|
|
|
|
|
C01AB51
|
Proscillaridin, combinations
|
|
|
|
|
C01AC
|
|
Strophantus glycosides
|
|
|
|
|
|
C01AC01
|
G-strophanthin
|
|
|
|
|
|
C01AC03
|
Cymarin
|
|
|
|
|
C01AX
|
|
Other cardiac glycosides
|
|
|
|
|
|
C01AX02
|
Peruvoside
|
|
|
|
C01B
|
|
|
Antiarrhythmics, class I and III
|
|
|
|
|
C01BA
|
|
Antiarrhythmics, class Ia
|
|
|
|
|
|
C01BA01
|
Quinidine
|
|
|
|
|
|
C01BA02
|
Procainamide
|
|
|
|
|
|
C01BA03
|
Disopyramide
|
|
|
|
|
|
C01BA04
|
Sparteine
|
|
|
|
|
|
C01BA05
|
Ajmaline
|
|
|
|
|
|
C01BA08
|
Prajmaline
|
|
|
|
|
|
C01BA12
|
Lorajmine
|
|
|
|
|
|
C01BA51
|
Quinidine, combinations excluding psycholeptics
|
|
|
|
|
|
C01BA71
|
Quinidine, combinations with psycholeptics
|
|
|
|
|
C01BB
|
|
Antiarrhythmics, class Ib
|
|
|
|
|
|
C01BB01
|
Lidocaine
|
|
|
|
|
|
C01BB02
|
Mexiletine
|
|
|
|
|
|
C01BB03
|
Tocainide
|
|
|
|
|
|
C01BB04
|
Aprindine
|
|
|
|
|
C01BC
|
|
Antiarrhythmics, class Ic
|
|
|
|
|
|
C01BC03
|
Propafenone
|
|
|
|
|
|
C01BC04
|
Flecainide
|
|
|
|
|
|
C01BC07
|
Lorcainide
|
|
|
|
|
|
C01BC08
|
Encainide
|
|
|
|
|
|
C01BC09
|
Ethacizine
|
|
|
|
|
C01BD
|
|
Antiarrhythmics, class III
|
|
|
|
|
|
C01BD01
|
Amiodarone
|
|
|
|
|
|
C01BD02
|
Bretylium tosilate
|
|
|
|
|
|
C01BD03
|
Bunaftine
|
|
|
|
|
|
C01BD04
|
Dofetilide
|
|
|
|
|
|
C01BD05
|
Ibutilide
|
|
|
|
|
|
C01BD06
|
Tedisamil
|
|
|
|
|
|
C01BD07
|
Dronedarone
|
|
|
|
|
C01BG
|
|
Other antiarrhythmics, class I and III
|
|
|
|
|
|
C01BG01
|
Moracizine
|
|
|
|
|
|
C01BG07
|
Cibenzoline
|
|
|
|
|
|
C01BG11
|
Vernakalant
|
|
|
|
C01C
|
|
|
Cardiac stimulants excluding cardiac glycosides
|
|
|
|
|
C01CA
|
|
Adrenergic and dopaminergic agents
|
|
|
|
|
|
C01CA01
|
Etilefrine
|
|
|
|
|
|
C01CA02
|
Isoprenaline
|
|
|
|
|
|
C01CA03
|
Norepinephrine
|
|
|
|
|
|
C01CA04
|
Dopamine
|
|
|
|
|
|
C01CA05
|
Norfenefrine
|
|
|
|
|
|
C01CA06
|
Phenylephrine
|
|
|
|
|
|
C01CA07
|
Dobutamine
|
|
|
|
|
|
C01CA08
|
Oxedrine
|
|
|
|
|
|
C01CA09
|
Metaraminol
|
|
|
|
|
|
C01CA10
|
Methoxamine
|
|
|
|
|
|
C01CA11
|
Mephentermine
|
|
|
|
|
|
C01CA12
|
Dimetofrine
|
|
|
|
|
|
C01CA13
|
Prenalterol
|
|
|
|
|
|
C01CA14
|
Dopexamine
|
|
|
|
|
|
C01CA15
|
Gepefrine
|
|
|
|
|
|
C01CA16
|
Ibopamine
|
|
|
|
|
|
C01CA17
|
Midodrine
|
|
|
|
|
|
C01CA18
|
Octopamine
|
|
|
|
|
|
C01CA19
|
Fenoldopam
|
|
|
|
|
|
C01CA21
|
Cafedrine
|
|
|
|
|
|
C01CA22
|
Arbutamine
|
|
|
|
|
|
C01CA23
|
Theodrenaline
|
|
|
|
|
|
C01CA24
|
Epinephrine
|
|
|
|
|
|
C01CA25
|
Amezinium metilsulfate
|
|
|
|
|
|
C01CA26
|
Ephedrine
|
|
|
|
|
|
C01CA27
|
droxidopa
|
|
|
|
|
|
C01CA30
|
Combinations
|
|
|
|
|
|
C01CA51
|
Etilefrine, combinations
|
|
|
|
|
C01CE
|
|
Phosphodiesterase inhibitors
|
|
|
|
|
|
C01CE01
|
Amrinone
|
|
|
|
|
|
C01CE02
|
Milrinone
|
|
|
|
|
|
C01CE03
|
Enoximone
|
|
|
|
|
|
C01CE04
|
Bucladesine
|
|
|
|
|
C01CX
|
|
Other cardiac stimulants
|
|
|
|
|
|
C01CX06
|
Angiotensinamide
|
|
|
|
|
|
C01CX07
|
Xamoterol
|
|
|
|
|
|
C01CX08
|
Levosimendan
|
|
|
|
C01D
|
|
|
Vasodilators used in cardiac diseases
|
|
|
|
|
C01DA
|
|
Organic nitrates
|
|
|
|
|
|
C01DA02
|
Glyceryl trinitrate
|
|
|
|
|
|
C01DA04
|
Methylpropylpropanediol dinitrate
|
|
|
|
|
|
C01DA05
|
Pentaerithrityl tetranitrate
|
|
|
|
|
|
C01DA07
|
Propatylnitrate
|
|
|
|
|
|
C01DA08
|
Isosorbide dinitrate
|
|
|
|
|
|
C01DA09
|
Trolnitrate
|
|
|
|
|
|
C01DA13
|
Eritrityl tetranitrate
|
|
|
|
|
|
C01DA14
|
Isosorbide mononitrate
|
|
|
|
|
|
C01DA20
|
Organic nitrates in combination
|
|
|
|
|
|
C01DA38
|
Tenitramine
|
|
|
|
|
|
C01DA52
|
Glyceryl trinitrate, combinations
|
|
|
|
|
|
C01DA54
|
Methylpropylpropanediol dinitrate, combinations
|
|
|
|
|
|
C01DA55
|
Pentaerithrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA57
|
Propatylnitrate, combinations
|
|
|
|
|
|
C01DA58
|
Isosorbide dinitrate, combinations
|
|
|
|
|
|
C01DA59
|
Trolnitrate, combinations
|
|
|
|
|
|
C01DA63
|
Eritrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA70
|
Organic nitrates in combination with psycholeptics
|
|
|
|
|
C01DB
|
|
Quinolone vasodilators
|
|
|
|
|
|
C01DB01
|
Flosequinan
|
|
|
|
|
C01DX
|
|
Other vasodilators used in cardiac diseases
|
|
|
|
|
|
C01DX01
|
Itramin tosilate
|
|
|
|
|
|
C01DX02
|
Prenylamine
|
|
|
|
|
|
C01DX03
|
Oxyfedrine
|
|
|
|
|
|
C01DX04
|
Benziodarone
|
|
|
|
|
|
C01DX05
|
Carbocromen
|
|
|
|
|
|
C01DX06
|
Hexobendine
|
|
|
|
|
|
C01DX07
|
Etafenone
|
|
|
|
|
|
C01DX08
|
Heptaminol
|
|
|
|
|
|
C01DX09
|
Imolamine
|
|
|
|
|
|
C01DX10
|
Dilazep
|
|
|
|
|
|
C01DX11
|
Trapidil
|
|
|
|
|
|
C01DX12
|
Molsidomine
|
|
|
|
|
|
C01DX13
|
Efloxate
|
|
|
|
|
|
C01DX14
|
Cinepazet
|
|
|
|
|
|
C01DX15
|
Cloridarol
|
|
|
|
|
|
C01DX16
|
Nicorandil
|
|
|
|
|
|
C01DX18
|
Linsidomine
|
|
|
|
|
|
C01DX19
|
Nesiritide
|
|
|
|
|
|
C01DX51
|
Itramin tosilate, combinations
|
|
|
|
|
|
C01DX52
|
Prenylamine, combinations
|
|
|
|
|
|
C01DX53
|
Oxyfedrine, combinations
|
|
|
|
|
|
C01DX54
|
Benziodarone, combinations
|
|
|
|
C01E
|
|
|
Other cardiac preparations
|
|
|
|
|
C01EA
|
|
Prostaglandins
|
|
|
|
|
|
C01EA01
|
Alprostadil
|
|
|
|
|
C01EB
|
|
Other cardiac preparations
|
|
|
|
|
|
C01EB02
|
Camphor
|
|
|
|
|
|
C01EB03
|
Indometacin
|
|
|
|
|
|
C01EB04
|
Crataegus glycosides
|
|
|
|
|
|
C01EB05
|
Creatinolfosfate
|
|
|
|
|
|
C01EB06
|
Fosfocreatine
|
|
|
|
|
|
C01EB07
|
Fructose 1,6-diphosphate
|
|
|
|
|
|
C01EB09
|
Ubidecarenone
|
|
|
|
|
|
C01EB10
|
Adenosine
|
|
|
|
|
|
C01EB11
|
Tiracizine
|
|
|
|
|
|
C01EB12
|
tedisamil (בוטל, קוד חדש C01BD06)
|
|
|
|
|
|
C01EB13
|
Acadesine
|
|
|
|
|
|
C01EB15
|
Trimetazidine
|
|
|
|
|
|
C01EB16
|
Ibuprofen
|
|
|
|
|
|
C01EB17
|
Ivabradine
|
|
|
|
|
|
C01EB18
|
Ranolazine
|
|
|
|
|
|
C01EB19
|
icatibant (בוטל, קוד חדש B06AC02)
|
|
|
|
|
|
C01EB21
|
Regadenoson
|
|
|
|
|
C01EX
|
|
Other cardiac combination products
|
|
|
|
|
|
|
empty
|
|
|
C02
|
|
|
|
Antihypertensives
|
|
|
|
C02A
|
|
|
Antiadrenergic agents, centrally acting
|
|
|
|
|
C02AA
|
|
Rauvolfia alkaloids
|
|
|
|
|
|
C02AA01
|
Rescinnamine
|
|
|
|
|
|
C02AA02
|
Reserpine
|
|
|
|
|
|
C02AA03
|
Combinations of rauwolfia alkaloids
|
|
|
|
|
|
C02AA04
|
Rauwolfia alkaloids, whole root
|
|
|
|
|
|
C02AA05
|
Deserpidine
|
|
|
|
|
|
C02AA06
|
Methoserpidine
|
|
|
|
|
|
C02AA07
|
Bietaserpine
|
|
|
|
|
|
C02AA52
|
Reserpine, combinations
|
|
|
|
|
|
C02AA53
|
Combinations of rauwolfia alkoloids, combinations
|
|
|
|
|
|
C02AA57
|
Bietaserpine, combinations
|
|
|
|
|
C02AB
|
|
Methyldopa
|
|
|
|
|
|
C02AB01
|
Methyldopa (levorotatory)
|
|
|
|
|
|
C02AB02
|
Methyldopa (racemic)
|
|
|
|
|
C02AC
|
|
Imidazoline receptor agonists
|
|
|
|
|
|
C02AC01
|
Clonidine
|
|
|
|
|
|
C02AC02
|
Guanfacine
|
|
|
|
|
|
C02AC04
|
Tolonidine
|
|
|
|
|
|
C02AC05
|
Moxonidine
|
|
|
|
|
|
C02AC06
|
Rilmenidine
|
|
|
|
C02B
|
|
|
Antiadrenergic agents, ganglion-blocking
|
|
|
|
|
C02BA
|
|
Sulfonium derivatives
|
|
|
|
|
|
C02BA01
|
Trimetaphan
|
|
|
|
|
C02BB
|
|
Secondary and tertiary amines
|
|
|
|
|
|
C02BB01
|
Mecamylamine
|
|
|
|
|
C02BC
|
|
Bisquaternary ammonium compounds
|
|
|
|
|
|
|
empty
|
|
|
|
C02C
|
|
|
Antiadrenergic agents, peripherally acting
|
|
|
|
|
C02CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
C02CA01
|
Prazosin
|
|
|
|
|
|
C02CA02
|
Indoramin
|
|
|
|
|
|
C02CA03
|
Trimazosin
|
|
|
|
|
|
C02CA04
|
Doxazosin
|
|
|
|
|
|
C02CA06
|
Urapidil
|
|
|
|
|
C02CC
|
|
Guanidine derivatives
|
|
|
|
|
|
C02CC01
|
Betanidine
|
|
|
|
|
|
C02CC02
|
Guanethidine
|
|
|
|
|
|
C02CC03
|
Guanoxan
|
|
|
|
|
|
C02CC04
|
Debrisoquine
|
|
|
|
|
|
C02CC05
|
Guanoclor
|
|
|
|
|
|
C02CC06
|
Guanazodine
|
|
|
|
|
|
C02CC07
|
Guanoxabenz
|
|
|
|
C02D
|
|
|
Arteriolar smooth muscle, agents acting on
|
|
|
|
|
C02DA
|
|
Thiazide derivatives
|
|
|
|
|
|
C02DA01
|
Diazoxide
|
|
|
|
|
C02DB
|
|
Hydrazinophthalazine derivatives
|
|
|
|
|
|
C02DB01
|
Dihydralazine
|
|
|
|
|
|
C02DB02
|
Hydralazine
|
|
|
|
|
|
C02DB03
|
Endralazine
|
|
|
|
|
|
C02DB04
|
Cadralazine
|
|
|
|
|
C02DC
|
|
Pyrimidine derivatives
|
|
|
|
|
|
C02DC01
|
Minoxidil
|
|
|
|
|
C02DD
|
|
Nitroferricyanide derivatives
|
|
|
|
|
|
C02DD01
|
Nitroprusside
|
|
|
|
|
C02DG
|
|
Guanidine derivatives
|
|
|
|
|
|
C02DG01
|
Pinacidil
|
|
|
|
C02K
|
|
|
Other antihypertensives
|
|
|
|
|
C02KA
|
|
Alkaloids, excluding rauwolfia
|
|
|
|
|
|
C02KA01
|
Veratrum
|
|
|
|
|
C02KB
|
|
Tyrosine hydroxylase inhibitors
|
|
|
|
|
|
C02KB01
|
Metirosine
|
|
|
|
|
C02KC
|
|
MAO inhibitors
|
|
|
|
|
|
C02KC01
|
Pargyline
|
|
|
|
|
C02KD
|
|
Serotonin antagonists
|
|
|
|
|
|
C02KD01
|
Ketanserin
|
|
|
|
|
C02KX
|
|
Other antihypertensives
|
|
|
|
|
|
C02KX01
|
Bosentan
|
|
|
|
|
|
C02KX02
|
Ambrisentan
|
|
|
|
|
|
C02KX03
|
Sitaxentan
|
|
|
|
|
|
C02KX04
|
macitentan
|
|
|
|
|
|
C02KX05
|
riociguat
|
|
|
|
|
|
C02KX52
|
ambrisentan and tadalafil
|
|
|
|
C02L
|
|
|
Antihypertensives and diuretics in combination
|
|
|
|
|
C02LA
|
|
Rauwolfia alkaloids and diuretics in combination
|
|
|
|
|
|
C02LA01
|
Reserpine and diuretics
|
|
|
|
|
|
C02LA02
|
Rescinnamine and diuretics
|
|
|
|
|
|
C02LA03
|
Deserpidine and diuretics
|
|
|
|
|
|
C02LA04
|
Methoserpidine and diuretics
|
|
|
|
|
|
C02LA07
|
Bietaserpine and diuretics
|
|
|
|
|
|
C02LA08
|
Rauwolfia alkaloids, whole root and diuretics
|
|
|
|
|
|
C02LA09
|
Syrosingopine and diuretics
|
|
|
|
|
|
C02LA50
|
Combinations of rauwolfia alkaloids and diuretics including other combinations
|
|
|
|
|
|
C02LA51
|
Reserpine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA52
|
Rescinnamine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA71
|
Reserpine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LB
|
|
Methyldopa and diuretics in combination
|
|
|
|
|
|
C02LB01
|
Methyldopa (levorotatory) and diuretics
|
|
|
|
|
C02LC
|
|
Imidazoline receptor agonists in combination with diuretics
|
|
|
|
|
|
C02LC01
|
Clonidine and diuretics
|
|
|
|
|
|
C02LC05
|
Moxonidine and diuretics
|
|
|
|
|
|
C02LC51
|
Clonidine and diuretics, combinations with other drugs
|
|
|
|
|
C02LE
|
|
Alpha-adrenoreceptor antagonists and diuretics
|
|
|
|
|
|
C02LE01
|
Prazosin and diuretics
|
|
|
|
|
C02LF
|
|
Guanidine derivatives and diuretics
|
|
|
|
|
|
C02LF01
|
Guanethidine and diuretics
|
|
|
|
|
C02LG
|
|
Hydrazinophthalazine derivatives and diuretics
|
|
|
|
|
|
C02LG01
|
Dihydralazine and diuretics
|
|
|
|
|
|
C02LG02
|
Hydralazine and diuretics
|
|
|
|
|
|
C02LG03
|
Picodralazine and diuretics
|
|
|
|
|
|
C02LG51
|
Dihydralazine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LG73
|
Picodralazine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LK
|
|
Alkaloids, excluding rauwolfia, in combination with diuretics
|
|
|
|
|
|
C02LK01
|
Veratrum and diuretics
|
|
|
|
|
C02LL
|
|
MAO inhibitors and diuretics
|
|
|
|
|
|
C02LL01
|
Pargyline and diuretics
|
|
|
|
C02LN
|
|
|
Serotonin antagonists and diuretics
|
|
|
|
|
|
|
empty
|
|
|
|
C02LX
|
|
|
Other antihypertensives and diuretics
|
|
|
|
|
|
C02LX01
|
Pinacidil and diuretics
|
|
|
|
C02N
|
|
|
Combinations of antihypertensives in ATC-group C02
|
|
|
|
|
|
|
empty
|
|
|
C03
|
|
|
|
Diuretics
|
|
|
|
C03A
|
|
|
Low-ceiling diuretics, thiazides
|
|
|
|
|
C03AA
|
|
Thiazides, plain
|
|
|
|
|
|
C03AA01
|
Bendroflumethiazide
|
|
|
|
|
|
C03AA02
|
Hydroflumethiazide
|
|
|
|
|
|
C03AA03
|
Hydrochlorothiazide
|
|
|
|
|
|
C03AA04
|
Chlorothiazide
|
|
|
|
|
|
C03AA05
|
Polythiazide
|
|
|
|
|
|
C03AA06
|
Trichlormethiazide
|
|
|
|
|
|
C03AA07
|
Cyclopenthiazide
|
|
|
|
|
|
C03AA08
|
Methyclothiazide
|
|
|
|
|
|
C03AA09
|
Cyclothiazide
|
|
|
|
|
|
C03AA13
|
Mebutizide
|
|
|
|
|
C03AB
|
|
Thiazides and potassium in combination
|
|
|
|
|
|
C03AB01
|
Bendroflumethiazide and potassium
|
|
|
|
|
|
C03AB02
|
Hydroflumethiazide and potassium
|
|
|
|
|
|
C03AB03
|
Hydrochlorothiazide and potassium
|
|
|
|
|
|
C03AB04
|
Chlorothiazide and potassium
|
|
|
|
|
|
C03AB05
|
Polythiazide and potassium
|
|
|
|
|
|
C03AB06
|
Trichlormethiazide and potassium
|
|
|
|
|
|
C03AB07
|
Cyclopenthiazide and potassium
|
|
|
|
|
|
C03AB08
|
Methyclothiazide and potassium
|
|
|
|
|
|
C03AB09
|
Cyclothiazide and potassium
|
|
|
|
|
C03AH
|
|
Thiazides, combinations with psycholeptics and/or analgesics
|
|
|
|
|
|
C03AH01
|
Chlorothiazide, combinations
|
|
|
|
|
|
C03AH02
|
Hydroflumethiazide, combinations
|
|
|
|
|
C03AX
|
|
Thiazides, combinations with other drugs
|
|
|
|
|
|
C03AX01
|
Hydrochlorothiazide, combinations
|
|
|
|
C03B
|
|
|
Low-ceiling diuretics, excluding thiazides
|
|
|
|
|
C03BA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03BA02
|
Quinethazone
|
|
|
|
|
|
C03BA03
|
Clopamide
|
|
|
|
|
|
C03BA04
|
Chlortalidone
|
|
|
|
|
|
C03BA05
|
Mefruside
|
|
|
|
|
|
C03BA07
|
Clofenamide
|
|
|
|
|
|
C03BA08
|
Metolazone
|
|
|
|
|
|
C03BA09
|
Meticrane
|
|
|
|
|
|
C03BA10
|
Xipamide
|
|
|
|
|
|
C03BA11
|
Indapamide
|
|
|
|
|
|
C03BA12
|
Clorexolone
|
|
|
|
|
|
C03BA13
|
Fenquizone
|
|
|
|
|
|
C03BA82
|
Clorexolone, combinations with psycholeptics
|
|
|
|
|
C03BB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03BB02
|
Quinethazone and potassium
|
|
|
|
|
|
C03BB03
|
Clopamide and potassium
|
|
|
|
|
|
C03BB04
|
Chlortalidone and potassium
|
|
|
|
|
|
C03BB05
|
Mefruside and potassium
|
|
|
|
|
|
C03BB07
|
Clofenamide and potassium
|
|
|
|
|
C03BC
|
|
Mercurial diuretics
|
|
|
|
|
|
C03BC01
|
Mersalyl
|
|
|
|
|
C03BD
|
|
Xanthine derivatives
|
|
|
|
|
|
C03BD01
|
Theobromine
|
|
|
|
|
C03BK
|
|
Sulfonamides, combinations with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
|
C03BX
|
|
Other low-ceiling diuretics
|
|
|
|
|
|
C03BX03
|
Cicletanine
|
|
|
|
C03C
|
|
|
High-ceiling diuretics
|
|
|
|
|
C03CA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03CA01
|
Furosemide
|
|
|
|
|
|
C03CA02
|
Bumetanide
|
|
|
|
|
|
C03CA03
|
Piretanide
|
|
|
|
|
|
C03CA04
|
Torasemide
|
|
|
|
|
C03CB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03CB01
|
Furosemide and potassium
|
|
|
|
|
|
C03CB02
|
Bumetanide and potassium
|
|
|
|
|
C03CC
|
|
Aryloxyacetic acid derivatives
|
|
|
|
|
|
C03CC01
|
Etacrynic acid
|
|
|
|
|
|
C03CC02
|
Tienilic acid
|
|
|
|
|
C03CD
|
|
Pyrazolone derivatives
|
|
|
|
|
|
C03CD01
|
Muzolimine
|
|
|
|
|
C03CX
|
|
Other high-ceiling diuretics
|
|
|
|
|
|
C03CX01
|
Etozolin
|
|
|
|
C03D
|
|
|
Potassium-sparing agents
|
|
|
|
|
C03DA
|
|
Aldosterone antagonists
|
|
|
|
|
|
C03DA01
|
Spironolactone
|
|
|
|
|
|
C03DA02
|
Potassium canrenoate
|
|
|
|
|
|
C03DA03
|
Canrenone
|
|
|
|
|
|
C03DA04
|
Eplerenone
|
|
|
|
|
|
C03DA05
|
finerenone
|
|
|
|
|
C03DB
|
|
Other potassium-sparing agents
|
|
|
|
|
|
C03DB01
|
Amiloride
|
|
|
|
|
|
C03DB02
|
Triamterene
|
|
|
|
C03E
|
|
|
Diuretics and potassium-sparing agents in combination
|
|
|
|
|
C03EA
|
|
Low-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EA01
|
Hydrochlorothiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA02
|
Trichlormethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA03
|
Epitizide and potassium-sparing agents
|
|
|
|
|
|
C03EA04
|
Altizide and potassium-sparing agents
|
|
|
|
|
|
C03EA05
|
Mebutizide and potassium-sparing agents
|
|
|
|
|
|
C03EA06
|
Chlortalidone and potassium-sparing agents
|
|
|
|
|
|
C03EA07
|
Cyclopenthiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA12
|
Metolazone and potassium-sparing agents
|
|
|
|
|
|
C03EA13
|
Bendroflumethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA14
|
Butizide and potassium-sparing agents
|
|
|
|
|
C03EB
|
|
High-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EB01
|
Furosemide and potassium-sparing agents
|
|
|
|
|
|
C03EB02
|
Bumetanide and potassium-sparing agents
|
|
|
|
C03X
|
|
|
Other diuretics
|
|
|
|
|
C03XA
|
|
Vasopressin antagonists
|
|
|
|
|
|
C03XA01
|
Tolvaptan
|
|
|
|
|
|
C03XA02
|
Conivaptan
|
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
|
|
|
|
|
|
C04AA01
|
Isoxsuprine
|
|
|
|
|
|
C04AA02
|
Buphenine
|
|
|
|
|
|
C04AA31
|
Bamethan
|
|
|
|
|
C04AB
|
|
Imidazoline derivatives
|
|
|
|
|
|
C04AB01
|
Phentolamine
|
|
|
|
|
|
C04AB02
|
Tolazoline
|
|
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C04AC01
|
Nicotinic acid
|
|
|
|
|
|
C04AC02
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C04AC03
|
Inositol nicotinate
|
|
|
|
|
|
C04AC07
|
Ciclonicate
|
|
|
|
|
C04AD
|
|
Purine derivatives
|
|
|
|
|
|
C04AD01
|
Pentifylline
|
|
|
|
|
|
C04AD02
|
Xantinol nicotinate
|
|
|
|
|
|
C04AD03
|
Pentoxifylline
|
|
|
|
|
|
C04AD04
|
Etofylline nicotinate
|
|
|
|
|
C04AE
|
|
Ergot alkaloids
|
|
|
|
|
|
C04AE01
|
Ergoloid mesylates
|
|
|
|
|
|
C04AE02
|
Nicergoline
|
|
|
|
|
|
C04AE04
|
Dihydroergocristine
|
|
|
|
|
|
C04AE51
|
Ergoloid mesylates, combinations
|
|
|
|
|
|
C04AE54
|
Dihydroergocristine, combinations
|
|
|
|
|
C04AF
|
|
Enzymes
|
|
|
|
|
|
C04AF01
|
Kallidinogenase
|
|
|
|
|
C04AX
|
|
Other peripheral vasodilators
|
|
|
|
|
|
C04AX01
|
Cyclandelate
|
|
|
|
|
|
C04AX02
|
Phenoxybenzamine
|
|
|
|
|
|
C04AX07
|
Vincamine
|
|
|
|
|
|
C04AX10
|
Moxisylyte
|
|
|
|
|
|
C04AX11
|
Bencyclane
|
|
|
|
|
|
C04AX13
|
piribedil (בוטל, קוד חדש N04BC08)
|
|
|
|
|
|
C04AX17
|
Vinburnine
|
|
|
|
|
|
C04AX19
|
Sulcotidil
|
|
|
|
|
|
C04AX20
|
Buflomedil
|
|
|
|
|
|
C04AX21
|
Naftidrofuryl
|
|
|
|
|
|
C04AX23
|
Butalamine
|
|
|
|
|
|
C04AX24
|
Visnadine
|
|
|
|
|
|
C04AX26
|
Cetiedil
|
|
|
|
|
|
C04AX27
|
Cinepazide
|
|
|
|
|
|
C04AX28
|
Ifenprodil
|
|
|
|
|
|
C04AX30
|
Azapetine
|
|
|
|
|
|
C04AX32
|
Fasudil
|
|
|
C05
|
|
|
|
Vasoprotectives
|
|
|
|
C05A
|
|
|
Agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
C05AA
|
|
Corticosteroids
|
|
|
|
|
|
C05AA01
|
Hydrocortisone
|
|
|
|
|
|
C05AA04
|
Prednisolone
|
|
|
|
|
|
C05AA05
|
Betamethasone
|
|
|
|
|
|
C05AA06
|
Fluorometholone
|
|
|
|
|
|
C05AA08
|
Fluocortolone
|
|
|
|
|
|
C05AA09
|
Dexamethasone
|
|
|
|
|
|
C05AA10
|
Fluocinolone acetonide
|
|
|
|
|
|
C05AA11
|
Fluocinonide
|
|
|
|
|
|
C05AA12
|
Triamcinolone
|
|
|
|
|
C05AB
|
|
Antibiotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
C05AD
|
|
Local anesthetics
|
|
|
|
|
|
C05AD01
|
Lidocaine
|
|
|
|
|
|
C05AD02
|
Tetracaine
|
|
|
|
|
|
C05AD03
|
Benzocaine
|
|
|
|
|
|
C05AD04
|
Cinchocaine
|
|
|
|
|
|
C05AD05
|
Procaine
|
|
|
|
|
|
C05AD06
|
Oxetacaine
|
|
|
|
|
|
C05AD07
|
Pramocaine
|
|
|
|
|
C05AE
|
|
Muscle relaxants
|
|
|
|
|
|
C05AE01
|
Glyceryl trinitrate
|
|
|
|
|
|
C05AE02
|
Isosorbide dinitrate
|
|
|
|
|
C05AX
|
|
Other agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
|
C05AX01
|
Aluminium preparations
|
|
|
|
|
|
C05AX02
|
Bismuth preparations, combinations
|
|
|
|
|
|
C05AX03
|
Other preparations, combinations
|
|
|
|
|
|
C05AX04
|
Zinc preparations
|
|
|
|
|
|
C05AX05
|
Tribenoside
|
|
|
|
C05B
|
|
|
Antivaricose therapy
|
|
|
|
|
C05BA
|
|
Heparins or heparinoids for topical use
|
|
|
|
|
|
C05BA01
|
Organo-heparinoid
|
|
|
|
|
|
C05BA02
|
Sodium apolate
|
|
|
|
|
|
C05BA03
|
Heparin
|
|
|
|
|
|
C05BA04
|
Pentosan polysulfate sodium
|
|
|
|
|
|
C05BA51
|
Heparinoid, combinations
|
|
|
|
|
|
C05BA53
|
Heparin, combinations
|
|
|
|
|
C05BB
|
|
Sclerosing agents for local injection
|
|
|
|
|
|
C05BB01
|
Monoethanolamine oleate
|
|
|
|
|
|
C05BB02
|
Polidocanol
|
|
|
|
|
|
C05BB03
|
Invert sugar
|
|
|
|
|
|
C05BB04
|
Sodium tetradecyl sulfate
|
|
|
|
|
|
C05BB05
|
Phenol
|
|
|
|
|
|
C05BB56
|
Glucose, combinations
|
|
|
|
|
C05BX
|
|
Other sclerosing agents
|
|
|
|
|
|
C05BX01
|
Calcium dobesilate
|
|
|
|
|
|
C05BX51
|
Calcium dobesilate, combinations
|
|
|
|
C05C
|
|
|
Capillary stabilising agents
|
|
|
|
|
C05CA
|
|
Bioflavonoids
|
|
|
|
|
|
C05CA01
|
Rutoside
|
|
|
|
|
|
C05CA02
|
Monoxerutin
|
|
|
|
|
|
C05CA03
|
Diosmin
|
|
|
|
|
|
C05CA04
|
Troxerutin
|
|
|
|
|
|
C05CA05
|
Hidrosmin
|
|
|
|
|
|
C05CA51
|
Rutoside, combinations
|
|
|
|
|
|
C05CA53
|
Diosmin, combinations
|
|
|
|
|
|
C05CA54
|
Troxerutin, combinations
|
|
|
|
|
C05CX
|
|
Other capillary stabilising agents
|
|
|
|
|
|
C05CX01
|
Tribenoside
|
|
|
|
|
|
C05CX02
|
Naftazone
|
|
|
|
|
|
C05CX03
|
Hippocastani semen
|
|
|
C07
|
|
|
|
Beta blocking agents
|
|
|
|
C07A
|
|
|
Beta blocking agents
|
|
|
|
|
C07AA
|
|
Beta blocking agents, non-selective
|
|
|
|
|
|
C07AA01
|
Alprenolol
|
|
|
|
|
|
C07AA02
|
Oxprenolol
|
|
|
|
|
|
C07AA03
|
Pindolol
|
|
|
|
|
|
C07AA05
|
Propranolol
|
|
|
|
|
|
C07AA06
|
Timolol
|
|
|
|
|
|
C07AA07
|
Sotalol
|
|
|
|
|
|
C07AA12
|
Nadolol
|
|
|
|
|
|
C07AA14
|
Mepindolol
|
|
|
|
|
|
C07AA15
|
Carteolol
|
|
|
|
|
|
C07AA16
|
Tertatolol
|
|
|
|
|
|
C07AA17
|
Bopindolol
|
|
|
|
|
|
C07AA19
|
Bupranolol
|
|
|
|
|
|
C07AA23
|
Penbutolol
|
|
|
|
|
|
C07AA27
|
Cloranolol
|
|
|
|
|
|
C07AA57
|
Sotalol, combinations (בוטל, קוד חדש C07FX02)
|
|
|
|
|
C07AB
|
|
Beta blocking agents, selective
|
|
|
|
|
|
C07AB01
|
Practolol
|
|
|
|
|
|
C07AB02
|
Metoprolol
|
|
|
|
|
|
C07AB03
|
Atenolol
|
|
|
|
|
|
C07AB04
|
Acebutolol
|
|
|
|
|
|
C07AB05
|
Betaxolol
|
|
|
|
|
|
C07AB06
|
Bevantolol
|
|
|
|
|
|
C07AB07
|
Bisoprolol
|
|
|
|
|
|
C07AB08
|
Celiprolol
|
|
|
|
|
|
C07AB09
|
Esmolol
|
|
|
|
|
|
C07AB10
|
Epanolol
|
|
|
|
|
|
C07AB11
|
S-atenolol
|
|
|
|
|
|
C07AB12
|
Nebivolol
|
|
|
|
|
|
C07AB13
|
Talinolol
|
|
|
|
|
|
C07AB52
|
Metoprolol, combinations (בוטל, קוד חדש C07FX03)
|
|
|
|
|
|
C07AB57
|
Bisoprolol, combinations (בוטל, קוד חדש C07FX04)
|
|
|
|
|
C07AG
|
|
Alpha and beta blocking agents
|
|
|
|
|
|
C07AG01
|
Labetalol
|
|
|
|
|
|
C07AG02
|
Carvedilol
|
|
|
|
C07B
|
|
|
Beta blocking agents and thiazides
|
|
|
|
|
C07BA
|
|
Beta blocking agents, non-selective, and thiazides
|
|
|
|
|
|
C07BA02
|
Oxprenolol and thiazides
|
|
|
|
|
|
C07BA05
|
Propranolol and thiazides
|
|
|
|
|
|
C07BA06
|
Timolol and thiazides
|
|
|
|
|
|
C07BA07
|
Sotalol and thiazides
|
|
|
|
|
|
C07BA12
|
Nadolol and thiazides
|
|
|
|
|
|
C07BA68
|
Metipranolol and thiazides, combinations
|
|
|
|
|
C07BB
|
|
Beta blocking agents, selective, and thiazides
|
|
|
|
|
|
C07BB02
|
Metoprolol and thiazides
|
|
|
|
|
|
C07BB03
|
Atenolol and thiazides
|
|
|
|
|
|
C07BB04
|
Acebutolol and thiazides
|
|
|
|
|
|
C07BB06
|
Bevantolol and thiazides
|
|
|
|
|
|
C07BB07
|
Bisoprolol and thiazides
|
|
|
|
|
|
C07BB12
|
Nebivolol and thiazides
|
|
|
|
|
|
C07BB52
|
Metoprolol and thiazides, combinations
|
|
|
|
|
C07BG
|
|
Alpha and beta blocking agents and thiazides
|
|
|
|
|
|
C07BG01
|
Labetalol and thiazides
|
|
|
|
C07C
|
|
|
Beta blocking agents and other diuretics
|
|
|
|
|
C07CA
|
|
Beta blocking agents, non-selective, and other diuretics
|
|
|
|
|
|
C07CA02
|
Oxprenolol and other diuretics
|
|
|
|
|
|
C07CA03
|
Pindolol and other diuretics
|
|
|
|
|
|
C07CA17
|
Bopindolol and other diuretics
|
|
|
|
|
|
C07CA23
|
Penbutolol and other diuretics
|
|
|
|
|
C07CB
|
|
Beta blocking agents, selective, and other diuretics
|
|
|
|
|
|
C07CB02
|
Metoprolol and other diuretics
|
|
|
|
|
|
C07CB03
|
Atenolol and other diuretics
|
|
|
|
|
|
C07CB53
|
Atenolol and other diuretics, combinations
|
|
|
|
|
C07CG
|
|
Alpha and beta blocking agents and other diuretics
|
|
|
|
|
|
C07CG01
|
Labetalol and other diuretics
|
|
|
|
C07D
|
|
|
Beta blocking agents, thiazides and other diuretics
|
|
|
|
|
C07DA
|
|
Beta blocking agents, non-selective, thiazides and other diuretics
|
|
|
|
|
|
C07DA06
|
Timolol, thiazides and other diuretics
|
|
|
|
|
C07DB
|
|
Beta blocking agents, selective, thiazides and other diuretics
|
|
|
|
|
|
C07DB01
|
Atenolol, thiazides and other diuretics
|
|
|
|
C07E
|
|
|
Beta blocking agents and vasodilators
|
|
|
|
|
C07EA
|
|
Beta blocking agents, non-selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
|
C07EB
|
|
Beta blocking agents, selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
C07F
|
|
|
Beta blocking agents and other antihypertensives
|
|
|
|
|
C07FA
|
|
Beta blocking agents, non-selective, and other antihypertensives
|
|
|
|
|
|
C07FA05
|
Propranolol and other antihypertensives (בוטל, קוד חדש C07FX01)
|
|
|
|
|
C07FB
|
|
Beta blocking agents and calcium channel blockers
|
|
|
|
|
|
C07FB02
|
metoprolol and felodipine (בוטל, קוד חדש C07FB13)
|
|
|
|
|
|
C07FB03
|
atenolol and nifedipine
|
|
|
|
|
|
C07FB07
|
bisoprolol and amlodipine
|
|
|
|
|
|
C07FB12
|
nebivolol and amlodipine
|
|
|
|
|
|
C07FB13
|
metoprolol and amlodipine
|
|
|
|
|
C07FX
|
|
Beta blocking agents, other combinations
|
|
|
|
|
|
C07FX01
|
propranolol and other combinations
|
|
|
|
|
|
C07FX02
|
sotalol and acetylsalicylic acid
|
|
|
|
|
|
C07FX03
|
metoprolol and acetylsalicylic acid
|
|
|
|
|
|
C07FX04
|
bisoprolol and acetylsalicylic acid
|
|
|
|
|
|
C07FX05
|
metoprolol and ivabradine
|
|
|
|
|
|
C07FX06
|
carvedilol and ivabradine
|
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
|
|
C08C
|
|
|
Selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
C08CA
|
|
Dihydropyridine derivatives
|
|
|
|
|
|
C08CA01
|
Amlodipine
|
|
|
|
|
|
C08CA02
|
Felodipine
|
|
|
|
|
|
C08CA03
|
Isradipine
|
|
|
|
|
|
C08CA04
|
Nicardipine
|
|
|
|
|
|
C08CA05
|
Nifedipine
|
|
|
|
|
|
C08CA06
|
Nimodipine
|
|
|
|
|
|
C08CA07
|
Nisoldipine
|
|
|
|
|
|
C08CA08
|
Nitrendipine
|
|
|
|
|
|
C08CA09
|
Lacidipine
|
|
|
|
|
|
C08CA10
|
Nilvadipine
|
|
|
|
|
|
C08CA11
|
Manidipine
|
|
|
|
|
|
C08CA12
|
Barnidipine
|
|
|
|
|
|
C08CA13
|
Lercanidipine
|
|
|
|
|
|
C08CA14
|
Cilnidipine
|
|
|
|
|
|
C08CA15
|
Benidipine
|
|
|
|
|
|
C08CA16
|
Clevidipine
|
|
|
|
|
|
C08CA55
|
Nifedipine, combinations
|
|
|
|
|
C08CX
|
|
Other selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
|
C08CX01
|
Mibefradil
|
|
|
|
C08D
|
|
|
Selective calcium channel blockers with direct cardiac effects
|
|
|
|
|
C08DA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08DA01
|
Verapamil
|
|
|
|
|
|
C08DA02
|
Gallopamil
|
|
|
|
|
|
C08DA51
|
Verapamil, combinations
|
|
|
|
|
C08DB
|
|
Benzothiazepine derivatives
|
|
|
|
|
|
C08DB01
|
Diltiazem
|
|
|
|
C08E
|
|
|
Non-selective calcium channel blockers
|
|
|
|
|
C08EA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08EA01
|
Fendiline
|
|
|
|
|
|
C08EA02
|
Bepridil
|
|
|
|
|
C08EX
|
|
Other non-selective calcium channel blockers
|
|
|
|
|
|
C08EX01
|
Lidoflazine
|
|
|
|
|
|
C08EX02
|
Perhexiline
|
|
|
|
C08G
|
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
C08GA
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
|
C08GA01
|
Nifedipine and diuretics
|
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
|
|
C09A
|
|
|
ACE inhibitors, plain
|
|
|
|
|
C09AA
|
|
ACE inhibitors, plain
|
|
|
|
|
|
C09AA01
|
Captopril
|
|
|
|
|
|
C09AA02
|
Enalapril
|
|
|
|
|
|
C09AA03
|
Lisinopril
|
|
|
|
|
|
C09AA04
|
Perindopril
|
|
|
|
|
|
C09AA05
|
Ramipril
|
|
|
|
|
|
C09AA06
|
Quinaprl
|
|
|
|
|
|
C09AA07
|
Benazepril
|
|
|
|
|
|
C09AA08
|
Cilazapril
|
|
|
|
|
|
C09AA09
|
Fosinopril
|
|
|
|
|
|
C09AA10
|
Trandolapril
|
|
|
|
|
|
C09AA11
|
Spirapril
|
|
|
|
|
|
C09AA12
|
Delapril
|
|
|
|
|
|
C09AA13
|
Moexipril
|
|
|
|
|
|
C09AA14
|
Temocapril
|
|
|
|
|
|
C09AA15
|
Zofenopril
|
|
|
|
|
|
C09AA16
|
Imidapril
|
|
|
|
C09B
|
|
|
ACE inhibitors, combinations
|
|
|
|
|
C09BA
|
|
ACE inhibitors and diuretics
|
|
|
|
|
|
C09BA01
|
Captopril and diuretics
|
|
|
|
|
|
C09BA02
|
Enalapril and diuretics
|
|
|
|
|
|
C09BA03
|
Lisinopril and diuretics
|
|
|
|
|
|
C09BA04
|
Perindopril and diuretics
|
|
|
|
|
|
C09BA05
|
Ramipril and diuretics
|
|
|
|
|
|
C09BA06
|
Quinapril and diuretics
|
|
|
|
|
|
C09BA07
|
Benazepril and diuretics
|
|
|
|
|
|
C09BA08
|
Cilazapril and diuretics
|
|
|
|
|
|
C09BA09
|
Fosinopril and diuretics
|
|
|
|
|
|
C09BA12
|
Delapril and diuretics
|
|
|
|
|
|
C09BA13
|
Moexipril and diuretics
|
|
|
|
|
|
C09BA15
|
Zofenopril and diuretics
|
|
|
|
|
C09BB
|
|
ACE inhibitors and calcium channel blockers
|
|
|
|
|
|
C09BB02
|
Enalapril and lercanidipine
|
|
|
|
|
|
C09BB03
|
Lisinopril and amlodipine
|
|
|
|
|
|
C09BB04
|
Perindopril and amlodipine
|
|
|
|
|
|
C09BB05
|
Ramipril and felodipine
|
|
|
|
|
|
C09BB06
|
Enalapril and nitrendipine
|
|
|
|
|
|
C09BB07
|
Ramipril and amlodipine
|
|
|
|
|
|
C09BB10
|
Trandolapril and verapamil
|
|
|
|
|
|
C09BB12
|
Delapril and manidipine
|
|
|
|
C09C
|
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
C09CA
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
|
C09CA01
|
Losartan
|
|
|
|
|
|
C09CA02
|
Eprosartan
|
|
|
|
|
|
C09CA03
|
Valsartan
|
|
|
|
|
|
C09CA04
|
Irbesartan
|
|
|
|
|
|
C09CA05
|
Tasosartan
|
|
|
|
|
|
C09CA06
|
Candesartan
|
|
|
|
|
|
C09CA07
|
Telmisartan
|
|
|
|
|
|
C09CA08
|
Olmesartan medoxomil
|
|
|
|
|
|
C09CA09
|
Azilsartan medoxomil
|
|
|
|
C09D
|
|
|
Angiotensin II antagonists, combinations
|
|
|
|
|
C09DA
|
|
Angiotensin II antagonists and diuretics
|
|
|
|
|
|
C09DA01
|
Losartan and diuretics
|
|
|
|
|
|
C09DA02
|
Eprosartan and diuretics
|
|
|
|
|
|
C09DA03
|
Valsartan and diuretics
|
|
|
|
|
|
C09DA04
|
Irbesartan and diuretics
|
|
|
|
|
|
C09DA06
|
Candesartan and diuretics
|
|
|
|
|
|
C09DA07
|
Telmisartan and diuretics
|
|
|
|
|
|
C09DA08
|
Olmesartan medoxomil and diuretics
|
|
|
|
|
C09DB
|
|
Angiotensin II antagonists and calcium channel blockers
|
|
|
|
|
|
C09DB01
|
Valsartan and amlodipine
|
|
|
|
|
|
C09DB02
|
Olmesartan medoxomil and amlodipine
|
|
|
|
|
|
C09DB04
|
Telmisartan and amlodipine
|
|
|
|
|
|
C09DB05
|
Irbesartan and amlodipine
|
|
|
|
|
|
C09DB06
|
Losartan and amlodipine
|
|
|
|
|
C09DX
|
|
Angiotensin II antagonists, other combinations
|
|
|
|
C09X
|
|
|
Other agents acting on the renin-angiotensin system
|
|
|
|
|
|
C09DX01
|
Valsartan, amlodipine and hydrochlorothiazide
|
|
|
|
|
|
C09DX02
|
Valsartan and aliskiren
|
|
|
|
|
|
C09DX03
|
Olmesartan medoxomil, amlodipine and hydrochlorothiazide
|
|
|
|
|
C09XA
|
|
Renin-inhibitors
|
|
|
|
|
|
C09XA01
|
Remikiren
|
|
|
|
|
|
C09XA02
|
Aliskiren
|
|
|
|
|
|
C09XA52
|
Aliskiren and hydrochlorothiazide
|
|
|
|
|
|
C09XA53
|
Aliskiren and amlodipine
|
|
|
|
|
|
C09XA54
|
Aliskiren, amlodipine and hydrochlorothiazide
|
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
|
|
C10AA01
|
Simvastatin
|
|
|
|
|
|
C10AA02
|
Lovastatin
|
|
|
|
|
|
C10AA03
|
Pravastatin
|
|
|
|
|
|
C10AA04
|
Fluvastatin
|
|
|
|
|
|
C10AA05
|
Atorvastatin
|
|
|
|
|
|
C10AA06
|
Cerivastatin
|
|
|
|
|
|
C10AA07
|
Rosuvastatin
|
|
|
|
|
|
C10AA08
|
Pitavastatin
|
|
|
|
|
|
C10AA51
|
simvastatin, combinations (בוטל, קוד חדש C10BX01)
|
|
|
|
|
|
C10AA52
|
lovastatin, combinations (בוטל, קוד חדש C10BA01)
|
|
|
|
|
|
C10AA53
|
pravastatin, combinations (בוטל, קוד חדש C10BX02)
|
|
|
|
|
|
C10AA55
|
atorvastatin, combinations (בוטל, קוד חדש C10BX03)
|
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
|
|
C10AB01
|
Clofibrate
|
|
|
|
|
|
C10AB02
|
Bezafibrate
|
|
|
|
|
|
C10AB03
|
Aluminium clofibrate
|
|
|
|
|
|
C10AB04
|
Gemfibrozil
|
|
|
|
|
|
C10AB05
|
Fenofibrate
|
|
|
|
|
|
C10AB06
|
Simfibrate
|
|
|
|
|
|
C10AB07
|
Ronifibrate
|
|
|
|
|
|
C10AB08
|
Ciprofibrate
|
|
|
|
|
|
C10AB09
|
Etofibrate
|
|
|
|
|
|
C10AB10
|
Clofibride
|
|
|
|
|
|
C10AB11
|
Choline fenofibrate
|
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C10AD01
|
Niceritrol
|
|
|
|
|
|
C10AD02
|
Nicotinic acid
|
|
|
|
|
|
C10AD03
|
Nicofuranose
|
|
|
|
|
|
C10AD04
|
Aluminium nicotinate
|
|
|
|
|
|
C10AD05
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C10AD06
|
Acipimox
|
|
|
|
|
|
C10AD52
|
Nicotinic acid, combinations
|
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
|
|
|
C10AX01
|
Dextrothyroxine
|
|
|
|
|
|
C10AX02
|
Probucol
|
|
|
|
|
|
C10AX03
|
Tiadenol
|
|
|
|
|
|
C10AX04
|
benfluorex (בוטל, קוד חדש A10BX06)
|
|
|
|
|
|
C10AX05
|
Meglutol
|
|
|
|
|
|
C10AX06
|
Omega-3-triglycerides
|
|
|
|
|
|
C10AX07
|
Magnesium pyridoxal 5-phosphate glutamate
|
|
|
|
|
|
C10AX08
|
Policosanol
|
|
|
|
|
|
C10AX09
|
Ezetimibe
|
|
|
|
|
|
C10AX10
|
Alipogene tiparvovec
|
|
|
|
|
|
C10AX11
|
Mipomersen
|
|
|
|
|
|
C10AX12
|
Lomitapide
|
|
|
|
|
|
C10AX13
|
evolocumab
|
|
|
|
|
|
C10AX14
|
alirocumab
|
|
|
|
|
|
C10AX15
|
bempedoic acid
|
|
|
|
|
|
C10AX16
|
inclisiran
|
|
|
|
|
|
C10AX17
|
evinacumab
|
|
|
|
|
|
C10AX18
|
volanesorsen
|
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
|
|
|
|
C10BA
|
|
Combinations of various lipid modifying agents
|
|
|
|
|
|
C10BA01
|
Lovastatin and nicotinic acid
|
|
|
|
|
|
C10BA02
|
Simvastatin and ezetimibe
|
|
|
|
|
|
C10BA03
|
Pravastatin and fenofibrate
|
|
|
|
|
|
C10BA04
|
Simvastatin and fenofibrate
|
|
|
|
|
|
C10BA05
|
Atorvastatin and ezetimibe
|
|
|
|
|
|
C10BA06
|
rosuvastatin and ezetimibe
|
|
|
|
|
|
C10BA07
|
rosuvastatin and omega-3 fatty acids
|
|
|
|
|
|
C10BA08
|
atorvastatin and omega-3 fatty acids
|
|
|
|
|
|
C10BA09
|
rosuvastatin and fenofibrate
|
|
|
|
|
|
C10BA10
|
bempedoic acid and ezetimibe
|
|
|
|
|
|
C10BA11
|
pravastatin and ezetimibe
|
|
|
|
|
|
C10BA12
|
pravastatin, ezetimibe and fenofibrate
|
|
|
|
|
C10BX
|
|
HMG CoA reductase inhibitors, other combinations
|
|
|
|
|
|
C10BX01
|
Simvastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX02
|
Pravastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX03
|
Atorvastatin and amlodipine
|
|
|
|
|
|
C10BX04
|
Simvastatin, acetylsalicylic acid and ramipril
|
| D
|
|
|
|
|
Dermatologicals
|
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
|
|
D01A
|
|
|
Antifungals for topical use
|
|
|
|
|
D01AA
|
|
Antibiotics
|
|
|
|
|
|
D01AA01
|
Nystatin
|
|
|
|
|
|
D01AA02
|
Natamycin
|
|
|
|
|
|
D01AA03
|
Hachimycin
|
|
|
|
|
|
D01AA04
|
Pecilocin
|
|
|
|
|
|
D01AA06
|
Mepartricin
|
|
|
|
|
|
D01AA07
|
Pyrrolnitrin
|
|
|
|
|
|
D01AA08
|
Griseofulvin
|
|
|
|
|
|
D01AA20
|
Combinations
|
|
|
|
|
D01AC
|
|
Imidazole and triazole derivatives
|
|
|
|
|
|
D01AC01
|
Clotrimazole
|
|
|
|
|
|
D01AC02
|
Miconazole
|
|
|
|
|
|
D01AC03
|
Econazole
|
|
|
|
|
|
D01AC04
|
Clomidazole
|
|
|
|
|
|
D01AC05
|
Isoconazole
|
|
|
|
|
|
D01AC06
|
Tiabendazole
|
|
|
|
|
|
D01AC07
|
Tioconazole
|
|
|
|
|
|
D01AC08
|
Ketoconazole
|
|
|
|
|
|
D01AC09
|
Sulconazole
|
|
|
|
|
|
D01AC10
|
Bifonazole
|
|
|
|
|
|
D01AC11
|
Oxiconazole
|
|
|
|
|
|
D01AC12
|
Fenticonazole
|
|
|
|
|
|
D01AC13
|
Omoconazole
|
|
|
|
|
|
D01AC14
|
Sertaconazole
|
|
|
|
|
|
D01AC15
|
Fluconazole
|
|
|
|
|
|
D01AC16
|
Flutrimazole
|
|
|
|
|
|
D01AC17
|
Eberconazole
|
|
|
|
|
|
D01AC20
|
Combinations
|
|
|
|
|
|
D01AC52
|
Miconazole, combinations
|
|
|
|
|
|
D01AC60
|
Bifonazole, combinations
|
|
|
|
|
D01AE
|
|
Other antifungals for topical use
|
|
|
|
|
|
D01AE01
|
Bromochlorosalicylanilide
|
|
|
|
|
|
D01AE02
|
Methylrosaniline
|
|
|
|
|
|
D01AE03
|
Tribromometacresol
|
|
|
|
|
|
D01AE04
|
Undecylenic acid
|
|
|
|
|
|
D01AE05
|
Polynoxylin
|
|
|
|
|
|
D01AE06
|
2-(4-chlorphenoxy)-ethanol
|
|
|
|
|
|
D01AE07
|
Chlorphenesin
|
|
|
|
|
|
D01AE08
|
Ticlatone
|
|
|
|
|
|
D01AE09
|
Sulbentine
|
|
|
|
|
|
D01AE10
|
Ethyl hydroxybenzoate
|
|
|
|
|
|
D01AE11
|
Haloprogin
|
|
|
|
|
|
D01AE12
|
Salicylic acid
|
|
|
|
|
|
D01AE13
|
Selenium sulfide
|
|
|
|
|
|
D01AE14
|
Ciclopirox
|
|
|
|
|
|
D01AE15
|
Terbinafine
|
|
|
|
|
|
D01AE16
|
Amorolfine
|
|
|
|
|
|
D01AE17
|
Dimazole
|
|
|
|
|
|
D01AE18
|
Tolnaftate
|
|
|
|
|
|
D01AE19
|
Tolciclate
|
|
|
|
|
|
D01AE20
|
Combinations
|
|
|
|
|
|
D01AE21
|
Flucytosine
|
|
|
|
|
|
D01AE22
|
Naftifine
|
|
|
|
|
|
D01AE23
|
Butenafine
|
|
|
|
|
|
D01AE54
|
Undecylenic acid, combinations
|
|
|
|
D01B
|
|
|
Antifungals for systemic use
|
|
|
|
|
D01BA
|
|
Antifungals for systemic use
|
|
|
|
|
|
D01BA01
|
Griseofulvin
|
|
|
|
|
|
D01BA02
|
Terbinafine
|
|
|
D02
|
|
|
|
Emollients and protectives
|
|
|
|
D02A
|
|
|
Emollients and protectives
|
|
|
|
|
D02AA
|
|
Silicone products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AB
|
|
Zinc products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AC
|
|
Soft paraffin and fat products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AD
|
|
Liquid plasters
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AE
|
|
Carbamide products
|
|
|
|
|
|
D02AE01
|
Carbamide
|
|
|
|
|
|
D02AE51
|
Carbamide, combinations
|
|
|
|
|
D02AF
|
|
Salicylic acid preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AX
|
|
Other emollients and protectives
|
|
|
|
|
|
|
empty
|
|
|
|
D02B
|
|
|
Protectives against UV-radiation
|
|
|
|
|
D02BA
|
|
Protectives against UV-radiation for topical use
|
|
|
|
|
|
D02BA01
|
Aminobenzoic acid
|
|
|
|
|
|
D02BA02
|
Octinoxate
|
|
|
|
|
D02BB
|
|
Protectives against UV-radiation for systemic use
|
|
|
|
|
|
D02BB01
|
Betacarotene
|
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
|
|
D03A
|
|
|
Cicatrizants
|
|
|
|
|
D03AA
|
|
Cod-liver oil ointments
|
|
|
|
|
|
|
empty
|
|
|
|
|
D03AX
|
|
Other cicatrizants
|
|
|
|
|
|
D03AX01
|
Cadexomer iodine
|
|
|
|
|
|
D03AX02
|
Dextranomer
|
|
|
|
|
|
D03AX03
|
Dexpanthenol
|
|
|
|
|
|
D03AX04
|
Calcium pantothenate
|
|
|
|
|
|
D03AX05
|
Hyaluronic acid
|
|
|
|
|
|
D03AX06
|
Becaplermin
|
|
|
|
|
|
D03AX07
|
glyceryl trinitrate (בוטל, קוד חדש C05AE01)
|
|
|
|
|
|
D03AX08
|
isosorbide dinitrate (בוטל, קוד חדש C05AE02)
|
|
|
|
|
|
D03AX09
|
Crilanomer
|
|
|
|
|
|
D03AX10
|
Enoxolone
|
|
|
|
|
|
D03AX11
|
Sodium chlorite (tetrachlorodecaoxide)
|
|
|
|
|
|
D03AX12
|
trolamine
|
|
|
|
|
|
D03AX13
|
Betulae cortex
|
|
|
|
|
|
D03AX14
|
Centella asiatica herba
|
|
|
|
|
|
D03AX15
|
trafermin
|
|
|
|
D03B
|
|
|
Enzymes
|
|
|
|
|
D03BA
|
|
Proteolytic enzymes
|
|
|
|
|
|
D03BA01
|
Trypsin
|
|
|
|
|
|
D03BA02
|
Clostridiopeptidase
|
|
|
|
|
|
D03BA03
|
bromelains
|
|
|
|
|
|
D03BA52
|
Clostridiopeptidase, combinations
|
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
|
|
D04A
|
|
|
Antipruritics, including antihistamines, anesthetics, etc.
|
|
|
|
|
D04AA
|
|
Antihistamines for topical use
|
|
|
|
|
|
D04AA01
|
Thonzylamine
|
|
|
|
|
|
D04AA02
|
Mepyramine
|
|
|
|
|
|
D04AA03
|
Thenalidine
|
|
|
|
|
|
D04AA04
|
Tripelennamine
|
|
|
|
|
|
D04AA09
|
Chloropyramine
|
|
|
|
|
|
D04AA10
|
Promethazine
|
|
|
|
|
|
D04AA12
|
Tolpropamine
|
|
|
|
|
|
D04AA13
|
Dimetindene
|
|
|
|
|
|
D04AA14
|
Clemastine
|
|
|
|
|
|
D04AA15
|
Bamipine
|
|
|
|
|
|
D04AA22
|
Isothipendyl
|
|
|
|
|
|
D04AA32
|
Diphenhydramine
|
|
|
|
|
|
D04AA33
|
Diphenhydramine methylbromide
|
|
|
|
|
|
D04AA34
|
Chlorphenoxamine
|
|
|
|
|
D04AB
|
|
Anesthetics for topical use
|
|
|
|
|
|
D04AB01
|
Lidocaine
|
|
|
|
|
|
D04AB02
|
Cinchocaine
|
|
|
|
|
|
D04AB03
|
Oxybuprocaine
|
|
|
|
|
|
D04AB04
|
Benzocaine
|
|
|
|
|
|
D04AB05
|
Quinisocaine
|
|
|
|
|
|
D04AB06
|
Tetracaine
|
|
|
|
|
|
D04AB07
|
Pramocaine
|
|
|
|
|
D04AX
|
|
Other antipruritics
|
|
|
|
|
|
|
empty
|
|
|
D05
|
|
|
|
Antipsoriatics
|
|
|
|
D05A
|
|
|
Antipsoriatics for topical use
|
|
|
|
|
D05AA
|
|
Tars
|
|
|
|
|
|
|
empty
|
|
|
|
|
D05AC
|
|
Antracen derivatives
|
|
|
|
|
|
D05AC01
|
Dithranol
|
|
|
|
|
|
D05AC51
|
Dithranol, combinations
|
|
|
|
|
D05AD
|
|
Psoralens for topical use
|
|
|
|
|
|
D05AD01
|
Trioxysalen
|
|
|
|
|
|
D05AD02
|
Methoxsalen
|
|
|
|
|
D05AX
|
|
Other antipsoriatics for topical use
|
|
|
|
|
|
D05AX01
|
Fumaric acid
|
|
|
|
|
|
D05AX02
|
Calcipotriol
|
|
|
|
|
|
D05AX03
|
Calcitriol
|
|
|
|
|
|
D05AX04
|
Tacalcitol
|
|
|
|
|
|
D05AX05
|
Tazarotene
|
|
|
|
|
|
D05AX52
|
Calcipotriol, combinations
|
|
|
|
D05B
|
|
|
Antipsoriatics for systemic use
|
|
|
|
|
D05BA
|
|
Psoralens for systemic use
|
|
|
|
|
|
D05BA01
|
Trioxysalen
|
|
|
|
|
|
D05BA02
|
Methoxsalen
|
|
|
|
|
|
D05BA03
|
Bergapten
|
|
|
|
|
D05BB
|
|
Retinoids for treatment of psoriasis
|
|
|
|
|
|
D05BB01
|
Etretinate
|
|
|
|
|
|
D05BB02
|
Acitretin
|
|
|
|
|
D05BX
|
|
Other antipsoriatics for systemic use
|
|
|
|
|
|
D05BX51
|
Fumaric acid derivatives, combinations
|
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
|
|
D06A
|
|
|
Antibiotics for topical use
|
|
|
|
|
D06AA
|
|
Tetracycline and derivatives
|
|
|
|
|
|
D06AA01
|
Demeclocycline
|
|
|
|
|
|
D06AA02
|
Chlortetracycline
|
|
|
|
|
|
D06AA03
|
Oxytetracycline
|
|
|
|
|
|
D06AA04
|
Tetracycline
|
|
|
|
|
D06AX
|
|
Other antibiotics for topical use
|
|
|
|
|
|
D06AX01
|
Fusidic acid
|
|
|
|
|
|
D06AX02
|
Chloramphenicol
|
|
|
|
|
|
D06AX04
|
Neomycin
|
|
|
|
|
|
D06AX05
|
Bacitracin
|
|
|
|
|
|
D06AX07
|
Gentamicin
|
|
|
|
|
|
D06AX08
|
Tyrothricin
|
|
|
|
|
|
D06AX09
|
Mupirocin
|
|
|
|
|
|
D06AX10
|
Virginiamycin
|
|
|
|
|
|
D06AX11
|
Rifaximin
|
|
|
|
|
|
D06AX12
|
Amikacin
|
|
|
|
|
|
D06AX13
|
Retapamulin
|
|
|
|
D06B
|
|
|
Chemotherapeutics for topical use
|
|
|
|
|
D06BA
|
|
Sulfonamides
|
|
|
|
|
|
D06BA01
|
Silver sulfadiazine
|
|
|
|
|
|
D06BA02
|
Sulfathiazole
|
|
|
|
|
|
D06BA03
|
Mafenide
|
|
|
|
|
|
D06BA04
|
Sulfamethizole
|
|
|
|
|
|
D06BA05
|
Sulfanilamide
|
|
|
|
|
|
D06BA06
|
Sulfamerazine
|
|
|
|
|
D06BB
|
|
Antivirals
|
|
|
|
|
|
D06BB01
|
Idoxuridine
|
|
|
|
|
|
D06BB02
|
Tromantadine
|
|
|
|
|
|
D06BB03
|
Aciclovir
|
|
|
|
|
|
D06BB04
|
Podophyllotoxin
|
|
|
|
|
|
D06BB05
|
Inosine
|
|
|
|
|
|
D06BB06
|
Penciclovir
|
|
|
|
|
|
D06BB07
|
Lysozyme
|
|
|
|
|
|
D06BB08
|
Ibacitabine
|
|
|
|
|
|
D06BB09
|
Edoxudine
|
|
|
|
|
|
D06BB10
|
Imiquimod
|
|
|
|
|
|
D06BB11
|
Docosanol
|
|
|
|
|
|
D06BB12
|
Sinecatechins
|
|
|
|
|
|
D06BB53
|
Aciclovir, combinations
|
|
|
|
|
D06BX
|
|
Other chemotherapeutics
|
|
|
|
|
|
D06BX01
|
Metronidazole
|
|
|
|
|
|
D06BX02
|
Ingenol mebutate
|
|
|
|
|
|
D06BX03
|
tirbanibulin
|
|
|
|
D06C
|
|
|
Antibiotics and chemotherapeutics, combinations
|
|
|
|
|
|
|
empty
|
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
|
|
D07A
|
|
|
Corticosteroids, plain
|
|
|
|
|
D07AA
|
|
Corticosteroids, weak (group I)
|
|
|
|
|
|
D07AA01
|
Methylprednisolone
|
|
|
|
|
|
D07AA02
|
Hydrocortisone
|
|
|
|
|
|
D07AA03
|
Prednisolone
|
|
|
|
|
D07AB
|
|
Corticosteroids, moderately potent (group II)
|
|
|
|
|
|
D07AB01
|
Clobetasone
|
|
|
|
|
|
D07AB02
|
Hydrocortisone butyrate
|
|
|
|
|
|
D07AB03
|
Flumetasone
|
|
|
|
|
|
D07AB04
|
Fluocortin
|
|
|
|
|
|
D07AB05
|
Fluperolone
|
|
|
|
|
|
D07AB06
|
Fluorometholone
|
|
|
|
|
|
D07AB07
|
Fluprednidene
|
|
|
|
|
|
D07AB08
|
Desonide
|
|
|
|
|
|
D07AB09
|
Triamcinolone
|
|
|
|
|
|
D07AB10
|
Alclometasone
|
|
|
|
|
|
D07AB11
|
Hydrocortisone buteprate
|
|
|
|
|
|
D07AB19
|
Dexamethasone
|
|
|
|
|
|
D07AB21
|
Clocortolone
|
|
|
|
|
|
D07AB30
|
Combinations of corticosteroids
|
|
|
|
|
D07AC
|
|
Corticosteroids, potent (group III)
|
|
|
|
|
|
D07AC01
|
Betamethasone
|
|
|
|
|
|
D07AC02
|
Fluclorolone
|
|
|
|
|
|
D07AC03
|
Desoximetasone
|
|
|
|
|
|
D07AC04
|
Fluocinolone acetonide
|
|
|
|
|
|
D07AC05
|
Fluocortolone
|
|
|
|
|
|
D07AC06
|
Diflucortolone
|
|
|
|
|
|
D07AC07
|
Fludroxycortide
|
|
|
|
|
|
D07AC08
|
Fluocinonide
|
|
|
|
|
|
D07AC09
|
Budesonide
|
|
|
|
|
|
D07AC10
|
Diflorasone
|
|
|
|
|
|
D07AC11
|
Amcinonide
|
|
|
|
|
|
D07AC12
|
Halometasone
|
|
|
|
|
|
D07AC13
|
Mometasone
|
|
|
|
|
|
D07AC14
|
Methylprednisolone aceponate
|
|
|
|
|
|
D07AC15
|
Beclometasone
|
|
|
|
|
|
D07AC16
|
Hydrocortisone aceponate
|
|
|
|
|
|
D07AC17
|
Fluticasone
|
|
|
|
|
|
D07AC18
|
Prednicarbate
|
|
|
|
|
|
D07AC19
|
Difluprednate
|
|
|
|
|
|
D07AC21
|
Ulobetasol
|
|
|
|
|
D07AD
|
|
Corticosteroids, very potent (group IV)
|
|
|
|
|
|
D07AD01
|
Clobetasol
|
|
|
|
|
|
D07AD02
|
Halcinonide
|
|
|
|
D07B
|
|
|
Corticosteroids, combinations with antiseptics
|
|
|
|
|
D07BA
|
|
Corticosteroids, weak, combinations with antiseptics
|
|
|
|
|
|
D07BA01
|
Prednisolone and antiseptics
|
|
|
|
|
|
D07BA04
|
Hydrocortisone and antiseptics
|
|
|
|
|
D07BB
|
|
Corticosteroids, moderately potent, combinations with antiseptics
|
|
|
|
|
|
D07BB01
|
Flumetasone and antiseptics
|
|
|
|
|
|
D07BB02
|
Desonide and antiseptics
|
|
|
|
|
|
D07BB03
|
Triamcinolone and antiseptics
|
|
|
|
|
|
D07BB04
|
Hydrocortisone butyrate and antiseptics
|
|
|
|
|
D07BC
|
|
Corticosteroids, potent, combinations with antiseptics
|
|
|
|
|
|
D07BC01
|
Betamethasone and antiseptics
|
|
|
|
|
|
D07BC02
|
Fluocinolone acetonide and antiseptics
|
|
|
|
|
|
D07BC03
|
Fluocortolone and antiseptics
|
|
|
|
|
|
D07BC04
|
Diflucortolone and antiseptics
|
|
|
|
|
D07BD
|
|
Corticosteroids, very potent, combinations with antiseptics
|
|
|
|
|
|
|
empty
|
|
|
|
D07C
|
|
|
Corticosteroids, combinations with antibiotics
|
|
|
|
|
D07CA
|
|
Corticosteroids, weak, combinations with antibiotics
|
|
|
|
|
|
D07CA01
|
Hydrocortisone and antibiotics
|
|
|
|
|
|
D07CA02
|
Methylprednisolone and antibiotics
|
|
|
|
|
|
D07CA03
|
Prednisolone and antibiotics
|
|
|
|
|
D07CB
|
|
Corticosteroids, moderately potent, combinations with antibiotics
|
|
|
|
|
|
D07CB01
|
Triamcinolone and antibiotics
|
|
|
|
|
|
D07CB02
|
Fluprednidene and antibiotics
|
|
|
|
|
|
D07CB03
|
Fluorometholone and antibiotics
|
|
|
|
|
|
D07CB04
|
Dexamethasone and antibiotics
|
|
|
|
|
|
D07CB05
|
Flumetasone and antibiotics
|
|
|
|
|
D07CC
|
|
Corticosteroids, potent, combinations with antibiotics
|
|
|
|
|
|
D07CC01
|
Betamethasone and antibiotics
|
|
|
|
|
|
D07CC02
|
Fluocinolone acetonide and antibiotics
|
|
|
|
|
|
D07CC03
|
Fludroxycortide and antibiotics
|
|
|
|
|
|
D07CC04
|
Beclometasone and antibiotics
|
|
|
|
|
|
D07CC05
|
Fluocinonide and antibiotics
|
|
|
|
|
|
D07CC06
|
Fluocortolone and antibiotics
|
|
|
|
|
D07CD
|
|
Corticosteroids, very potent, combinations with antibiotics
|
|
|
|
|
|
D07CD01
|
Clobetasol and antibiotics
|
|
|
|
D07X
|
|
|
Corticosteroids, other combinations
|
|
|
|
|
D07XA
|
|
Corticosteroids, weak, other combinations
|
|
|
|
|
|
D07XA01
|
Hydrocortisone
|
|
|
|
|
|
D07XA02
|
Prednisolone
|
|
|
|
|
D07XB
|
|
Corticosteroids, moderately potent, other combinations
|
|
|
|
|
|
D07XB01
|
Flumetasone
|
|
|
|
|
|
D07XB02
|
Triamcinolone
|
|
|
|
|
|
D07XB03
|
Fluprednidene
|
|
|
|
|
|
D07XB04
|
Fluorometholone
|
|
|
|
|
|
D07XB05
|
Dexamethasone
|
|
|
|
|
|
D07XB30
|
Combinations of corticosteroids
|
|
|
|
|
D07XC
|
|
Corticosteroids, potent, other combinations
|
|
|
|
|
|
D07XC01
|
Betamethasone
|
|
|
|
|
|
D07XC02
|
Desoximetasone
|
|
|
|
|
|
D07XC03
|
Mometasone
|
|
|
|
|
|
D07XC04
|
Diflucortolone
|
|
|
|
|
D07XD
|
|
Corticosteroids, very potent, other combinations
|
|
|
|
|
|
|
empty
|
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
|
|
D08A
|
|
|
Antiseptics and disinfectants
|
|
|
|
|
D08AA
|
|
Acridine derivatives
|
|
|
|
|
|
D08AA01
|
Ethacridine lactate
|
|
|
|
|
|
D08AA02
|
Aminoacridine
|
|
|
|
|
|
D08AA03
|
Euflavine
|
|
|
|
|
D08AB
|
|
Aluminium agents
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AC
|
|
Biguanides and amidines
|
|
|
|
|
|
D08AC01
|
Dibrompropamidine
|
|
|
|
|
|
D08AC02
|
Chlorhexidine
|
|
|
|
|
|
D08AC03
|
Propamidine
|
|
|
|
|
|
D08AC04
|
Hexamidine
|
|
|
|
|
|
D08AC05
|
Polihexanide
|
|
|
|
|
|
D08AC52
|
Chlorhexidine, combinations
|
|
|
|
|
D08AD
|
|
Boric acid products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AE
|
|
Phenol and derivatives
|
|
|
|
|
|
D08AE01
|
Hexachlorophene
|
|
|
|
|
|
D08AE02
|
Policresulen
|
|
|
|
|
|
D08AE03
|
Phenol
|
|
|
|
|
|
D08AE04
|
Triclosan
|
|
|
|
|
|
D08AE05
|
Chloroxylenol
|
|
|
|
|
|
D08AE06
|
Biphenylol
|
|
|
|
|
D08AF
|
|
Nitrofuran derivatives
|
|
|
|
|
|
D08AF01
|
Nitrofural
|
|
|
|
|
D08AG
|
|
Iodine products
|
|
|
|
|
|
D08AG01
|
Iodine/octylphenoxypolyglycolether
|
|
|
|
|
|
D08AG02
|
Povidone-iodine
|
|
|
|
|
|
D08AG03
|
Iodine
|
|
|
|
|
|
D08AG04
|
Diiodohydroxypropane
|
|
|
|
|
D08AH
|
|
Quinoline derivatives
|
|
|
|
|
|
D08AH01
|
Dequalinium
|
|
|
|
|
|
D08AH02
|
Chlorquinaldol
|
|
|
|
|
|
D08AH03
|
Oxyquinoline
|
|
|
|
|
|
D08AH30
|
Clioquinol
|
|
|
|
|
D08AJ
|
|
Quaternary ammonium compounds
|
|
|
|
|
|
D08AJ01
|
Benzalkonium
|
|
|
|
|
|
D08AJ02
|
Cetrimonium
|
|
|
|
|
|
D08AJ03
|
Cetylpyridinium
|
|
|
|
|
|
D08AJ04
|
Cetrimide
|
|
|
|
|
|
D08AJ05
|
Benzoxonium chloride
|
|
|
|
|
|
D08AJ06
|
Didecyldimethylammonium chloride
|
|
|
|
|
|
D08AJ08
|
Benzethonium chloride
|
|
|
|
|
|
D08AJ57
|
Octenidine, combinations
|
|
|
|
|
|
D08AJ58
|
Benzethonium chloride, combinations
|
|
|
|
|
|
D08AJ59
|
Dodeclonium bromide, combinations
|
|
|
|
|
D08AK
|
|
Mercurial products
|
|
|
|
|
|
D08AK01
|
Mercuric amidochloride
|
|
|
|
|
|
D08AK02
|
Phenylmercuric borate
|
|
|
|
|
|
D08AK03
|
Mercuric chloride
|
|
|
|
|
|
D08AK04
|
Mercurochrome
|
|
|
|
|
|
D08AK05
|
Mercury, metallic
|
|
|
|
|
|
D08AK06
|
Thiomersal
|
|
|
|
|
|
D08AK30
|
Mercuric iodide
|
|
|
|
|
D08AL
|
|
Silver compounds
|
|
|
|
|
|
D08AL01
|
Silver nitrate
|
|
|
|
|
|
D08AL30
|
Silver
|
|
|
|
|
D08AX
|
|
Other antiseptics and disinfectants
|
|
|
|
|
|
D08AX01
|
Hydrogen peroxide
|
|
|
|
|
|
D08AX02
|
Eosin
|
|
|
|
|
|
D08AX03
|
Propanol
|
|
|
|
|
|
D08AX04
|
Tosylchloramide sodium
|
|
|
|
|
|
D08AX05
|
Isopropanol
|
|
|
|
|
|
D08AX06
|
Potassium permanganate
|
|
|
|
|
|
D08AX07
|
Sodium hypochlorite
|
|
|
|
|
|
D08AX08
|
Ethanol
|
|
|
|
|
|
D08AX53
|
Propanol, combinations
|
|
|
D09
|
|
|
|
Medicated dressings
|
|
|
|
D09A
|
|
|
Medicated dressings
|
|
|
|
|
D09AA
|
|
Medicated dressings with antiinfectives
|
|
|
|
|
|
D09AA01
|
Framycetin
|
|
|
|
|
|
D09AA02
|
Fusidic acid
|
|
|
|
|
|
D09AA03
|
Nitrofural
|
|
|
|
|
|
D09AA04
|
Phenylmercuric nitrate
|
|
|
|
|
|
D09AA05
|
Benzododecinium
|
|
|
|
|
|
D09AA06
|
Triclosan
|
|
|
|
|
|
D09AA07
|
Cetylpyridinium
|
|
|
|
|
|
D09AA08
|
Aluminium chlorohydrate
|
|
|
|
|
|
D09AA09
|
Povidone-iodine
|
|
|
|
|
|
D09AA10
|
Clioquinol
|
|
|
|
|
|
D09AA11
|
Benzalkonium
|
|
|
|
|
|
D09AA12
|
Chlorhexidine
|
|
|
|
|
|
D09AA13
|
Iodoform
|
|
|
|
|
D09AB
|
|
Zinc bandages
|
|
|
|
|
|
D09AB01
|
Zinc bandage without supplements
|
|
|
|
|
|
D09AB02
|
Zinc bandage with supplements
|
|
|
|
|
D09AX
|
|
Soft paraffin dressings
|
|
|
|
|
|
|
empty
|
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
|
|
D10A
|
|
|
Anti-acne preparations for topical use
|
|
|
|
|
D10AA
|
|
Corticosteroids, combinations for treatment of acne
|
|
|
|
|
|
D10AA01
|
Fluorometholone
|
|
|
|
|
|
D10AA02
|
Methylprednisolone
|
|
|
|
|
|
D10AA03
|
Dexamethasone
|
|
|
|
|
D10AB
|
|
Preparations containing sulfur
|
|
|
|
|
|
D10AB01
|
Bithionol
|
|
|
|
|
|
D10AB02
|
Sulfur
|
|
|
|
|
|
D10AB03
|
Tioxolone
|
|
|
|
|
|
D10AB05
|
Mesulfen
|
|
|
|
|
D10AD
|
|
Retinoids for topical use in acne
|
|
|
|
|
|
D10AD01
|
Tretinoin
|
|
|
|
|
|
D10AD02
|
Retinol
|
|
|
|
|
|
D10AD03
|
Adapalene
|
|
|
|
|
|
D10AD04
|
Isotretinoin
|
|
|
|
|
|
D10AD05
|
Motretinide
|
|
|
|
|
|
D10AD51
|
Tretinoin, combinations
|
|
|
|
|
|
D10AD53
|
Adapalene, combinations
|
|
|
|
|
|
D10AD54
|
Isotretinoin, combinations
|
|
|
|
|
D10AE
|
|
Peroxides
|
|
|
|
|
|
D10AE01
|
Benzoyl peroxide
|
|
|
|
|
|
D10AE51
|
Benzoyl peroxide, combinations
|
|
|
|
|
D10AF
|
|
Anti-infectives for treatment of acne
|
|
|
|
|
|
D10AF01
|
Clindamycin
|
|
|
|
|
|
D10AF02
|
Erythromycin
|
|
|
|
|
|
D10AF03
|
Chloramphenicol
|
|
|
|
|
|
D10AF04
|
Meclocycline
|
|
|
|
|
|
D10AF51
|
Clindamycin, combinations
|
|
|
|
|
|
D10AF52
|
Erythromycin, combinations
|
|
|
|
|
D10AX
|
|
Other anti-acne preparations for topical use
|
|
|
|
|
|
D10AX01
|
Aluminium chloride
|
|
|
|
|
|
D10AX02
|
Resorcinol
|
|
|
|
|
|
D10AX03
|
Azelaic acid
|
|
|
|
|
|
D10AX04
|
Aluminium oxide
|
|
|
|
|
|
D10AX05
|
Dapsone
|
|
|
|
|
|
D10AX30
|
Various combinations
|
|
|
|
D10B
|
|
|
Anti-acne preparations for systemic use
|
|
|
|
|
D10BA
|
|
Retinoids for treatment of acne
|
|
|
|
|
|
D10BA01
|
Isotretinoin
|
|
|
|
|
D10BX
|
|
Other anti-acne preparations for systemic use
|
|
|
|
|
|
D10BX01
|
Ichtasol
|
|
|
D11
|
|
|
|
Other dermatological preparations
|
|
|
|
D11A
|
|
|
Other dermatological preparations
|
|
|
|
|
D11AA
|
|
Antihidrotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AC
|
|
Medicated shampoos
|
|
|
|
|
|
D11AC01
|
Cetrimide
|
|
|
|
|
|
D11AC02
|
Cadmium compounds
|
|
|
|
|
|
D11AC03
|
Selenium compounds
|
|
|
|
|
|
D11AC06
|
Povidone-iodine
|
|
|
|
|
|
D11AC08
|
Sulfur compounds
|
|
|
|
|
|
D11AC09
|
Xenysalate
|
|
|
|
|
|
D11AC30
|
Others
|
|
|
|
|
D11AE
|
|
Androgens for topical use
|
|
|
|
|
|
D11AE01
|
Metandienone
|
|
|
|
|
D11AF
|
|
Wart and anti-corn preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AH
|
|
Agents for dermatitis, excluding corticosteroids
|
|
|
|
|
|
D11AH01
|
Tacrolimus
|
|
|
|
|
|
D11AH02
|
Pimecrolimus
|
|
|
|
|
|
D11AH03
|
Cromoglicic acid
|
|
|
|
|
|
D11AH04
|
Alitretinoin
|
|
|
|
|
|
D11AH05
|
Dupilumab
|
|
|
|
|
|
D11AH06
|
Crisaborole
|
|
|
|
|
|
D11AH07
|
Tralokinumab
|
|
|
|
|
|
D11AH08
|
abrocitinib
|
|
|
|
|
|
D11AH09
|
ruxolitinib
|
|
|
|
|
|
D11AH10
|
lebrikizumab
|
|
|
|
|
|
D11AH11
|
delgocitinib
|
|
|
|
|
|
D11AH12
|
nemolizumab
|
|
|
|
|
D11AX
|
|
Other dermatologicals
|
|
|
|
|
|
D11AX01
|
Minoxidil
|
|
|
|
|
|
D11AX02
|
Gamolenic acid
|
|
|
|
|
|
D11AX03
|
Calcium gluconate
|
|
|
|
|
|
D11AX04
|
Lithium succinate
|
|
|
|
|
|
D11AX05
|
Magnesium sulfate
|
|
|
|
|
|
D11AX06
|
Mequinol
|
|
|
|
|
|
D11AX08
|
Tiratricol
|
|
|
|
|
|
D11AX09
|
Oxaceprol
|
|
|
|
|
|
D11AX10
|
Finasteride
|
|
|
|
|
|
D11AX11
|
Hydroquinone
|
|
|
|
|
|
D11AX12
|
Pyrithione zinc
|
|
|
|
|
|
D11AX13
|
Monobenzone
|
|
|
|
|
|
D11AX14
|
Tacrolimus (בוטל, קוד חדש D11AH01)
|
|
|
|
|
|
D11AX15
|
Pimecrolimus (בוטל, קוד חדש D11AH02)
|
|
|
|
|
|
D11AX16
|
Eflornithine
|
|
|
|
|
|
D11AX17
|
cromoglicic acid (בוטל, קוד חדש D11AH03)
|
|
|
|
|
|
D11AX18
|
Diclofenac
|
|
|
|
|
|
D11AX19
|
alitretinoin (בוטל, קוד חדש D11AH04)
|
|
|
|
|
|
D11AX52
|
Gamolenic acid, combinations
|
|
|
|
|
|
D11AX57
|
Collagen, combinations
|
| G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
|
|
G01A
|
|
|
Antiinfectives and antiseptics, excluding combinations with corticosteroids
|
|
|
|
|
G01AA
|
|
Antibiotics
|
|
|
|
|
|
G01AA01
|
Nystatin
|
|
|
|
|
|
G01AA02
|
Natamycin
|
|
|
|
|
|
G01AA03
|
Amphotericin B
|
|
|
|
|
|
G01AA04
|
Candicidin
|
|
|
|
|
|
G01AA05
|
Chloramphenicol
|
|
|
|
|
|
G01AA06
|
Hachimycin
|
|
|
|
|
|
G01AA07
|
Oxytetracycline
|
|
|
|
|
|
G01AA08
|
Carfecillin
|
|
|
|
|
|
G01AA09
|
Mepartricin
|
|
|
|
|
|
G01AA10
|
Clindamycin
|
|
|
|
|
|
G01AA11
|
Pentamycin
|
|
|
|
|
|
G01AA51
|
Nystatin, combinations
|
|
|
|
|
G01AB
|
|
Arsenic compounds
|
|
|
|
|
|
G01AB01
|
Acetarsol
|
|
|
|
|
G01AC
|
|
Quinoline derivatives
|
|
|
|
|
|
G01AC01
|
Diiodohydroxyquinoline
|
|
|
|
|
|
G01AC02
|
Clioquinol
|
|
|
|
|
|
G01AC03
|
Chlorquinaldol
|
|
|
|
|
|
G01AC05
|
Dequalinium
|
|
|
|
|
|
G01AC06
|
Broxyquinoline
|
|
|
|
|
|
G01AC30
|
Oxyquinoline
|
|
|
|
|
G01AD
|
|
Organic acids
|
|
|
|
|
|
G01AD01
|
Lactic acid
|
|
|
|
|
|
G01AD02
|
Acetic acid
|
|
|
|
|
|
G01AD03
|
Ascorbic acid
|
|
|
|
|
G01AE
|
|
Sulfonamides
|
|
|
|
|
|
G01AE01
|
Sulfatolamide
|
|
|
|
|
|
G01AE10
|
Combinations of sulfonamides
|
|
|
|
|
G01AF
|
|
Imidazole derivatives
|
|
|
|
|
|
G01AF01
|
Metronidazole
|
|
|
|
|
|
G01AF02
|
Clotrimazole
|
|
|
|
|
|
G01AF04
|
Miconazole
|
|
|
|
|
|
G01AF05
|
Econazole
|
|
|
|
|
|
G01AF06
|
Ornidazole
|
|
|
|
|
|
G01AF07
|
Isoconazole
|
|
|
|
|
|
G01AF08
|
Tioconazole
|
|
|
|
|
|
G01AF11
|
Ketoconazole
|
|
|
|
|
|
G01AF12
|
Fenticonazole
|
|
|
|
|
|
G01AF13
|
Azanidazole
|
|
|
|
|
|
G01AF14
|
Propenidazole
|
|
|
|
|
|
G01AF15
|
Butoconazole
|
|
|
|
|
|
G01AF16
|
Omoconazole
|
|
|
|
|
|
G01AF17
|
Oxiconazole
|
|
|
|
|
|
G01AF18
|
Flutrimazole
|
|
|
|
|
|
G01AF20
|
Combinations of imidazole derivatives
|
|
|
|
|
G01AG
|
|
Triazole derivatives
|
|
|
|
|
|
G01AG02
|
Terconazole
|
|
|
|
|
G01AX
|
|
Other anti-infectives and antiseptics
|
|
|
|
|
|
G01AX01
|
Clodantoin
|
|
|
|
|
|
G01AX02
|
Inosine
|
|
|
|
|
|
G01AX03
|
Policresulen
|
|
|
|
|
|
G01AX05
|
Nifuratel
|
|
|
|
|
|
G01AX06
|
Furazolidone
|
|
|
|
|
|
G01AX09
|
Methylrosaniline
|
|
|
|
|
|
G01AX11
|
Povidone-iodine
|
|
|
|
|
|
G01AX12
|
Ciclopirox
|
|
|
|
|
|
G01AX13
|
Protiofate
|
|
|
|
|
|
G01AX14
|
Lactobacillus fermentum
|
|
|
|
|
|
G01AX15
|
Copper usnate
|
|
|
|
|
|
G01AX66
|
Octenidine, combinations
|
|
|
|
G01B
|
|
|
Antiinfectives/antiseptics in combination with corticosteroids
|
|
|
|
|
G01BA
|
|
Antibiotics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BC
|
|
Quinoline derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BD
|
|
Antiseptics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BE
|
|
Sulfonamides and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BF
|
|
Imidazole derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
G02
|
|
|
|
Other gynecologicals
|
|
|
|
G02A
|
|
|
Oxytocics
|
|
|
|
|
G02AB
|
|
Ergot alkaloids
|
|
|
|
|
|
G02AB01
|
Methylergometrine
|
|
|
|
|
|
G02AB02
|
Ergot alkaloids
|
|
|
|
|
|
G02AB03
|
Ergometrine
|
|
|
|
|
G02AC
|
|
Ergot alkaloids and oxytocin including analogues, in combination
|
|
|
|
|
|
G02AC01
|
Methylergometrine and oxytocin
|
|
|
|
|
G02AD
|
|
Prostaglandins
|
|
|
|
|
|
G02AD01
|
Dinoprost
|
|
|
|
|
|
G02AD02
|
Dinoprostone
|
|
|
|
|
|
G02AD03
|
Gemeprost
|
|
|
|
|
|
G02AD04
|
Carboprost
|
|
|
|
|
|
G02AD05
|
Sulprostone
|
|
|
|
|
|
G02AD06
|
Misoprostol
|
|
|
|
|
G02AX
|
|
Other oxytocics
|
|
|
|
|
|
|
empty
|
|
|
|
G02B
|
|
|
Contraceptives for topical use
|
|
|
|
|
G02BA
|
|
Intrauterine contraceptives
|
|
|
|
|
|
G02BA01
|
Plastic IUD
|
|
|
|
|
|
G02BA02
|
Plastic IUD with copper
|
|
|
|
|
|
G02BA03
|
Plastic IUD with progestogen
|
|
|
|
|
G02BB
|
|
Intravaginal contraceptives
|
|
|
|
|
|
G02BB01
|
Vaginal ring with progestogen and estrogen
|
|
|
|
G02C
|
|
|
Other gynecologicals
|
|
|
|
|
G02CA
|
|
Sympathomimetics, labour repressants
|
|
|
|
|
|
G02CA01
|
Ritodrine
|
|
|
|
|
|
G02CA02
|
Buphenine
|
|
|
|
|
|
G02CA03
|
Fenoterol
|
|
|
|
|
G02CB
|
|
Prolactin inhibitors
|
|
|
|
|
|
G02CB01
|
Bromocriptine
|
|
|
|
|
|
G02CB02
|
Lisuride
|
|
|
|
|
|
G02CB03
|
Cabergoline
|
|
|
|
|
|
G02CB04
|
Quinagolide
|
|
|
|
|
|
G02CB05
|
Metergoline
|
|
|
|
|
|
G02CB06
|
Terguride
|
|
|
|
|
G02CC
|
|
Anti-inflammatory products for vaginal administration
|
|
|
|
|
|
G02CC01
|
Ibuprofen
|
|
|
|
|
|
G02CC02
|
Naproxen
|
|
|
|
|
|
G02CC03
|
Benzydamine
|
|
|
|
|
|
G02CC04
|
Flunoxaprofen
|
|
|
|
|
G02CX
|
|
Other gynecologicals
|
|
|
|
|
|
G02CX01
|
Atosiban
|
|
|
|
|
|
G02CX02
|
flibanserin
|
|
|
|
|
|
G02CX03
|
Agni casti fructus
|
|
|
|
|
|
G02CX04
|
Cimicifugae rhizoma
|
|
|
|
|
|
G02CX05
|
bremelanotide
|
|
|
|
|
|
G02CX06
|
fezolinetant
|
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
|
|
G03A
|
|
|
Hormonal contraceptives for systemic use
|
|
|
|
|
G03AA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03AA01
|
Etynodiol and ethinylestradiol
|
|
|
|
|
|
G03AA02
|
Quingestanol and ethinylestradiol
|
|
|
|
|
|
G03AA03
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AA04
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AA05
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AA06
|
Norgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA07
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA08
|
Medroxyprogesterone and ethinylestradiol
|
|
|
|
|
|
G03AA09
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AA10
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AA11
|
Norgestimate and ethinylestradiol
|
|
|
|
|
|
G03AA12
|
Drospirenone and ethinylestradiol
|
|
|
|
|
|
G03AA13
|
Norelgestromin and ethinylestradiol
|
|
|
|
|
|
G03AA14
|
Nomegestrol and estradiol
|
|
|
|
|
|
G03AA15
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
G03AB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03AB01
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AB02
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AB03
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AB04
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AB05
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AB06
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AB07
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
|
G03AB08
|
Dienogest and estradiol
|
|
|
|
|
G03AC
|
|
Progestogens
|
|
|
|
|
|
G03AC01
|
Norethisterone
|
|
|
|
|
|
G03AC02
|
Lynestrenol
|
|
|
|
|
|
G03AC03
|
Levonorgestrel (בוטל, קוד חדש G03AD01)
|
|
|
|
|
|
G03AC04
|
Quingestanol
|
|
|
|
|
|
G03AC05
|
Megestrol
|
|
|
|
|
|
G03AC06
|
Medroxyprogesterone
|
|
|
|
|
|
G03AC07
|
Norgestrienone
|
|
|
|
|
|
G03AC08
|
Etonogestrel
|
|
|
|
|
|
G03AC09
|
Desogestrel
|
|
|
|
|
G03AD
|
|
Emergency contraceptives
|
|
|
|
|
|
G03AD01
|
Levonorgestrel
|
|
|
|
|
|
G03AD02
|
Ulipristal
|
|
|
|
G03B
|
|
|
Androgens
|
|
|
|
|
G03BA
|
|
3-oxoandrosten-(4) derivatives
|
|
|
|
|
|
G03BA01
|
Fluoxymesterone
|
|
|
|
|
|
G03BA02
|
Methyltestosterone
|
|
|
|
|
|
G03BA03
|
Testosterone
|
|
|
|
|
G03BB
|
|
5-androstanon-(3) derivatives
|
|
|
|
|
|
G03BB01
|
Mesterolone
|
|
|
|
|
|
G03BB02
|
Androstanolone
|
|
|
|
G03C
|
|
|
Estrogens
|
|
|
|
|
G03CA
|
|
Natural and semisynthetic estrogens, plain
|
|
|
|
|
|
G03CA01
|
Ethinylestradiol
|
|
|
|
|
|
G03CA03
|
Estradiol
|
|
|
|
|
|
G03CA04
|
Estriol
|
|
|
|
|
|
G03CA06
|
Chlorotrianisene
|
|
|
|
|
|
G03CA07
|
Estrone
|
|
|
|
|
|
G03CA09
|
Promestriene
|
|
|
|
|
|
G03CA53
|
Estradiol, combinations
|
|
|
|
|
|
G03CA57
|
Conjugated estrogens
|
|
|
|
|
G03CB
|
|
Synthetic estrogens, plain
|
|
|
|
|
|
G03CB01
|
Dienestrol
|
|
|
|
|
|
G03CB02
|
Diethylstilbestrol
|
|
|
|
|
|
G03CB03
|
Methallenestril
|
|
|
|
|
|
G03CB04
|
Moxestrol
|
|
|
|
|
G03CC
|
|
Estrogens, combinations with other drugs
|
|
|
|
|
|
G03CC02
|
Dienestrol
|
|
|
|
|
|
G03CC03
|
Methallenestril
|
|
|
|
|
|
G03CC04
|
Estrone
|
|
|
|
|
|
G03CC05
|
Diethylstilbestrol
|
|
|
|
|
|
G03CC06
|
Estriol
|
|
|
|
|
G03CX
|
|
Other estrogens
|
|
|
|
|
|
G03CX01
|
Tibolone
|
|
|
|
G03D
|
|
|
Progestogens
|
|
|
|
|
G03DA
|
|
Pregnen-(4) derivatives
|
|
|
|
|
|
G03DA01
|
Gestonorone
|
|
|
|
|
|
G03DA02
|
Medroxyprogesterone
|
|
|
|
|
|
G03DA03
|
Hydroxyprogesterone
|
|
|
|
|
|
G03DA04
|
Progesterone
|
|
|
|
|
G03DB
|
|
Pregnadien derivatives
|
|
|
|
|
|
G03DB01
|
Dydrogesterone
|
|
|
|
|
|
G03DB02
|
Megestrol
|
|
|
|
|
|
G03DB03
|
Medrogestone
|
|
|
|
|
|
G03DB04
|
Nomegestrol
|
|
|
|
|
|
G03DB05
|
Demegestone
|
|
|
|
|
|
G03DB06
|
Chlormadinone
|
|
|
|
|
|
G03DB07
|
Promegestone
|
|
|
|
|
|
G03DB08
|
Dienogest
|
|
|
|
|
G03DC
|
|
Estren derivatives
|
|
|
|
|
|
G03DC01
|
Allylestrenol
|
|
|
|
|
|
G03DC02
|
Norethisterone
|
|
|
|
|
|
G03DC03
|
Lynestrenol
|
|
|
|
|
|
G03DC04
|
Ethisterone
|
|
|
|
|
|
G03DC05
|
Tibolone (בוטל, קוד חדש G03CX01)
|
|
|
|
|
|
G03DC06
|
Etynodiol
|
|
|
|
|
|
G03DC31
|
Methylestrenolone
|
|
|
|
G03E
|
|
|
Androgens and female sex hormones in combination
|
|
|
|
|
G03EA
|
|
Androgens and estrogens
|
|
|
|
|
|
G03EA01
|
Methyltestosterone and estrogen
|
|
|
|
|
|
G03EA02
|
Testosterone and estrogen
|
|
|
|
|
|
G03EA03
|
Prasterone and estrogen
|
|
|
|
|
G03EB
|
|
Androgen, progestogen and estrogen in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
G03EK
|
|
Androgens and female sex hormones in combination with other drugs
|
|
|
|
|
|
G03EK01
|
Methyltestosterone
|
|
|
|
G03F
|
|
|
Progestogens and estrogens in combination
|
|
|
|
|
G03FA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03FA01
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FA02
|
Hydroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA03
|
Ethisterone and estrogen
|
|
|
|
|
|
G03FA04
|
Progesterone and estrogen
|
|
|
|
|
|
G03FA05
|
Methylnortestosterone and estrogen
|
|
|
|
|
|
G03FA06
|
Etynodiol and estrogen
|
|
|
|
|
|
G03FA07
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FA08
|
Megestrol and estrogen
|
|
|
|
|
|
G03FA09
|
Noretynodrel and estrogen
|
|
|
|
|
|
G03FA10
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FA11
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FA12
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA13
|
Norgestimate and estrogen
|
|
|
|
|
|
G03FA14
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FA15
|
Dienogest and estrogen
|
|
|
|
|
|
G03FA16
|
Trimegestone and estrogen
|
|
|
|
|
|
G03FA17
|
Drospirenone and estrogen
|
|
|
|
|
G03FB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03FB01
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FB02
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FB03
|
Chlormadinone and estrogen
|
|
|
|
|
|
G03FB04
|
Megestrol and estrogen
|
|
|
|
|
|
G03FB05
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FB06
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FB07
|
Medrogestone and estrogen
|
|
|
|
|
|
G03FB08
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FB09
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FB10
|
Desogestrel and estrogen
|
|
|
|
|
|
G03FB11
|
Trimegestone and estrogen
|
|
|
|
G03G
|
|
|
Gonadotropins and other ovulation stimulants
|
|
|
|
|
G03GA
|
|
Gonadotropins
|
|
|
|
|
|
G03GA01
|
chorionic gonadotrophin
|
|
|
|
|
|
G03GA02
|
Human menopausal gonadotropin
|
|
|
|
|
|
G03GA03
|
Serum gonadotropin
|
|
|
|
|
|
G03GA04
|
Urofollitropin
|
|
|
|
|
|
G03GA05
|
Follitropin alfa
|
|
|
|
|
|
G03GA06
|
Follitropin beta
|
|
|
|
|
|
G03GA07
|
Lutropin alfa
|
|
|
|
|
|
G03GA08
|
Choriogonadotropin alfa
|
|
|
|
|
|
G03GA09
|
Corifollitropin alfa
|
|
|
|
|
|
G03GA10
|
follitropin delta
|
|
|
|
|
|
G03GA30
|
Combinations
|
|
|
|
|
G03GB
|
|
Ovulation stimulants, synthetic
|
|
|
|
|
|
G03GB01
|
Cyclofenil
|
|
|
|
|
|
G03GB02
|
Clomifene
|
|
|
|
|
|
G03GB03
|
Epimestrol
|
|
|
|
G03H
|
|
|
Antiandrogens
|
|
|
|
|
G03HA
|
|
Antiandrogens, plain
|
|
|
|
|
|
G03HA01
|
Cyproterone
|
|
|
|
|
G03HB
|
|
Antiandrogens and estrogens
|
|
|
|
|
|
G03HB01
|
Cyproterone and estrogen
|
|
|
|
G03X
|
|
|
Other sex hormones and modulators of the genital system
|
|
|
|
|
G03XA
|
|
Antigonadotropins and similar agents
|
|
|
|
|
|
G03XA01
|
Danazol
|
|
|
|
|
|
G03XA02
|
Gestrinone
|
|
|
|
|
G03XB
|
|
Antiprogestogens
|
|
|
|
|
|
G03XB01
|
Mifepristone
|
|
|
|
|
G03XC
|
|
Selective estrogen receptor modulators
|
|
|
|
|
|
G03XC01
|
Raloxifene
|
|
|
|
|
|
G03XC02
|
Bazedoxifene
|
|
|
|
|
|
G03XC03
|
Lasofoxifene
|
|
|
|
|
|
G03XC04
|
Ormeloxifene
|
|
|
G04
|
|
|
|
Urologicals
|
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
|
|
G04BA01
|
Ammonium chloride
|
|
|
|
|
|
G04BA03
|
Calcium chloride
|
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
|
|
|
empty
|
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
|
G04BE05
|
phentolamine (בוטל, קוד חדש V03AB36)
|
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
G04BX01
|
Magnesium hydroxide
|
|
|
|
|
|
G04BX03
|
Acetohydroxamic acid
|
|
|
|
|
|
G04BX06
|
Phenazopyridine
|
|
|
|
|
|
G04BX10
|
Succinimide
|
|
|
|
|
|
G04BX11
|
Collagen
|
|
|
|
|
|
G04BX12
|
Phenyl salicylate
|
|
|
|
|
|
G04BX13
|
Dimethyl sulfoxide
|
|
|
|
|
|
G04BX14
|
Dapoxetine
|
|
|
|
|
|
G04BX15
|
Pentosan polysulfate sodium
|
|
|
|
|
|
G04BX16
|
tiopronin
|
|
|
|
|
|
G04BX17
|
sodium salicylate and methenamine
|
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
G04CA01
|
Alfuzosin
|
|
|
|
|
|
G04CA02
|
Tamsulosin
|
|
|
|
|
|
G04CA03
|
Terazosin
|
|
|
|
|
|
G04CA04
|
Silodosin
|
|
|
|
|
|
G04CA51
|
Alfuzosin and finasteride
|
|
|
|
|
|
G04CA52
|
Tamsulosin and dutasteride
|
|
|
|
|
|
G04CA53
|
Tamsulosin and solifenacin
|
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
|
|
G04CB01
|
Finasteride
|
|
|
|
|
|
G04CB02
|
Dutasteride
|
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
|
|
|
|
|
G04CX01
|
Prunus africanae cortex
|
|
|
|
|
|
G04CX02
|
Sabalis serrulatae fructus
|
|
|
|
|
|
G04CX03
|
Mepartricin
|
|
|
|
|
|
G04CX04
|
fexapotide
|
| H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
|
|
H01A
|
|
|
Anterior pituitary lobe hormones and analogues
|
|
|
|
|
H01AA
|
|
Adrenocorticotropic hormone
|
|
|
|
|
|
H01AA01
|
Corticotropin
|
|
|
|
|
|
H01AA02
|
Tetracosactide
|
|
|
|
|
H01AB
|
|
Thyrotropin
|
|
|
|
|
|
H01AB01
|
Thyrotropin
|
|
|
|
|
H01AC
|
|
Somatropin and somatropin agonists
|
|
|
|
|
|
H01AC01
|
Somatropin
|
|
|
|
|
|
H01AC02
|
Somatrem
|
|
|
|
|
|
H01AC03
|
Mecasermin
|
|
|
|
|
|
H01AC04
|
Sermorelin
|
|
|
|
|
|
H01AC05
|
Mecasermin rinfabate
|
|
|
|
|
|
H01AC06
|
Tesamorelin
|
|
|
|
|
H01AX
|
|
Other anterior pituitary lobe hormones and analogues
|
|
|
|
|
|
H01AX01
|
Pegvisomant
|
|
|
|
H01B
|
|
|
Posterior pituitary lobe hormones
|
|
|
|
|
H01BA
|
|
Vasopressin and analogues
|
|
|
|
|
|
H01BA01
|
vasopressin (argipressin)
|
|
|
|
|
|
H01BA02
|
Desmopressin
|
|
|
|
|
|
H01BA03
|
Lypressin
|
|
|
|
|
|
H01BA04
|
Terlipressin
|
|
|
|
|
|
H01BA05
|
Ornipressin
|
|
|
|
|
|
H01BA06
|
Argipressin (בוטל)
|
|
|
|
|
H01BB
|
|
Oxytocin and analogues
|
|
|
|
|
|
H01BB01
|
Demoxytocin
|
|
|
|
|
|
H01BB02
|
Oxytocin
|
|
|
|
|
|
H01BB03
|
Carbetocin
|
|
|
|
H01C
|
|
|
Hypothalamic hormones
|
|
|
|
|
H01CA
|
|
Gonadotropin-releasing hormones
|
|
|
|
|
|
H01CA01
|
Gonadorelin
|
|
|
|
|
|
H01CA02
|
Nafarelin
|
|
|
|
|
|
H01CA03
|
histrelin (בוטל, קוד חדש L02AE05)
|
|
|
|
|
H01CB
|
|
Somatostatin and analogues
|
|
|
|
|
|
H01CB01
|
Somatostatin
|
|
|
|
|
|
H01CB02
|
Octreotide
|
|
|
|
|
|
H01CB03
|
Lanreotide
|
|
|
|
|
|
H01CB04
|
Vapreotide
|
|
|
|
|
|
H01CB05
|
Pasireotide
|
|
|
|
|
H01CC
|
|
Anti-gonadotropin-releasing hormones
|
|
|
|
|
|
H01CC01
|
Ganirelix
|
|
|
|
|
|
H01CC02
|
Cetrorelix
|
|
|
|
|
|
H01CC03
|
elagolix
|
|
|
|
|
|
H01CC54
|
relugolix, estradiol and norethisterone
|
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
|
|
H02A
|
|
|
Corticosteroids for systemic use, plain
|
|
|
|
|
H02AA
|
|
Mineralocorticoids
|
|
|
|
|
|
H02AA01
|
Aldosterone
|
|
|
|
|
|
H02AA02
|
Fludrocortisone
|
|
|
|
|
|
H02AA03
|
Desoxycortone
|
|
|
|
|
H02AB
|
|
Glucocorticoids
|
|
|
|
|
|
H02AB01
|
Betamethasone
|
|
|
|
|
|
H02AB02
|
Dexamethasone
|
|
|
|
|
|
H02AB03
|
Fluocortolone
|
|
|
|
|
|
H02AB04
|
Methylprednisolone
|
|
|
|
|
|
H02AB05
|
Paramethasone
|
|
|
|
|
|
H02AB06
|
Prednisolone
|
|
|
|
|
|
H02AB07
|
Prednisone
|
|
|
|
|
|
H02AB08
|
Triamcinolone
|
|
|
|
|
|
H02AB09
|
Hydrocortisone
|
|
|
|
|
|
H02AB10
|
Cortisone
|
|
|
|
|
|
H02AB11
|
Prednylidene
|
|
|
|
|
|
H02AB12
|
Rimexolone
|
|
|
|
|
|
H02AB13
|
Deflazacort
|
|
|
|
|
|
H02AB14
|
Cloprednol
|
|
|
|
|
|
H02AB15
|
Meprednisone
|
|
|
|
|
|
H02AB17
|
Cortivazol
|
|
|
|
H02B
|
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
H02BX
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
|
H02BX01
|
Methylprednisolone, combinations
|
|
|
|
H02C
|
|
|
Antiadrenal preparations
|
|
|
|
|
H02CA
|
|
Anticorticosteroids
|
|
|
|
|
|
H02CA01
|
Trilostane
|
|
|
H03
|
|
|
|
Thyroid therapy
|
|
|
|
H03A
|
|
|
Thyroid preparations
|
|
|
|
|
H03AA
|
|
Thyroid hormones
|
|
|
|
|
|
H03AA01
|
Levothyroxine sodium
|
|
|
|
|
|
H03AA02
|
Liothyronine sodium
|
|
|
|
|
|
H03AA03
|
Combinations of levothyroxine and liothyronine
|
|
|
|
|
|
H03AA04
|
Tiratricol
|
|
|
|
|
|
H03AA05
|
Thyroid gland preparations
|
|
|
|
H03B
|
|
|
Antithyroid preparations
|
|
|
|
|
H03BA
|
|
Thiouracils
|
|
|
|
|
|
H03BA01
|
Methylthiouracil
|
|
|
|
|
|
H03BA02
|
Propylthiouracil
|
|
|
|
|
|
H03BA03
|
Benzylthiouracil
|
|
|
|
|
H03BB
|
|
Sulphur-containing imidazole derivatives
|
|
|
|
|
|
H03BB01
|
Carbimazole
|
|
|
|
|
|
H03BB02
|
Thiamazole
|
|
|
|
|
|
H03BB52
|
Thiamazole, combinations
|
|
|
|
|
H03BC
|
|
Perchlorates
|
|
|
|
|
|
H03BC01
|
Potassium perchlorate
|
|
|
|
|
H03BX
|
|
Other antithyroid preparations
|
|
|
|
|
|
H03BX01
|
Diiodotyrosine
|
|
|
|
|
|
H03BX02
|
Dibromotyrosine
|
|
|
|
H03C
|
|
|
Iodine therapy
|
|
|
|
|
H03CA
|
|
Iodine therapy
|
|
|
|
|
|
|
empty
|
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
|
|
H04A
|
|
|
Glycogenolytic hormones
|
|
|
|
|
H04AA
|
|
Glycogenolytic hormones
|
|
|
|
|
|
H04AA01
|
Glucagon
|
|
|
H05
|
|
|
|
Calcium homeostasis
|
|
|
|
H05A
|
|
|
Parathyroid hormones and analogues
|
|
|
|
|
H05AA
|
|
Parathyroid hormones and analogues
|
|
|
|
|
|
H05AA01
|
Parathyroid gland extract
|
|
|
|
|
|
H05AA02
|
Teriparatide
|
|
|
|
|
|
H05AA03
|
Parathyroid hormone
|
|
|
|
H05B
|
|
|
Anti-parathyroid agents
|
|
|
|
|
H05BA
|
|
Calcitonin preparations
|
|
|
|
|
|
H05BA01
|
Calcitonin (salmon synthetic)
|
|
|
|
|
|
H05BA02
|
Calcitonin (pork natural)
|
|
|
|
|
|
H05BA03
|
Calcitonin (human synthetic)
|
|
|
|
|
|
H05BA04
|
Elcatonin
|
|
|
|
|
H05BX
|
|
Other anti-parathyroid agents
|
|
|
|
|
|
H05BX01
|
Cinacalcet
|
|
|
|
|
|
H05BX02
|
Paricalcitol
|
|
|
|
|
|
H05BX03
|
Doxercalciferol
|
| J
|
|
|
|
|
Antiinfectives for systemic use
|
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
|
|
J01AA
|
|
Tetracyclines
|
|
|
|
|
|
J01AA01
|
Demeclocycline
|
|
|
|
|
|
J01AA02
|
Doxycycline
|
|
|
|
|
|
J01AA03
|
Chlortetracycline
|
|
|
|
|
|
J01AA04
|
Lymecycline
|
|
|
|
|
|
J01AA05
|
Metacycline
|
|
|
|
|
|
J01AA06
|
Oxytetracycline
|
|
|
|
|
|
J01AA07
|
Tetracycline
|
|
|
|
|
|
J01AA08
|
Minocycline
|
|
|
|
|
|
J01AA09
|
Rolitetracycline
|
|
|
|
|
|
J01AA10
|
Penimepicycline
|
|
|
|
|
|
J01AA11
|
Clomocycline
|
|
|
|
|
|
J01AA12
|
Tigecycline
|
|
|
|
|
|
J01AA20
|
Combinations of tetracyclines
|
|
|
|
|
|
J01AA56
|
Oxytetracycline, combinations
|
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
|
|
J01BA
|
|
Amphenicols
|
|
|
|
|
|
J01BA01
|
Chloramphenicol
|
|
|
|
|
|
J01BA02
|
Thiamphenicol
|
|
|
|
|
|
J01BA52
|
Thiamphenicol, combinations
|
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
|
|
J01CA
|
|
Penicillins with extended spectrum
|
|
|
|
|
|
J01CA01
|
Ampicillin
|
|
|
|
|
|
J01CA02
|
Pivampicillin
|
|
|
|
|
|
J01CA03
|
Carbenicillin
|
|
|
|
|
|
J01CA04
|
Amoxicillin
|
|
|
|
|
|
J01CA05
|
Carindacillin
|
|
|
|
|
|
J01CA06
|
Bacampicillin
|
|
|
|
|
|
J01CA07
|
Epicillin
|
|
|
|
|
|
J01CA08
|
Pivmecillinam
|
|
|
|
|
|
J01CA09
|
Azlocillin
|
|
|
|
|
|
J01CA10
|
Mezlocillin
|
|
|
|
|
|
J01CA11
|
Mecillinam
|
|
|
|
|
|
J01CA12
|
Piperacillin
|
|
|
|
|
|
J01CA13
|
Ticarcillin
|
|
|
|
|
|
J01CA14
|
Metampicillin
|
|
|
|
|
|
J01CA15
|
Talampicillin
|
|
|
|
|
|
J01CA16
|
Sulbenicillin
|
|
|
|
|
|
J01CA17
|
Temocillin
|
|
|
|
|
|
J01CA18
|
Hetacillin
|
|
|
|
|
|
J01CA19
|
Aspoxicillin
|
|
|
|
|
|
J01CA20
|
Combinations
|
|
|
|
|
|
J01CA51
|
Ampicillin, combinations
|
|
|
|
|
J01CE
|
|
Beta-lactamase-sensitive penicillins
|
|
|
|
|
|
J01CE01
|
Benzylpenicillin
|
|
|
|
|
|
J01CE02
|
Phenoxymethylpenicillin
|
|
|
|
|
|
J01CE03
|
Propicillin
|
|
|
|
|
|
J01CE04
|
Azidocillin
|
|
|
|
|
|
J01CE05
|
Pheneticillin
|
|
|
|
|
|
J01CE06
|
Penamecillin
|
|
|
|
|
|
J01CE07
|
Clometocillin
|
|
|
|
|
|
J01CE08
|
Benzathine benzylpenicillin
|
|
|
|
|
|
J01CE09
|
Procaine benzylpenicillin
|
|
|
|
|
|
J01CE10
|
Benzathine phenoxymethylpenicillin
|
|
|
|
|
|
J01CE30
|
Combinations
|
|
|
|
|
J01CF
|
|
Beta-lactamase-resistant penicillins
|
|
|
|
|
|
J01CF01
|
Dicloxacillin
|
|
|
|
|
|
J01CF02
|
Cloxacillin
|
|
|
|
|
|
J01CF03
|
Methicillin
|
|
|
|
|
|
J01CF04
|
Oxacillin
|
|
|
|
|
|
J01CF05
|
Flucloxacillin
|
|
|
|
|
|
J01CF06
|
Nafcillin
|
|
|
|
|
J01CG
|
|
Beta-lactamase inhibitors
|
|
|
|
|
|
J01CG01
|
Sulbactam
|
|
|
|
|
|
J01CG02
|
Tazobactam
|
|
|
|
|
J01CR
|
|
Combinations of penicillins, including beta-lactamase inhibitors
|
|
|
|
|
|
J01CR01
|
Ampicillin and enzyme inhibitor
|
|
|
|
|
|
J01CR02
|
Amoxicillin and enzyme inhibitor
|
|
|
|
|
|
J01CR03
|
Ticarcillin and enzyme inhibitor
|
|
|
|
|
|
J01CR04
|
Sultamicillin
|
|
|
|
|
|
J01CR05
|
Piperacillin and enzyme inhibitor
|
|
|
|
|
|
J01CR50
|
Combinations of penicillins
|
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
|
|
J01DB
|
|
First-generation cephalosporins
|
|
|
|
|
|
J01DB01
|
Cefalexin
|
|
|
|
|
|
J01DB02
|
Cefaloridine
|
|
|
|
|
|
J01DB03
|
Cefalotin
|
|
|
|
|
|
J01DB04
|
Cefazolin
|
|
|
|
|
|
J01DB05
|
Cefadroxil
|
|
|
|
|
|
J01DB06
|
Cefazedone
|
|
|
|
|
|
J01DB07
|
Cefatrizine
|
|
|
|
|
|
J01DB08
|
Cefapirin
|
|
|
|
|
|
J01DB09
|
Cefradine
|
|
|
|
|
|
J01DB10
|
Cefacetrile
|
|
|
|
|
|
J01DB11
|
Cefroxadine
|
|
|
|
|
|
J01DB12
|
Ceftezole
|
|
|
|
|
J01DC
|
|
Second-generation cephalosporins
|
|
|
|
|
|
J01DC01
|
Cefoxitin
|
|
|
|
|
|
J01DC02
|
Cefuroxime
|
|
|
|
|
|
J01DC03
|
Cefamandole
|
|
|
|
|
|
J01DC04
|
Cefaclor
|
|
|
|
|
|
J01DC05
|
Cefotetan
|
|
|
|
|
|
J01DC06
|
Cefonicide
|
|
|
|
|
|
J01DC07
|
Cefotiam
|
|
|
|
|
|
J01DC08
|
Loracarbef
|
|
|
|
|
|
J01DC09
|
Cefmetazole
|
|
|
|
|
|
J01DC10
|
Cefprozil
|
|
|
|
|
|
J01DC11
|
Ceforanide
|
|
|
|
|
|
J01DC12
|
Cefminox
|
|
|
|
|
|
J01DC13
|
Cefbuperazone
|
|
|
|
|
|
J01DC14
|
Flomoxef
|
|
|
|
|
J01DD
|
|
Third-generation cephalosporins
|
|
|
|
|
|
J01DD01
|
Cefotaxime
|
|
|
|
|
|
J01DD02
|
Ceftazidime
|
|
|
|
|
|
J01DD03
|
Cefsulodin
|
|
|
|
|
|
J01DD04
|
Ceftriaxone
|
|
|
|
|
|
J01DD05
|
Cefmenoxime
|
|
|
|
|
|
J01DD06
|
Latamoxef
|
|
|
|
|
|
J01DD07
|
Ceftizoxime
|
|
|
|
|
|
J01DD08
|
Cefixime
|
|
|
|
|
|
J01DD09
|
Cefodizime
|
|
|
|
|
|
J01DD10
|
Cefetamet
|
|
|
|
|
|
J01DD11
|
Cefpiramide
|
|
|
|
|
|
J01DD12
|
Cefoperazone
|
|
|
|
|
|
J01DD13
|
Cefpodoxime
|
|
|
|
|
|
J01DD14
|
Ceftibuten
|
|
|
|
|
|
J01DD15
|
Cefdinir
|
|
|
|
|
|
J01DD16
|
Cefditoren
|
|
|
|
|
|
J01DD17
|
Cefcapene
|
|
|
|
|
|
J01DD18
|
cefteram
|
|
|
|
|
|
J01DD51
|
cefotaxime and beta-lactamase inhibitor
|
|
|
|
|
|
J01DD52
|
ceftazidime and beta-lactamase inhibitor
|
|
|
|
|
|
J01DD54
|
Ceftriaxone, combinations (בוטל, קוד חדש J01DD63)
|
|
|
|
|
|
J01DD62
|
Cefoperazone, combinations
|
|
|
|
|
|
J01DD63
|
ceftriaxone and beta-lactamase inhibitor
|
|
|
|
|
|
J01DD64
|
cefpodoxime and beta-lactamase inhibitor
|
|
|
|
|
J01DE
|
|
Fourth-generation cephalosporins
|
|
|
|
|
|
J01DE01
|
Cefepime
|
|
|
|
|
|
J01DE02
|
Cefpirome
|
|
|
|
|
|
J01DE03
|
Cefozopran
|
|
|
|
|
J01DF
|
|
Monobactams
|
|
|
|
|
|
J01DF01
|
Aztreonam
|
|
|
|
|
|
J01DF02
|
Carumonam
|
|
|
|
|
J01DH
|
|
Carbapenems
|
|
|
|
|
|
J01DH02
|
Meropenem
|
|
|
|
|
|
J01DH03
|
Ertapenem
|
|
|
|
|
|
J01DH04
|
Doripenem
|
|
|
|
|
|
J01DH05
|
Biapenem
|
|
|
|
|
|
J01DH06
|
tebipenem pivoxil
|
|
|
|
|
|
J01DH51
|
Imipenem and enzyme inhibitor
|
|
|
|
|
|
J01DH52
|
meropenem and vaborbactam
|
|
|
|
|
|
J01DH55
|
Panipenem and betamipron
|
|
|
|
|
|
J01DH56
|
imipenem, cilastatin and relebactam
|
|
|
|
|
J01DI
|
|
Other cephalosporins and penems
|
|
|
|
|
|
J01DI01
|
Ceftobiprole medocaril
|
|
|
|
|
|
J01DI02
|
Ceftaroline fosamil
|
|
|
|
|
|
J01DI03
|
Faropenem
|
|
|
|
|
|
J01DI04
|
cefiderocol
|
|
|
|
|
|
J01DI54
|
ceftolozane and beta-lactamase inhibitor
|
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
|
|
|
|
|
J01EA
|
|
Trimethoprim and derivatives
|
|
|
|
|
|
J01EA01
|
Trimethoprim
|
|
|
|
|
|
J01EA02
|
Brodimoprim
|
|
|
|
|
|
J01EA03
|
Iclaprim
|
|
|
|
|
J01EB
|
|
Short-acting sulfonamides
|
|
|
|
|
|
J01EB01
|
Sulfaisodimidine
|
|
|
|
|
|
J01EB02
|
Sulfamethizole
|
|
|
|
|
|
J01EB03
|
Sulfadimidine
|
|
|
|
|
|
J01EB04
|
Sulfapyridine
|
|
|
|
|
|
J01EB05
|
Sulfafurazole
|
|
|
|
|
|
J01EB06
|
Sulfanilamide
|
|
|
|
|
|
J01EB07
|
Sulfathiazole
|
|
|
|
|
|
J01EB08
|
Sulfathiourea
|
|
|
|
|
|
J01EB20
|
Combinations
|
|
|
|
|
J01EC
|
|
Intermediate-acting sulfonamides
|
|
|
|
|
|
J01EC01
|
Sulfamethoxazole
|
|
|
|
|
|
J01EC02
|
Sulfadiazine
|
|
|
|
|
|
J01EC03
|
Sulfamoxole
|
|
|
|
|
|
J01EC20
|
Combinations
|
|
|
|
|
J01ED
|
|
Long-acting sulfonamides
|
|
|
|
|
|
J01ED01
|
Sulfadimethoxine
|
|
|
|
|
|
J01ED02
|
Sulfalene
|
|
|
|
|
|
J01ED03
|
Sulfametomidine
|
|
|
|
|
|
J01ED04
|
Sulfametoxydiazine
|
|
|
|
|
|
J01ED05
|
Sulfamethoxypyridazine
|
|
|
|
|
|
J01ED06
|
Sulfaperin
|
|
|
|
|
|
J01ED07
|
Sulfamerazine
|
|
|
|
|
|
J01ED08
|
Sulfaphenazole
|
|
|
|
|
|
J01ED09
|
Sulfamazon
|
|
|
|
|
|
J01ED20
|
Combinations
|
|
|
|
|
J01EE
|
|
Combinations of sulfonamides and trimethoprim, including derivatives
|
|
|
|
|
|
J01EE01
|
Sulfamethoxazole and trimethoprim
|
|
|
|
|
|
J01EE02
|
Sulfadiazine and trimethoprim
|
|
|
|
|
|
J01EE03
|
Sulfametrole and trimethoprim
|
|
|
|
|
|
J01EE04
|
Sulfamoxole and trimethoprim
|
|
|
|
|
|
J01EE05
|
Sulfadimidine and trimethoprim
|
|
|
|
|
|
J01EE06
|
Sulfadiazine and tetroxoprim
|
|
|
|
|
|
J01EE07
|
Sulfamerazine and trimethoprim
|
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
|
|
|
|
|
J01FA
|
|
Macrolides
|
|
|
|
|
|
J01FA01
|
Erythromycin
|
|
|
|
|
|
J01FA02
|
Spiramycin
|
|
|
|
|
|
J01FA03
|
Midecamycin
|
|
|
|
|
|
J01FA05
|
Oleandomycin
|
|
|
|
|
|
J01FA06
|
Roxithromycin
|
|
|
|
|
|
J01FA07
|
Josamycin
|
|
|
|
|
|
J01FA08
|
Troleandomycin
|
|
|
|
|
|
J01FA09
|
Clarithromycin
|
|
|
|
|
|
J01FA10
|
Azithromycin
|
|
|
|
|
|
J01FA11
|
Miocamycin
|
|
|
|
|
|
J01FA12
|
Rokitamycin
|
|
|
|
|
|
J01FA13
|
Dirithromycin
|
|
|
|
|
|
J01FA14
|
Flurithromycin
|
|
|
|
|
|
J01FA15
|
Telithromycin
|
|
|
|
|
J01FF
|
|
Lincosamides
|
|
|
|
|
|
J01FF01
|
Clindamycin
|
|
|
|
|
|
J01FF02
|
Lincomycin
|
|
|
|
|
J01FG
|
|
Streptogramins
|
|
|
|
|
|
J01FG01
|
Pristinamycin
|
|
|
|
|
|
J01FG02
|
Quinupristin/dalfopristin
|
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
|
|
|
|
|
J01GA
|
|
Streptomycins
|
|
|
|
|
|
J01GA01
|
Streptomycin
|
|
|
|
|
|
J01GA02
|
Streptoduocin
|
|
|
|
|
J01GB
|
|
Other aminoglycosides
|
|
|
|
|
|
J01GB01
|
Tobramycin
|
|
|
|
|
|
J01GB03
|
Gentamicin
|
|
|
|
|
|
J01GB04
|
Kanamycin
|
|
|
|
|
|
J01GB05
|
Neomycin
|
|
|
|
|
|
J01GB06
|
Amikacin
|
|
|
|
|
|
J01GB07
|
Netilmicin
|
|
|
|
|
|
J01GB08
|
Sisomicin
|
|
|
|
|
|
J01GB09
|
Dibekacin
|
|
|
|
|
|
J01GB10
|
Ribostamycin
|
|
|
|
|
|
J01GB11
|
Isepamicin
|
|
|
|
|
|
J01GB12
|
Arbekacin
|
|
|
|
|
|
J01GB13
|
Bekanamycin
|
|
|
|
J01M
|
|
|
Quinolone antibacterials
|
|
|
|
|
J01MA
|
|
Fluoroquinolones
|
|
|
|
|
|
J01MA01
|
Ofloxacin
|
|
|
|
|
|
J01MA02
|
Ciprofloxacin
|
|
|
|
|
|
J01MA03
|
Pefloxacin
|
|
|
|
|
|
J01MA04
|
Enoxacin
|
|
|
|
|
|
J01MA05
|
Temafloxacin
|
|
|
|
|
|
J01MA06
|
Norfloxacin
|
|
|
|
|
|
J01MA07
|
Lomefloxacin
|
|
|
|
|
|
J01MA08
|
Fleroxacin
|
|
|
|
|
|
J01MA09
|
Sparfloxacin
|
|
|
|
|
|
J01MA10
|
Rufloxacin
|
|
|
|
|
|
J01MA11
|
Grepafloxacin
|
|
|
|
|
|
J01MA12
|
Levofloxacin
|
|
|
|
|
|
J01MA13
|
Trovafloxacin
|
|
|
|
|
|
J01MA14
|
Moxifloxacin
|
|
|
|
|
|
J01MA15
|
Gemifloxacin
|
|
|
|
|
|
J01MA16
|
Gatifloxacin
|
|
|
|
|
|
J01MA17
|
Prulifloxacin
|
|
|
|
|
|
J01MA18
|
Pazufloxacin
|
|
|
|
|
|
J01MA19
|
Garenoxacin
|
|
|
|
|
|
J01MA21
|
Sitafloxacin
|
|
|
|
|
J01MB
|
|
Other quinolones
|
|
|
|
|
|
J01MB01
|
Rosoxacin
|
|
|
|
|
|
J01MB02
|
Nalidixic acid
|
|
|
|
|
|
J01MB03
|
Piromidic acid
|
|
|
|
|
|
J01MB04
|
Pipemidic acid
|
|
|
|
|
|
J01MB05
|
Oxolinic acid
|
|
|
|
|
|
J01MB06
|
Cinoxacin
|
|
|
|
|
|
J01MB07
|
Flumequine
|
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
|
|
J01RA
|
|
Combinations of antbacterials
|
|
|
|
|
|
J01RA01
|
Penicillins, combinations with other antibacterials
|
|
|
|
|
|
J01RA02
|
Sulfonamides, combinations with other antibacterials (excluding trimethoprim)
|
|
|
|
|
|
J01RA03
|
Cefuroxime, combinations with other antibacterials
|
|
|
|
|
|
J01RA04
|
Spiramycin, combinations with other antibacterials
|
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
|
|
|
|
|
|
J01XA01
|
Vancomycin
|
|
|
|
|
|
J01XA02
|
Teicoplanin
|
|
|
|
|
|
J01XA03
|
Telavancin
|
|
|
|
|
|
J01XA04
|
Dalbavancin
|
|
|
|
|
|
J01XA05
|
Oritavancin
|
|
|
|
|
J01XB
|
|
Polymyxins
|
|
|
|
|
|
J01XB01
|
Colistin
|
|
|
|
|
|
J01XB02
|
Polymyxin B
|
|
|
|
|
J01XC
|
|
Steroid antibacterials
|
|
|
|
|
|
J01XC01
|
Fusidic acid
|
|
|
|
|
J01XD
|
|
Imidazole derivatives
|
|
|
|
|
|
J01XD01
|
Metronidazole
|
|
|
|
|
|
J01XD02
|
Tinidazole
|
|
|
|
|
|
J01XD03
|
Ornidazole
|
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
|
|
|
|
|
|
J01XE01
|
Nitrofurantoin
|
|
|
|
|
|
J01XE02
|
Nifurtoinol
|
|
|
|
|
|
J01XE03
|
furazidin
|
|
|
|
|
|
J01XE51
|
nitrofurantoin, combinations
|
|
|
|
|
J01XX
|
|
Other antibacterials
|
|
|
|
|
|
J01XX01
|
Fosfomycin
|
|
|
|
|
|
J01XX02
|
Xibornol
|
|
|
|
|
|
J01XX03
|
Clofoctol
|
|
|
|
|
|
J01XX04
|
Spectinomycin
|
|
|
|
|
|
J01XX05
|
Methenamine
|
|
|
|
|
|
J01XX06
|
Mandelic acid
|
|
|
|
|
|
J01XX07
|
Nitroxoline
|
|
|
|
|
|
J01XX08
|
Linezolid
|
|
|
|
|
|
J01XX09
|
Daptomycin
|
|
|
|
|
|
J01XX10
|
Bacitracin
|
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
|
|
J02A
|
|
|
Antimycotics for systemic use
|
|
|
|
|
J02AA
|
|
Antibiotics
|
|
|
|
|
|
J02AA01
|
Amphotericin B
|
|
|
|
|
|
J02AA02
|
Hachimycin
|
|
|
|
|
J02AB
|
|
Imidazole derivatives
|
|
|
|
|
|
J02AB01
|
Miconazole
|
|
|
|
|
|
J02AB02
|
Ketoconazole
|
|
|
|
|
J02AC
|
|
Triazole derivatives
|
|
|
|
|
|
J02AC01
|
Fluconazole
|
|
|
|
|
|
J02AC02
|
Itraconazole
|
|
|
|
|
|
J02AC03
|
Voriconazole
|
|
|
|
|
|
J02AC04
|
Posaconazole
|
|
|
|
|
J02AX
|
|
Other antimycotics for systemic use
|
|
|
|
|
|
J02AX01
|
Flucytosine
|
|
|
|
|
|
J02AX04
|
Caspofungin
|
|
|
|
|
|
J02AX05
|
Micafungin
|
|
|
|
|
|
J02AX06
|
Anidulafungin
|
|
|
J04
|
|
|
|
Antimycobacterials
|
|
|
|
J04A
|
|
|
Drugs for treatment of tuberculosis
|
|
|
|
|
J04AA
|
|
Aminosalicylic acid and derivatives
|
|
|
|
|
|
J04AA01
|
Aminosalicylic acid
|
|
|
|
|
|
J04AA02
|
Sodium aminosalicylate
|
|
|
|
|
|
J04AA03
|
Calcium aminosalicylate
|
|
|
|
|
J04AB
|
|
Antibiotics
|
|
|
|
|
|
J04AB01
|
Cycloserine
|
|
|
|
|
|
J04AB02
|
Rifampicin
|
|
|
|
|
|
J04AB03
|
Rifamycin
|
|
|
|
|
|
J04AB04
|
Rifabutin
|
|
|
|
|
|
J04AB05
|
Rifapentin
|
|
|
|
|
|
J04AB30
|
Capreomycin
|
|
|
|
|
J04AC
|
|
Hydrazides
|
|
|
|
|
|
J04AC01
|
Isoniazid
|
|
|
|
|
|
J04AC51
|
Isoniazid, combinations
|
|
|
|
|
J04AD
|
|
Thiocarbamide derivatives
|
|
|
|
|
|
J04AD01
|
Protionamide
|
|
|
|
|
|
J04AD02
|
Tiocarlide
|
|
|
|
|
|
J04AD03
|
Ethionamide
|
|
|
|
|
J04AK
|
|
Other drugs for treatment of tuberculosis
|
|
|
|
|
|
J04AK01
|
Pyrazinamide
|
|
|
|
|
|
J04AK02
|
Ethambutol
|
|
|
|
|
|
J04AK03
|
Terizidone
|
|
|
|
|
|
J04AK04
|
Morinamide
|
|
|
|
|
J04AM
|
|
Combinations of drugs for treatment of tuberculosis
|
|
|
|
|
|
J04AM01
|
Streptomycin and isoniazid
|
|
|
|
|
|
J04AM02
|
Rifampicin and isoniazid
|
|
|
|
|
|
J04AM03
|
Ethambutol and isoniazid
|
|
|
|
|
|
J04AM04
|
Thioacetazone and isoniazid
|
|
|
|
|
|
J04AM05
|
Rifampicin, pyrazinamide and isoniazid
|
|
|
|
|
|
J04AM06
|
Rifampicin, pyrazinamide, ethambutol and isoniazid
|
|
|
|
J04B
|
|
|
Drugs for treatment of lepra
|
|
|
|
|
J04BA
|
|
Drugs for treatment of lepra
|
|
|
|
|
|
J04BA01
|
Clofazimine
|
|
|
|
|
|
J04BA02
|
Dapsone
|
|
|
|
|
|
J04BA03
|
Aldesulfone sodium
|
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
|
|
J05AA01
|
Metisazone
|
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
|
|
J05AB01
|
Aciclovir
|
|
|
|
|
|
J05AB02
|
Idoxuridine
|
|
|
|
|
|
J05AB03
|
Vidarabine
|
|
|
|
|
|
J05AB04
|
Ribavirin (בוטל, קוד חדש J05AP01)
|
|
|
|
|
|
J05AB06
|
Ganciclovir
|
|
|
|
|
|
J05AB09
|
Famciclovir
|
|
|
|
|
|
J05AB11
|
Valaciclovir
|
|
|
|
|
|
J05AB12
|
Cidofovir
|
|
|
|
|
|
J05AB13
|
Penciclovir
|
|
|
|
|
|
J05AB14
|
Valganciclovir
|
|
|
|
|
|
J05AB15
|
Brivudine
|
|
|
|
|
|
J05AB16
|
remdesivir
|
|
|
|
|
|
J05AB17
|
brincidofovir
|
|
|
|
|
|
J05AB54
|
Ribavirin, combinations (בוטל, קוד חדש L03AB60)
|
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
|
|
J05AC02
|
Rimantadine
|
|
|
|
|
|
J05AC03
|
Tromantadine
|
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
|
|
J05AD01
|
Foscarnet
|
|
|
|
|
|
J05AD02
|
Fosfonet
|
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
|
|
J05AE01
|
Saquinavir
|
|
|
|
|
|
J05AE02
|
Indinavir
|
|
|
|
|
|
J05AE03
|
Ritonavir
|
|
|
|
|
|
J05AE04
|
Nelfinavir
|
|
|
|
|
|
J05AE05
|
Amprenavir
|
|
|
|
|
|
J05AE06
|
lopinavir and ritonavir (בוטל, קוד חדש J05AR10)
|
|
|
|
|
|
J05AE07
|
Fosamprenavir
|
|
|
|
|
|
J05AE08
|
Atazanavir
|
|
|
|
|
|
J05AE09
|
Tipranavir
|
|
|
|
|
|
J05AE10
|
Darunavir
|
|
|
|
|
|
J05AE11
|
Telaprevir (בוטל, קוד חדש J05AP02)
|
|
|
|
|
|
J05AE12
|
Boceprevir (בוטל, קוד חדש J05AP03)
|
|
|
|
|
|
J05AE13
|
faldaprevir (בוטל, קוד חדש J05AP04)
|
|
|
|
|
|
J05AE14
|
simeprevir (בוטל, קוד חדש J05AP05)
|
|
|
|
|
|
J05AE15
|
asunaprevir (בוטל, קוד חדש J05AP06)
|
|
|
|
|
|
J05AE16
|
ensitrelvir
|
|
|
|
|
|
J05AE30
|
nirmatrelvir and ritonavir
|
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
|
|
J05AF13
|
tenofovir alafenamide
|
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
|
J05AJ
|
|
Integrase inhibitors
|
|
|
|
|
|
J05AJ01
|
raltegravir
|
|
|
|
|
|
J05AJ02
|
elvitegravir
|
|
|
|
|
|
J05AJ03
|
dolutegravir
|
|
|
|
|
|
J05AJ04
|
cabotegravir
|
|
|
|
|
J05AP
|
|
Antivirals for treatment of HCV infections
|
|
|
|
|
|
J05AP01
|
ribavirin
|
|
|
|
|
|
J05AP02
|
telaprevir
|
|
|
|
|
|
J05AP03
|
boceprevir
|
|
|
|
|
|
J05AP04
|
faldaprevir
|
|
|
|
|
|
J05AP05
|
simeprevir
|
|
|
|
|
|
J05AP06
|
asunaprevir
|
|
|
|
|
|
J05AP07
|
daclatasvir
|
|
|
|
|
|
J05AP08
|
sofosbuvir
|
|
|
|
|
|
J05AP09
|
dasabuvir
|
|
|
|
|
|
J05AP10
|
elbasvir
|
|
|
|
|
|
J05AP11
|
grazoprevir
|
|
|
|
|
|
J05AP51
|
sofosbuvir and ledipasvir
|
|
|
|
|
|
J05AP52
|
dasabuvir, ombitasvir, paritaprevir and ritonavir
|
|
|
|
|
|
J05AP53
|
ombitasvir, paritaprevir and ritonavir
|
|
|
|
|
|
J05AP54
|
elbasvir and grazoprevir
|
|
|
|
|
|
J05AP55
|
sofosbuvir and velpatasvir
|
|
|
|
|
|
J05AP56
|
sofosbuvir, velpatasvir and voxilaprevir
|
|
|
|
|
|
J05AP57
|
glecaprevir and pibrentasvir
|
|
|
|
|
|
J05AP58
|
daclatasvir, asunaprevir and beclabuvir
|
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
|
|
J05AR11
|
lamivudine, tenofovir disoproxil and efavirenz
|
|
|
|
|
|
J05AR12
|
lamivudine and tenofovir disoproxil
|
|
|
|
|
|
J05AR13
|
lamivudine, abacavir and dolutegravir
|
|
|
|
|
|
J05AR14
|
darunavir and cobicistat
|
|
|
|
|
|
J05AR15
|
atazanavir and cobicistat
|
|
|
|
|
|
J05AR16
|
lamivudine and raltegravir
|
|
|
|
|
|
J05AR17
|
emtricitabine and tenofovir alafenamide
|
|
|
|
|
|
J05AR18
|
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
|
|
|
|
|
|
J05AR19
|
emtricitabine, tenofovir alafenamide and rilpivirine
|
|
|
|
|
|
J05AR20
|
emtricitabine, tenofovir alafenamide and bictegravir
|
|
|
|
|
|
J05AR21
|
dolutegravir and rilpivirine
|
|
|
|
|
|
J05AR22
|
emtricitabine, tenofovir alafenamide, darunavir and cobicistat
|
|
|
|
|
|
J05AR23
|
atazanavir and ritonavir
|
|
|
|
|
|
J05AR24
|
lamivudine, tenofovir disoproxil and doravirine
|
|
|
|
|
|
J05AR25
|
lamivudine and dolutegravir
|
|
|
|
|
|
J05AR26
|
darunavir and ritonavir
|
|
|
|
|
|
J05AR27
|
lamivudine, tenofovir disoproxil and dolutegravir
|
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
|
J05AX08
|
Raltegravir (בוטל, קוד חדש J05AJ01)
|
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
|
J05AX11
|
Elvitegravir (בוטל, קוד חדש J05AJ02)
|
|
|
|
|
|
J05AX12
|
dolutegravir (בוטל, קוד חדש J05AJ03)
|
|
|
|
|
|
J05AX13
|
umifenovir
|
|
|
|
|
|
J05AX14
|
daclatasvir (בוטל, קוד חדש J05AP07)
|
|
|
|
|
|
J05AX15
|
sofosbuvir (בוטל, קוד חדש J05AP08)
|
|
|
|
|
|
J05AX16
|
dasabuvir (בוטל, קוד חדש J05AP09)
|
|
|
|
|
|
J05AX17
|
enisamium iodide
|
|
|
|
|
|
J05AX18
|
letermovir
|
|
|
|
|
|
J05AX19
|
tilorone
|
|
|
|
|
|
J05AX21
|
pentanedioic acid imidazolyl ethanamide
|
|
|
|
|
|
J05AX23
|
ibalizumab
|
|
|
|
|
|
J05AX24
|
tecovirimat
|
|
|
|
|
|
J05AX25
|
baloxavir marboxil
|
|
|
|
|
|
J05AX26
|
amenamevir
|
|
|
|
|
|
J05AX27
|
favipiravir
|
|
|
|
|
|
J05AX28
|
bulevirtide
|
|
|
|
|
|
J05AX29
|
fostemsavir
|
|
|
|
|
|
J05AX31
|
lenacapavir
|
|
|
|
|
|
J05AX65
|
sofosbuvir and ledipasvir (בוטל, קוד חדש J05AP51)
|
|
|
|
|
|
J05AX66
|
dasabuvir, ombitasvir, paritaprevir and ritonavir (בוטל, קוד חדש J05AP52)
|
|
|
|
|
|
J05AX67
|
ombitasvir, paritaprevir and ritonavir (בוטל, קוד חדש J05AP53)
|
|
|
|
|
|
J05AX68
|
elbasvir and grazoprevir (בוטל, קוד חדש J05AP54)
|
|
|
|
|
|
J05AX69
|
sofosbuvir and velpatasvir (בוטל, קוד חדש J05AP55)
|
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
|
J06BB16
|
Palivizumab (בוטל, קוד חדש J06BD01)
|
|
|
|
|
|
J06BB17
|
Motavizumab (בוטל, קוד חדש J06BD02)
|
|
|
|
|
|
J06BB18
|
raxibacumab (בוטל, קוד חדש J06BC02)
|
|
|
|
|
|
J06BB21
|
bezlotoxumab (בוטל, קוד חדש J06BC03)
|
|
|
|
|
|
J06BB22
|
obiltoxaximab (בוטל, קוד חדש J06BC04)
|
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
|
J06BC
|
|
Antibacterial monoclonal antibodies
|
|
|
|
|
|
J06BC01
|
Nebacumab
|
|
|
|
|
|
J06BC02
|
raxibacumab
|
|
|
|
|
|
J06BC03
|
bezlotoxumab
|
|
|
|
|
|
J06BC04
|
obiltoxaximab
|
|
|
|
|
|
J06BC05
|
[[]]
|
|
|
|
|
J06BD
|
|
Antiviral monoclonal antibodies
|
|
|
|
|
|
J06BD01
|
palivizumab
|
|
|
|
|
|
J06BD02
|
motavizumab
|
|
|
|
|
|
J06BD03
|
tixagevimab and cilgavimab
|
|
|
|
|
|
J06BD04
|
ansuvimab
|
|
|
|
|
|
J06BD05
|
sotrovimab
|
|
|
|
|
|
J06BD06
|
regdanvimab
|
|
|
|
|
|
J06BD07
|
casirivimab and imdevimab
|
|
|
|
|
|
J06BD08
|
nirsevimab
|
|
|
J07
|
|
|
|
Vaccines
|
|
|
|
J07A
|
|
|
Bacterial vaccines
|
|
|
|
|
J07AC
|
|
Anthrax vaccines
|
|
|
|
|
|
J07AC01
|
Anthrax antigen
|
|
|
|
|
J07AD
|
|
Brucellosis vaccines
|
|
|
|
|
|
J07AD01
|
Brucella antigen
|
|
|
|
|
J07AE
|
|
Cholera vaccines
|
|
|
|
|
|
J07AE01
|
Cholera, inactivated, whole cell
|
|
|
|
|
|
J07AE02
|
Cholera, live attenuated
|
|
|
|
|
|
J07AE51
|
Cholera, combinations with typhoid vaccine, inactivated, whole cell
|
|
|
|
|
J07AF
|
|
Diphtheria vaccines
|
|
|
|
|
|
J07AF01
|
Diphtheria toxoid
|
|
|
|
|
J07AG
|
|
Haemophilus influenzae B vaccines
|
|
|
|
|
|
J07AG01
|
Hemophilus influenzae B, purified antigen conjugated
|
|
|
|
|
|
J07AG51
|
Hemophilus influenzae B, combinations with toxoids
|
|
|
|
|
|
J07AG52
|
Hemophilus influenzae B, combinations with pertussis and toxoids
|
|
|
|
|
|
J07AG53
|
Hemophilus influenzae B, combinations with meningococcus C, conjugated
|
|
|
|
|
J07AH
|
|
Meningococcal vaccines
|
|
|
|
|
|
J07AH01
|
Meningococcus A, purified polysaccharides antigen
|
|
|
|
|
|
J07AH02
|
Other meningococcal monovalent purified polysaccharides antigen
|
|
|
|
|
|
J07AH03
|
Meningococcus A, C, bivalent purified polysaccharides antigen
|
|
|
|
|
|
J07AH04
|
Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen
|
|
|
|
|
|
J07AH05
|
Other meningococcal polyvalent purified polysaccharides antigen
|
|
|
|
|
|
J07AH06
|
Meningococcus B, outer membrane vesicle vaccine
|
|
|
|
|
|
J07AH07
|
Meningococcus C, purified polysaccharides antigen conjugated
|
|
|
|
|
|
J07AH08
|
Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen conjugated
|
|
|
|
|
|
J07AH09
|
Meningococcus B, multicomponent vaccine
|
|
|
|
|
|
J07AH10
|
Meningococcus A, purified polysaccharides antigen conjugated
|
|
|
|
|
J07AJ
|
|
Pertussis vaccines
|
|
|
|
|
|
J07AJ01
|
Pertussis, inactivated, whole cell
|
|
|
|
|
|
J07AJ02
|
Pertussis, purified antigen
|
|
|
|
|
|
J07AJ51
|
Pertussis, inactivated, whole cell, combinations with toxoids
|
|
|
|
|
|
J07AJ52
|
Pertussis, purified antigen, combinations with toxoids
|
|
|
|
|
J07AK
|
|
Plague vaccines
|
|
|
|
|
|
J07AK01
|
Plague, inactivated, whole cell
|
|
|
|
|
J07AL
|
|
Pneumococcal vaccines
|
|
|
|
|
|
J07AL01
|
Pneumococcus, purified polysaccharides antigen
|
|
|
|
|
|
J07AL02
|
Pneumococcus, purified polysaccharides antigen conjugated
|
|
|
|
|
|
J07AL52
|
Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated
|
|
|
|
|
J07AM
|
|
Tetanus vaccines
|
|
|
|
|
|
J07AM01
|
Tetanus toxoid
|
|
|
|
|
|
J07AM51
|
Tetanus toxoid, combinations with diphtheria toxoid
|
|
|
|
|
|
J07AM52
|
Tetanus toxoid, combinations with tetanus immunoglobulin
|
|
|
|
|
J07AN
|
|
Tuberculosis vaccines
|
|
|
|
|
|
J07AN01
|
Tuberculosis, live attenuated
|
|
|
|
|
J07AP
|
|
Typhoid vaccines
|
|
|
|
|
|
J07AP01
|
Typhoid, oral, live attenuated
|
|
|
|
|
|
J07AP02
|
Typhoid, inactivated, whole cell
|
|
|
|
|
|
J07AP03
|
Typhoid, purified polysaccharide antigen
|
|
|
|
|
|
J07AP10
|
Typhoid, combinations with paratyphi types
|
|
|
|
|
J07AR
|
|
Typhus (exanthematicus) vaccines
|
|
|
|
|
|
J07AR01
|
Typhus exanthematicus, inactivated, whole cell
|
|
|
|
|
J07AX
|
|
Other bacterial vaccines
|
|
|
|
|
|
|
empty
|
|
|
|
J07B
|
|
|
Viral vaccines
|
|
|
|
|
J07BA
|
|
Encephalitis vaccines
|
|
|
|
|
|
J07BA01
|
Encephalitis, tick borne, inactivated, whole virus
|
|
|
|
|
|
J07BA02
|
Encephalitis, Japanese, inactivated, whole virus
|
|
|
|
|
J07BB
|
|
Influenza vaccines
|
|
|
|
|
|
J07BB01
|
Influenza, inactivated, whole virus
|
|
|
|
|
|
J07BB02
|
Influenza, purified antigen
|
|
|
|
|
|
J07BB03
|
Influenza, live attenuated
|
|
|
|
|
J07BC
|
|
Hepatitis vaccines
|
|
|
|
|
|
J07BC01
|
Hepatitis B, purified antigen
|
|
|
|
|
|
J07BC02
|
Hepatitis A, inactivated, whole virus
|
|
|
|
|
|
J07BC20
|
Combinations
|
|
|
|
|
J07BD
|
|
Measles vaccines
|
|
|
|
|
|
J07BD01
|
Measles, live attenuated
|
|
|
|
|
|
J07BD51
|
Measles, combinations with mumps, live attenuated
|
|
|
|
|
|
J07BD52
|
Measles, combinations with mumps and rubella, live attenuated
|
|
|
|
|
|
J07BD53
|
Measles, combinations with rubella, live attenuated
|
|
|
|
|
|
J07BD54
|
Measles, combinations with mumps, rubella and varicella, live attenuated
|
|
|
|
|
J07BE
|
|
Mumps vaccines
|
|
|
|
|
|
J07BE01
|
Mumps, live attenuated
|
|
|
|
|
J07BF
|
|
Poliomyelitis vaccines
|
|
|
|
|
|
J07BF01
|
Poliomyelitis oral, monovalent live attenuated
|
|
|
|
|
|
J07BF02
|
Poliomyelitis oral, trivalent, live attenuated
|
|
|
|
|
|
J07BF03
|
Poliomyelitis, trivalent, inactivated, whole virus
|
|
|
|
|
|
J07BF04
|
Poliomyelitis oral, bivalent, live attenuated
|
|
|
|
|
J07BG
|
|
Rabies vaccines
|
|
|
|
|
|
J07BG01
|
Rabies, inactivated, whole virus
|
|
|
|
|
J07BH
|
|
Rotavirus diarrhea vaccines
|
|
|
|
|
|
J07BH01
|
Rota virus, live attenuated
|
|
|
|
|
|
J07BH02
|
Rota virus, pentavalent, live, reassorted
|
|
|
|
|
J07BJ
|
|
Rubella vaccines
|
|
|
|
|
|
J07BJ01
|
Rubella, live attenuated
|
|
|
|
|
|
J07BJ51
|
Rubella, combinations with mumps, live attenuated
|
|
|
|
|
J07BK
|
|
Varicella zoster vaccines
|
|
|
|
|
|
J07BK01
|
Varicella, live attenuated
|
|
|
|
|
|
J07BK02
|
Zoster, live attenuated
|
|
|
|
|
|
J07BK03
|
zoster, purified antigen
|
|
|
|
|
J07BL
|
|
Yellow fever vaccines
|
|
|
|
|
|
J07BL01
|
Yellow fever, live attenuated
|
|
|
|
|
J07BM
|
|
Papillomavirus vaccines
|
|
|
|
|
|
J07BM01
|
Papillomavirus (human types 6, 11, 16, 18) (Gardasil)
|
|
|
|
|
|
J07BM02
|
Papillomavirus (human types 16, 18) (Cervarix)
|
|
|
|
|
J07BX
|
|
Other viral vaccines
|
|
|
|
|
|
|
empty
|
|
|
|
J07C
|
|
|
Bacterial and viral vaccines
|
|
|
|
|
J07CA
|
|
Bacterial and viral vaccines, combined
|
|
|
|
|
|
J07CA01
|
Diphtheria-poliomyelitis-tetanus
|
|
|
|
|
|
J07CA02
|
Diphtheria-pertussis-poliomyelitis-tetanus
|
|
|
|
|
|
J07CA03
|
Diphtheria-rubella-tetanus
|
|
|
|
|
|
J07CA04
|
Hemophilus influenzae B and poliomyelitis
|
|
|
|
|
|
J07CA05
|
Diphtheria-hepatitis B-pertussis-tetanus
|
|
|
|
|
|
J07CA06
|
Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus
|
|
|
|
|
|
J07CA07
|
Diphtheria-hepatitis B-tetanus
|
|
|
|
|
|
J07CA08
|
Hemophilus influenzae B and hepatitis B
|
|
|
|
|
|
J07CA09
|
Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
|
|
|
|
|
|
J07CA10
|
Typhoid-hepatitis A
|
|
|
|
|
|
J07CA11
|
Diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B
|
|
|
|
|
|
J07CA12
|
Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
|
|
|
|
|
|
J07CA13
|
Diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C
|
|
|
|
J07X
|
|
|
Other vaccines
|
|
|
|
|
|
|
empty
|
| L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
|
|
L01A
|
|
|
Alkylating agents
|
|
|
|
|
L01AA
|
|
Nitrogen mustard analogues
|
|
|
|
|
|
L01AA01
|
Cyclophosphamide
|
|
|
|
|
|
L01AA02
|
Chlorambucil
|
|
|
|
|
|
L01AA03
|
Melphalan
|
|
|
|
|
|
L01AA05
|
Chlormethine
|
|
|
|
|
|
L01AA06
|
Ifosfamide
|
|
|
|
|
|
L01AA07
|
Trofosfamide
|
|
|
|
|
|
L01AA08
|
Prednimustine
|
|
|
|
|
|
L01AA09
|
Bendamustine
|
|
|
|
|
L01AB
|
|
Alkyl sulfonates
|
|
|
|
|
|
L01AB01
|
Busulfan
|
|
|
|
|
|
L01AB02
|
Treosulfan
|
|
|
|
|
|
L01AB03
|
Mannosulfan
|
|
|
|
|
L01AC
|
|
Ethylene imines
|
|
|
|
|
|
L01AC01
|
Thiotepa
|
|
|
|
|
|
L01AC02
|
Triaziquone
|
|
|
|
|
|
L01AC03
|
Carboquone
|
|
|
|
|
L01AD
|
|
Nitrosoureas
|
|
|
|
|
|
L01AD01
|
Carmustine
|
|
|
|
|
|
L01AD02
|
Lomustine
|
|
|
|
|
|
L01AD03
|
Semustine
|
|
|
|
|
|
L01AD04
|
Streptozocin
|
|
|
|
|
|
L01AD05
|
Fotemustine
|
|
|
|
|
|
L01AD06
|
Nimustine
|
|
|
|
|
|
L01AD07
|
Ranimustine
|
|
|
|
|
L01AG
|
|
Epoxides
|
|
|
|
|
|
L01AG01
|
Etoglucid
|
|
|
|
|
L01AX
|
|
Other alkylating agents
|
|
|
|
|
|
L01AX01
|
Mitobronitol
|
|
|
|
|
|
L01AX02
|
Pipobroman
|
|
|
|
|
|
L01AX03
|
Temozolomide
|
|
|
|
|
|
L01AX04
|
Dacarbazine
|
|
|
|
L01B
|
|
|
Antimetabolites
|
|
|
|
|
L01BA
|
|
Folic acid analogues
|
|
|
|
|
|
L01BA01
|
Methotrexate (בוטל, קוד חדש L04AX03)
|
|
|
|
|
|
L01BA03
|
Raltitrexed
|
|
|
|
|
|
L01BA04
|
Pemetrexed
|
|
|
|
|
|
L01BA05
|
Pralatrexate
|
|
|
|
|
L01BB
|
|
Purine analogues
|
|
|
|
|
|
L01BB02
|
Mercaptopurine
|
|
|
|
|
|
L01BB03
|
Tioguanine
|
|
|
|
|
|
L01BB04
|
Cladribine
|
|
|
|
|
|
L01BB05
|
Fludarabine
|
|
|
|
|
|
L01BB06
|
Clofarabine
|
|
|
|
|
|
L01BB07
|
Nelarabine
|
|
|
|
|
L01BC
|
|
Pyrimidine analogues
|
|
|
|
|
|
L01BC01
|
Cytarabine
|
|
|
|
|
|
L01BC02
|
Fluorouracil
|
|
|
|
|
|
L01BC03
|
Tegafur
|
|
|
|
|
|
L01BC04
|
Carmofur
|
|
|
|
|
|
L01BC05
|
Gemcitabine
|
|
|
|
|
|
L01BC06
|
Capecitabine
|
|
|
|
|
|
L01BC07
|
Azacitidine
|
|
|
|
|
|
L01BC08
|
Decitabine
|
|
|
|
|
|
L01BC52
|
Fluorouracil, combinations
|
|
|
|
|
|
L01BC53
|
Tegafur, combinations
|
|
|
|
L01C
|
|
|
Plant alkaloids and other natural products
|
|
|
|
|
L01CA
|
|
Vinca alkaloids and analogues
|
|
|
|
|
|
L01CA01
|
Vinblastine
|
|
|
|
|
|
L01CA02
|
Vincristine
|
|
|
|
|
|
L01CA03
|
Vindesine
|
|
|
|
|
|
L01CA04
|
Vinorelbine
|
|
|
|
|
|
L01CA05
|
Vinflunine
|
|
|
|
|
L01CB
|
|
Podophyllotoxin derivatives
|
|
|
|
|
|
L01CB01
|
Etoposide
|
|
|
|
|
|
L01CB02
|
Teniposide
|
|
|
|
|
L01CC
|
|
Colchicine derivatives
|
|
|
|
|
|
L01CC01
|
Demecolcine
|
|
|
|
|
L01CD
|
|
Taxanes
|
|
|
|
|
|
L01CD01
|
Paclitaxel
|
|
|
|
|
|
L01CD02
|
Docetaxel
|
|
|
|
|
|
L01CD03
|
Paclitaxel poliglumex
|
|
|
|
|
|
L01CD04
|
Cabazitaxel
|
|
|
|
|
L01CE
|
|
Topoisomerase 1 (TOP1) inhibitors
|
|
|
|
|
|
L01CE01
|
topotecan
|
|
|
|
|
|
L01CE02
|
irinotecan
|
|
|
|
|
|
L01CE03
|
etirinotecan pegol
|
|
|
|
|
|
L01CE04
|
belotecan
|
|
|
|
|
L01CX
|
|
Other plant alkaloids and natural products
|
|
|
|
|
|
L01CX01
|
Trabectedin
|
|
|
|
L01D
|
|
|
Cytotoxic antibiotics and related substances
|
|
|
|
|
L01DA
|
|
Actinomycines
|
|
|
|
|
|
L01DA01
|
Dactinomycin
|
|
|
|
|
L01DB
|
|
Anthracyclines and related substances
|
|
|
|
|
|
L01DB01
|
Doxorubicin
|
|
|
|
|
|
L01DB02
|
Daunorubicin
|
|
|
|
|
|
L01DB03
|
Epirubicin
|
|
|
|
|
|
L01DB04
|
Aclarubicin
|
|
|
|
|
|
L01DB05
|
Zorubicin
|
|
|
|
|
|
L01DB06
|
Idarubicin
|
|
|
|
|
|
L01DB07
|
Mitoxantrone
|
|
|
|
|
|
L01DB08
|
Pirarubicin
|
|
|
|
|
|
L01DB09
|
Valrubicin
|
|
|
|
|
|
L01DB10
|
Amrubicin
|
|
|
|
|
|
L01DB11
|
Pixantrone
|
|
|
|
|
L01DC
|
|
Other cytotoxic antibiotics
|
|
|
|
|
|
L01DC01
|
Bleomycin
|
|
|
|
|
|
L01DC02
|
Plicamycin
|
|
|
|
|
|
L01DC03
|
Mitomycin
|
|
|
|
|
|
L01DC04
|
Ixabepilone
|
|
|
|
L01E
|
|
|
Protein kinase inhibitors
|
|
|
|
|
L01EA
|
|
BCR-ABL tyrosine kinase inhibitors
|
|
|
|
|
|
L01EA01
|
imatinib
|
|
|
|
|
|
L01EA02
|
dasatinib
|
|
|
|
|
|
L01EA03
|
nilotinib
|
|
|
|
|
|
L01EA04
|
bosutinib
|
|
|
|
|
|
L01EA05
|
ponatinib
|
|
|
|
|
|
L01EA06
|
asciminib
|
|
|
|
|
L01EB
|
|
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
|
|
|
|
|
|
L01EB01
|
gefitinib
|
|
|
|
|
|
L01EB02
|
erlotinib
|
|
|
|
|
|
L01EB03
|
afatinib
|
|
|
|
|
|
L01EB04
|
osimertinib
|
|
|
|
|
|
L01EB05
|
rociletinib
|
|
|
|
|
|
L01EB06
|
olmutinib
|
|
|
|
|
|
L01EB07
|
dacomitinib
|
|
|
|
|
|
L01EB08
|
icotinib
|
|
|
|
|
L01EC
|
|
B-Raf serine-threonine kinase (BRAF) inhibitors
|
|
|
|
|
|
L01EC01
|
vemurafenib
|
|
|
|
|
|
L01EC02
|
dabrafenib
|
|
|
|
|
|
L01EC03
|
encorafenib
|
|
|
|
|
L01ED
|
|
Anaplastic lymphoma kinase (ALK) inhibitors
|
|
|
|
|
|
L01ED01
|
crizotinib
|
|
|
|
|
|
L01ED02
|
ceritinib
|
|
|
|
|
|
L01ED03
|
alectinib
|
|
|
|
|
|
L01ED04
|
brigatinib
|
|
|
|
|
|
L01ED05
|
lorlatinib
|
|
|
|
|
L01EE
|
|
Mitogen-activated protein kinase (MEK) inhibitors
|
|
|
|
|
|
L01EE01
|
trametinib
|
|
|
|
|
|
L01EE02
|
cobimetinib
|
|
|
|
|
|
L01EE03
|
binimetinib
|
|
|
|
|
|
L01EE04
|
selumetinib
|
|
|
|
|
L01EF
|
|
Cyclin-dependent kinase (CDK) inhibitors
|
|
|
|
|
|
L01EF01
|
palbociclib
|
|
|
|
|
|
L01EF02
|
ribociclib
|
|
|
|
|
|
L01EF03
|
abemaciclib
|
|
|
|
|
L01EG
|
|
Mammalian target of rapamycin (mTOR) kinase inhibitors
|
|
|
|
|
|
L01EG01
|
temsirolimus
|
|
|
|
|
|
L01EG02
|
everolimus
|
|
|
|
|
|
L01EG03
|
ridaforolimus
|
|
|
|
|
L01EH
|
|
Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
|
|
|
|
|
|
L01EH01
|
lapatinib
|
|
|
|
|
|
L01EH02
|
neratinib
|
|
|
|
|
|
L01EH03
|
tucatinib
|
|
|
|
|
L01EJ
|
|
Janus-associated kinase (JAK) inhibitors
|
|
|
|
|
|
L01EJ01
|
ruxolitinib
|
|
|
|
|
|
L01EJ02
|
fedratinib
|
|
|
|
|
|
L01EJ03
|
pacritinib
|
|
|
|
|
L01EK
|
|
Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
|
|
|
|
|
|
L01EK01
|
axitinib
|
|
|
|
|
|
L01EK02
|
cediranib
|
|
|
|
|
|
L01EK03
|
tivozanib
|
|
|
|
|
L01EL
|
|
Bruton's tyrosine kinase (BTK) inhibitors
|
|
|
|
|
|
L01EL01
|
ibrutinib
|
|
|
|
|
|
L01EL02
|
acalabrutinib
|
|
|
|
|
|
L01EL03
|
zanubrutinib
|
|
|
|
|
L01EM
|
|
Phosphatidylinositol-3-kinase (Pi3K) inhibitors
|
|
|
|
|
|
L01EM01
|
idelalisib
|
|
|
|
|
|
L01EM02
|
copanlisib
|
|
|
|
|
|
L01EM03
|
alpelisib
|
|
|
|
|
|
L01EM04
|
duvelisib
|
|
|
|
|
L01EN
|
|
Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
|
|
|
|
|
|
L01EN01
|
erdafitinib
|
|
|
|
|
|
L01EN02
|
pemigatinib
|
|
|
|
|
|
L01EN03
|
infigratinib
|
|
|
|
|
|
L01EN04
|
futibatinib
|
|
|
|
|
L01EX
|
|
Other protein kinase inhibitors
|
|
|
|
|
|
L01EX01
|
sunitinib
|
|
|
|
|
|
L01EX02
|
sorafenib
|
|
|
|
|
|
L01EX03
|
pazopanib
|
|
|
|
|
|
L01EX04
|
vandetanib
|
|
|
|
|
|
L01EX05
|
regorafenib
|
|
|
|
|
|
L01EX06
|
masitinib
|
|
|
|
|
|
L01EX07
|
cabozantinib
|
|
|
|
|
|
L01EX08
|
lenvatinib
|
|
|
|
|
|
L01EX09
|
nintedanib
|
|
|
|
|
|
L01EX10
|
midostaurin
|
|
|
|
|
|
L01EX11
|
quizartinib
|
|
|
|
|
|
L01EX12
|
larotrectinib
|
|
|
|
|
|
L01EX13
|
gilteritinib
|
|
|
|
|
|
L01EX14
|
entrectinib
|
|
|
|
|
|
L01EX15
|
pexidartinib
|
|
|
|
|
|
L01EX16
|
erdafitinib (בוטל, קוד חדש L01EN01)
|
|
|
|
|
|
L01EX17
|
capmatinib
|
|
|
|
|
|
L01EX18
|
avapritinib
|
|
|
|
|
|
L01EX19
|
ripretinib
|
|
|
|
|
|
L01EX20
|
pemigatinib (בוטל, קוד חדש L01EN02)
|
|
|
|
|
|
L01EX21
|
tepotinib
|
|
|
|
|
|
L01EX22
|
selpercatinib
|
|
|
|
|
|
L01EX23
|
pralsetinib
|
|
|
|
|
|
L01EX24
|
surufatinib
|
|
|
|
|
|
L01EX25
|
umbralisib
|
|
|
|
|
|
L01EX26
|
sitravatinib
|
|
|
|
|
|
L01EX27
|
capivasertib
|
|
|
|
L01F
|
|
|
Monoclonal antibodies and antibody drug conjugates
|
|
|
|
|
L01FA
|
|
CD20 (Clusters of Differentiation 20) inhibitors
|
|
|
|
|
|
L01FA01
|
rituximab
|
|
|
|
|
|
L01FA02
|
ofatumumab
|
|
|
|
|
|
L01FA03
|
obinutuzumab
|
|
|
|
|
L01FB
|
|
CD22 (Clusters of Differentiation 22) inhibitors
|
|
|
|
|
|
L01FB01
|
inotuzumab ozogamicin
|
|
|
|
|
|
L01FB02
|
moxetumomab pasudotox
|
|
|
|
|
L01FC
|
|
CD38 (Clusters of Differentiation 38) inhibitors
|
|
|
|
|
|
L01FC01
|
daratumumab
|
|
|
|
|
|
L01FC02
|
isatuximab
|
|
|
|
|
L01FD
|
|
HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
|
|
|
|
|
|
L01FD01
|
trastuzumab
|
|
|
|
|
|
L01FD02
|
pertuzumab
|
|
|
|
|
|
L01FD03
|
trastuzumab emtansine
|
|
|
|
|
|
L01FD04
|
trastuzumab deruxtecan
|
|
|
|
|
|
L01FD05
|
trastuzumab duocarmazine
|
|
|
|
|
|
L01FD06
|
margetuximab
|
|
|
|
|
L01FE
|
|
EGFR (Epidermal Growth Factor Receptor) inhibitors
|
|
|
|
|
|
L01FE01
|
cetuximab
|
|
|
|
|
|
L01FE02
|
panitumumab
|
|
|
|
|
|
L01FE03
|
necitumumab
|
|
|
|
|
L01FF
|
|
PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
|
|
|
|
|
|
L01FF01
|
nivolumab
|
|
|
|
|
|
L01FF02
|
pembrolizumab
|
|
|
|
|
|
L01FF03
|
durvalumab
|
|
|
|
|
|
L01FF04
|
avelumab
|
|
|
|
|
|
L01FF05
|
atezolizumab
|
|
|
|
|
|
L01FF06
|
cemiplimab
|
|
|
|
|
|
L01FF07
|
dostarlimab
|
|
|
|
|
|
L01FF08
|
prolgolimab
|
|
|
|
|
|
L01FF09
|
tislelizumab
|
|
|
|
|
|
L01FF10
|
retifanlimab
|
|
|
|
|
L01FG
|
|
VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
|
|
|
|
|
|
L01FG01
|
bevacizumab
|
|
|
|
|
|
L01FG02
|
ramucirumab
|
|
|
|
|
L01FX
|
|
Other monoclonal antibodies and antibody drug conjugates
|
|
|
|
|
|
L01FX01
|
edrecolomab
|
|
|
|
|
|
L01FX02
|
gemtuzumab ozogamicin
|
|
|
|
|
|
L01FX03
|
catumaxomab
|
|
|
|
|
|
L01FX04
|
ipilimumab
|
|
|
|
|
|
L01FX05
|
brentuximab vedotin
|
|
|
|
|
|
L01FX06
|
dinutuximab beta
|
|
|
|
|
|
L01FX07
|
blinatumomab
|
|
|
|
|
|
L01FX08
|
elotuzumab
|
|
|
|
|
|
L01FX09
|
mogamulizumab
|
|
|
|
|
|
L01FX10
|
olaratumab
|
|
|
|
|
|
L01FX11
|
bermekimab
|
|
|
|
|
|
L01FX12
|
tafasitamab
|
|
|
|
|
|
L01FX13
|
enfortumab vedotin
|
|
|
|
|
|
L01FX14
|
polatuzumab vedotin
|
|
|
|
|
|
L01FX15
|
belantamab mafodotin
|
|
|
|
|
|
L01FX16
|
oportuzumab monatox
|
|
|
|
|
|
L01FX17
|
sacituzumab govitecan
|
|
|
|
|
|
L01FX18
|
amivantamab
|
|
|
|
|
|
L01FX19
|
sabatolimab
|
|
|
|
|
|
L01FX20
|
tremelimumab
|
|
|
|
|
|
L01FX21
|
naxitamab
|
|
|
|
|
|
L01FX22
|
loncastuximab tesirine
|
|
|
|
|
|
L01FX23
|
tisotumab vedotin
|
|
|
|
|
|
L01FX24
|
teclistamab
|
|
|
|
|
|
L01FX25
|
mosunetuzumab
|
|
|
|
|
|
L01FX26
|
mirvetuximab soravtansine
|
|
|
|
|
|
L01FX27
|
epcoritamab
|
|
|
|
|
|
L01FX28
|
glofitamab
|
|
|
|
|
|
L01FX29
|
talquetamab
|
|
|
|
L01X
|
|
|
Other antineoplastic agents
|
|
|
|
|
L01XA
|
|
Platinum compounds
|
|
|
|
|
|
L01XA01
|
Cisplatin
|
|
|
|
|
|
L01XA02
|
Carboplatin
|
|
|
|
|
|
L01XA03
|
Oxaliplatin
|
|
|
|
|
|
L01XA04
|
Satraplatin
|
|
|
|
|
|
L01XA05
|
Polyplatillen
|
|
|
|
|
L01XB
|
|
Methylhydrazines
|
|
|
|
|
|
L01XB01
|
Procarbazine
|
|
|
|
|
L01XC
|
|
Monoclonal antibodies
|
|
|
|
|
|
L01XC01
|
Edrecolomab (בוטל, קוד חדש L01FX01)
|
|
|
|
|
|
L01XC02
|
Rituximab (בוטל, קוד חדש L01FA01)
|
|
|
|
|
|
L01XC03
|
Trastuzumab (בוטל, קוד חדש L01FD01)
|
|
|
|
|
|
L01XC04
|
Alemtuzumab (בוטל, קוד חדש L04AA34)
|
|
|
|
|
|
L01XC05
|
Gemtuzumab (בוטל, קוד חדש L01FX02)
|
|
|
|
|
|
L01XC06
|
Cetuximab (בוטל, קוד חדש L01FE01)
|
|
|
|
|
|
L01XC07
|
Bevacizumab (בוטל, קוד חדש L01FG01)
|
|
|
|
|
|
L01XC08
|
Panitumumab (בוטל, קוד חדש L01FE02)
|
|
|
|
|
|
L01XC09
|
Catumaxomab (בוטל, קוד חדש L01FX03)
|
|
|
|
|
|
L01XC10
|
Ofatumumab (בוטל, קוד חדש L01FA02)
|
|
|
|
|
|
L01XC11
|
Ipilimumab (בוטל, קוד חדש L01FX04)
|
|
|
|
|
|
L01XC12
|
Brentuximab vedotin (בוטל, קוד חדש L01FX05)
|
|
|
|
|
|
L01XC13
|
Pertuzumab (בוטל, קוד חדש L01FD02)
|
|
|
|
|
|
L01XC14
|
trastuzumab emtansine (בוטל, קוד חדש L01FD03)
|
|
|
|
|
|
L01XC15
|
obinutuzumab (בוטל, קוד חדש L01FA03)
|
|
|
|
|
|
L01XC16
|
dinutuximab beta (בוטל, קוד חדש L01FX06)
|
|
|
|
|
|
L01XC17
|
nivolumab (בוטל, קוד חדש L01FF01)
|
|
|
|
|
|
L01XC18
|
pembrolizumab (בוטל, קוד חדש L01FF02)
|
|
|
|
|
|
L01XC19
|
blinatumomab (בוטל, קוד חדש L01FX07)
|
|
|
|
|
|
L01XC21
|
ramucirumab (בוטל, קוד חדש L01FG02)
|
|
|
|
|
|
L01XC22
|
necitumumab (בוטל, קוד חדש L01FE03)
|
|
|
|
|
|
L01XC23
|
elotuzumab (בוטל, קוד חדש L01FX08)
|
|
|
|
|
|
L01XC24
|
daratumumab (בוטל, קוד חדש L01FC01)
|
|
|
|
|
|
L01XC25
|
mogamulizumab (בוטל, קוד חדש L01FX09)
|
|
|
|
|
|
L01XC26
|
inotuzumab ozogamicin (בוטל, קוד חדש L01FB01)
|
|
|
|
|
|
L01XC27
|
olaratumab (בוטל, קוד חדש L01FX10)
|
|
|
|
|
|
L01XC28
|
durvalumab (בוטל, קוד חדש L01FF03)
|
|
|
|
|
|
L01XC29
|
bermekimab (בוטל, קוד חדש L01FX11)
|
|
|
|
|
|
L01XC31
|
avelumab (בוטל, קוד חדש L01FF04)
|
|
|
|
|
|
L01XC32
|
atezolizumab (בוטל, קוד חדש L01FF05)
|
|
|
|
|
|
L01XC33
|
cemiplimab (בוטל, קוד חדש L01FF06)
|
|
|
|
|
|
L01XC34
|
moxetumomab pasudotox (בוטל, קוד חדש L01FB02)
|
|
|
|
|
|
L01XC35
|
tafasitamab (בוטל, קוד חדש L01FX12)
|
|
|
|
|
|
L01XC36
|
enfortumab vedotin (בוטל, קוד חדש L01FX13)
|
|
|
|
|
|
L01XC37
|
polatuzumab vedotin (בוטל, קוד חדש L01FX14)
|
|
|
|
|
|
L01XC38
|
isatuximab (בוטל, קוד חדש L01FC02)
|
|
|
|
|
|
L01XC39
|
belantamab mafodotin (בוטל, קוד חדש L01FX15)
|
|
|
|
|
|
L01XC40
|
dostarlimab (בוטל, קוד חדש L01FF07)
|
|
|
|
|
|
L01XC41
|
trastuzumab deruxtecan (בוטל, קוד חדש L01FD04)
|
|
|
|
|
L01XD
|
|
Sensitizers used in photodynamic/radiation therapy
|
|
|
|
|
|
L01XD01
|
Porfimer sodium
|
|
|
|
|
|
L01XD02
|
verteporfin (בוטל, קוד חדש S01LA01)
|
|
|
|
|
|
L01XD03
|
Methyl aminolevulinate
|
|
|
|
|
|
L01XD04
|
Aminolevulinic acid
|
|
|
|
|
|
L01XD05
|
Temoporfin
|
|
|
|
|
|
L01XD06
|
Efaproxiral
|
|
|
|
|
|
L01XD07
|
padeliporfin
|
|
|
|
|
L01XE
|
|
Protein kinase inhibitors (בוטל)
|
|
|
|
|
|
L01XE01
|
Imatinib (בוטל, קוד חדש L01EA01)
|
|
|
|
|
|
L01XE02
|
Gefitinib (בוטל, קוד חדש L01EB01)
|
|
|
|
|
|
L01XE03
|
Erlotinib (בוטל, קוד חדש L01EB02)
|
|
|
|
|
|
L01XE04
|
Sunitinib (בוטל, קוד חדש L01EX01)
|
|
|
|
|
|
L01XE05
|
Sorafenib (בוטל, קוד חדש L01EX02)
|
|
|
|
|
|
L01XE06
|
Dasatinib (בוטל, קוד חדש L01EA02)
|
|
|
|
|
|
L01XE07
|
Lapatinib (בוטל, קוד חדש L01EH01)
|
|
|
|
|
|
L01XE08
|
Nilotinib (בוטל, קוד חדש L01EA03)
|
|
|
|
|
|
L01XE09
|
Temsirolimus (בוטל, קוד חדש L01EG01)
|
|
|
|
|
|
L01XE10
|
Everolimus (בוטל, קוד חדש L01EG02)
|
|
|
|
|
|
L01XE11
|
Pazopanib (בוטל, קוד חדש L01EX03)
|
|
|
|
|
|
L01XE12
|
Vandetanib (בוטל, קוד חדש L01EX04)
|
|
|
|
|
|
L01XE13
|
Afatinib(בוטל, קוד חדש L01EB03)
|
|
|
|
|
|
L01XE14
|
Bosutinib(בוטל, קוד חדש L01EA04)
|
|
|
|
|
|
L01XE15
|
Vemurafenib (בוטל, קוד חדש L01EC01)
|
|
|
|
|
|
L01XE16
|
Crizotinib (בוטל, קוד חדש L01ED01)
|
|
|
|
|
|
L01XE17
|
Axitinib (בוטל, קוד חדש L01EK01)
|
|
|
|
|
|
L01XE18
|
Ruxolitinib (בוטל, קוד חדש L01EJ01)
|
|
|
|
|
|
L01XE19
|
Ridaforolimus (בוטל, קוד חדש L01EG03)
|
|
|
|
|
|
L01XE21
|
Regorafenib (בוטל, קוד חדש L01EX05)
|
|
|
|
|
|
L01XE22
|
Masitinib (בוטל, קוד חדש L01EX06)
|
|
|
|
|
|
L01XE23
|
dabrafenib (בוטל, קוד חדש L01EC02)
|
|
|
|
|
|
L01XE24
|
ponatinib (בוטל, קוד חדש L01EA05)
|
|
|
|
|
|
L01XE25
|
trametinib (בוטל, קוד חדש L01EE01)
|
|
|
|
|
|
L01XE26
|
cabozantinib (בוטל, קוד חדש L01EX07)
|
|
|
|
|
|
L01XE27
|
ibrutinib (בוטל, קוד חדש L01EL01)
|
|
|
|
|
|
L01XE28
|
ceritinib (בוטל, קוד חדש L01ED02)
|
|
|
|
|
|
L01XE29
|
lenvatinib (בוטל, קוד חדש L01EX08)
|
|
|
|
|
|
L01XE31
|
nintedanib(בוטל, קוד חדש L01EX09)
|
|
|
|
|
|
L01XE32
|
cediranib(בוטל, קוד חדש L01EK02)
|
|
|
|
|
|
L01XE33
|
palbociclib (בוטל, קוד חדש L01EF01)
|
|
|
|
|
|
L01XE34
|
tivozanib (בוטל, קוד חדש L01EK03)
|
|
|
|
|
|
L01XE35
|
osimertinib (בוטל, קוד חדש L01EB04)
|
|
|
|
|
|
L01XE36
|
alectinib (בוטל, קוד חדש L01ED03)
|
|
|
|
|
|
L01XE37
|
rociletinib (בוטל, קוד חדש L01EB05)
|
|
|
|
|
|
L01XE38
|
cobimetinib (בוטל, קוד חדש L01EE02)
|
|
|
|
|
|
L01XE39
|
midostaurin (בוטל, קוד חדש L01EX10)
|
|
|
|
|
|
L01XE40
|
olmutinib (בוטל, קוד חדש L01EB06)
|
|
|
|
|
|
L01XE41
|
binimetinib (בוטל, קוד חדש L01EE03)
|
|
|
|
|
|
L01XE42
|
ribociclib (בוטל, קוד חדש L01EF02)
|
|
|
|
|
|
L01XE43
|
brigatinib (בוטל, קוד חדש L01ED04)
|
|
|
|
|
|
L01XE44
|
lorlatinib (בוטל, קוד חדש L01ED05)
|
|
|
|
|
|
L01XE45
|
neratinib (בוטל, קוד חדש L01EH02)
|
|
|
|
|
|
L01XE46
|
encorafenib (בוטל, קוד חדש L01EC03)
|
|
|
|
|
|
L01XE47
|
dacomitinib (בוטל, קוד חדש L01EB07)
|
|
|
|
|
|
L01XE48
|
icotinib (בוטל, קוד חדש L01EB08)
|
|
|
|
|
|
L01XE50
|
abemaciclib (בוטל, קוד חדש L01EF03)
|
|
|
|
|
|
L01XE51
|
acalabrutinib (בוטל, קוד חדש L01EL02)
|
|
|
|
|
|
L01XE52
|
quizartinib (בוטל, קוד חדש L01EX11)
|
|
|
|
|
|
L01XE53
|
larotrectinib (בוטל, קוד חדש L01EX12)
|
|
|
|
|
|
L01XE54
|
gilteritinib (בוטל, קוד חדש L01EX13)
|
|
|
|
|
|
L01XE56
|
entrectinib (בוטל, קוד חדש L01EX14)
|
|
|
|
|
|
L01XE57
|
fedratinib (בוטל, קוד חדש L01EJ02)
|
|
|
|
|
L01XF
|
|
Retinoids for cancer treatment
|
|
|
|
|
|
L01XF01
|
tretinoin
|
|
|
|
|
|
L01XF02
|
alitretinoin
|
|
|
|
|
|
L01XF03
|
bexarotene
|
|
|
|
|
L01XG
|
|
Proteasome inhibitors
|
|
|
|
|
|
L01XG01
|
bortezomib
|
|
|
|
|
|
L01XG02
|
carfilzomib
|
|
|
|
|
|
L01XG03
|
ixazomib
|
|
|
|
|
L01XH
|
|
Histone deacetylase (HDAC) inhibitors
|
|
|
|
|
|
L01XH01
|
vorinostat
|
|
|
|
|
|
L01XH02
|
romidepsin
|
|
|
|
|
|
L01XH03
|
panobinostat
|
|
|
|
|
|
L01XH04
|
belinostat
|
|
|
|
|
|
L01XH05
|
entinostat
|
|
|
|
|
L01XJ
|
|
Hedgehog pathway inhibitors
|
|
|
|
|
|
L01XJ01
|
vismodegib
|
|
|
|
|
|
L01XJ02
|
sonidegib
|
|
|
|
|
|
L01XJ03
|
glasdegib
|
|
|
|
|
L01XK
|
|
Poly (ADP-ribose) polymerase (PARP) inhibitors
|
|
|
|
|
|
L01XK01
|
olaparib
|
|
|
|
|
|
L01XK02
|
niraparib
|
|
|
|
|
|
L01XK03
|
rucaparib
|
|
|
|
|
|
L01XK04
|
talazoparib
|
|
|
|
|
|
L01XK05
|
veliparib
|
|
|
|
|
L01XL
|
|
Antineoplastic cell and gene therapy
|
|
|
|
|
|
L01XL01
|
sitimagene ceradenovec
|
|
|
|
|
|
L01XL02
|
talimogene laherparepvec
|
|
|
|
|
|
L01XL03
|
axicabtagene ciloleucel
|
|
|
|
|
|
L01XL04
|
tisagenlecleucel
|
|
|
|
|
|
L01XL05
|
ciltacabtagene autoleucel
|
|
|
|
|
|
L01XL06
|
brexucabtagene autoleucel
|
|
|
|
|
|
L01XL07
|
idecabtagene vicleucel
|
|
|
|
|
|
L01XL08
|
lisocabtagene maraleucel
|
|
|
|
|
|
L01XL09
|
tabelecleucel
|
|
|
|
|
|
L01XL10
|
nadofaragene firadenovec
|
|
|
|
|
|
L01XL11
|
lifileucel
|
|
|
|
|
L01XX
|
|
Other antineoplastic agents
|
|
|
|
|
|
L01XX01
|
Amsacrine
|
|
|
|
|
|
L01XX02
|
Asparaginase
|
|
|
|
|
|
L01XX03
|
Altretamine
|
|
|
|
|
|
L01XX05
|
Hydroxycarbamide
|
|
|
|
|
|
L01XX07
|
Lonidamine
|
|
|
|
|
|
L01XX08
|
Pentostatin
|
|
|
|
|
|
L01XX09
|
Miltefosine (בוטל, קוד חדש P01CX04)
|
|
|
|
|
|
L01XX10
|
Masoprocol
|
|
|
|
|
|
L01XX11
|
Estramustine
|
|
|
|
|
|
L01XX14
|
Tretinoin (בוטל, קוד חדש L01XF01)
|
|
|
|
|
|
L01XX16
|
Mitoguazone
|
|
|
|
|
|
L01XX17
|
Topotecan (בוטל, קוד חדש L01CE01)
|
|
|
|
|
|
L01XX18
|
Tiazofurine
|
|
|
|
|
|
L01XX19
|
Irinotecan (בוטל, קוד חדש L01CE02)
|
|
|
|
|
|
L01XX22
|
Alitretinoin (בוטל, קוד חדש L01XF02)
|
|
|
|
|
|
L01XX23
|
Mitotane
|
|
|
|
|
|
L01XX24
|
Pegaspargase
|
|
|
|
|
|
L01XX25
|
Bexarotene (בוטל, קוד חדש L01XF03)
|
|
|
|
|
|
L01XX27
|
Arsenic trioxide
|
|
|
|
|
|
L01XX28
|
imatinib (בוטל, קוד חדש L01XE01)
|
|
|
|
|
|
L01XX29
|
Denileukin diftitox
|
|
|
|
|
|
L01XX31
|
gefitinib (בוטל, קוד חדש L01EB01)
|
|
|
|
|
|
L01XX32
|
Bortezomib (בוטל, קוד חדש L01XG01)
|
|
|
|
|
|
L01XX33
|
Celecoxib
|
|
|
|
|
|
L01XX34
|
erlotinib (בוטל, קוד חדש L01XE03)
|
|
|
|
|
|
L01XX35
|
Anagrelide
|
|
|
|
|
|
L01XX36
|
Oblimersen
|
|
|
|
|
|
L01XX37
|
Sitimagene ceradenovec (בוטל, קוד חדש L01XL01)
|
|
|
|
|
|
L01XX38
|
Vorinostat (בוטל, קוד חדש L01XH01)
|
|
|
|
|
|
L01XX39
|
Romidepsin (בוטל, קוד חדש L01XH02)
|
|
|
|
|
|
L01XX40
|
Omacetaxine mepesuccinate
|
|
|
|
|
|
L01XX41
|
Eribulin
|
|
|
|
|
|
L01XX42
|
Panobinostat (בוטל, קוד חדש L01XH03)
|
|
|
|
|
|
L01XX43
|
Vismodegib (בוטל, קוד חדש L01XJ01)
|
|
|
|
|
|
L01XX44
|
aflibercept
|
|
|
|
|
|
L01XX45
|
carfilzomib (בוטל, קוד חדש L01XG02)
|
|
|
|
|
|
L01XX46
|
olaparib (בוטל, קוד חדש L01XK01)
|
|
|
|
|
|
L01XX47
|
idelalisib (בוטל, קוד חדש L01EM01)
|
|
|
|
|
|
L01XX48
|
sonidegib (בוטל, קוד חדש L01XJ02)
|
|
|
|
|
|
L01XX49
|
belinostat (בוטל, קוד חדש L01XH04)
|
|
|
|
|
|
L01XX50
|
ixazomib (בוטל, קוד חדש L01XG03)
|
|
|
|
|
|
L01XX51
|
talimogene laherparepvec
|
|
|
|
|
|
L01XX52
|
venetoclax
|
|
|
|
|
|
L01XX53
|
vosaroxin
|
|
|
|
|
|
L01XX54
|
niraparib (בוטל, קוד חדש L01XK02)
|
|
|
|
|
|
L01XX55
|
rucaparib (בוטל, קוד חדש L01XK03)
|
|
|
|
|
|
L01XX56
|
etirinotecan pegol (בוטל, קוד חדש L01CE03)
|
|
|
|
|
|
L01XX57
|
plitidepsin
|
|
|
|
|
|
L01XX58
|
epacadostat
|
|
|
|
|
|
L01XX59
|
enasidenib
|
|
|
|
|
|
L01XX60
|
talazoparib (בוטל, קוד חדש L01XK04)
|
|
|
|
|
|
L01XX61
|
copanlisib (בוטל, קוד חדש L01EM02)
|
|
|
|
|
|
L01XX62
|
ivosidenib
|
|
|
|
|
|
L01XX63
|
glasdegib (בוטל, קוד חדש L01XJ03)
|
|
|
|
|
|
L01XX64
|
entinostat (בוטל, קוד חדש L01XH05)
|
|
|
|
|
|
L01XX65
|
alpelisib (בוטל, קוד חדש L01EM03)
|
|
|
|
|
|
L01XX66
|
selinexor
|
|
|
|
|
|
L01XX67
|
tagraxofusp
|
|
|
|
|
|
L01XX68
|
belotecan (בוטל, קוד חדש L01CE04)
|
|
|
|
|
|
L01XX69
|
lurbinectedin
|
|
|
|
|
|
L01XX70
|
axicabtagene ciloleucel (בוטל, קוד חדש L01XL03)
|
|
|
|
|
|
L01XX71
|
tisagenlecleucel (בוטל, קוד חדש L01XL04)
|
|
|
|
|
|
L01XX72
|
tazemetostat
|
|
|
|
|
|
L01XX73
|
sotorasib
|
|
|
|
|
|
L01XX74
|
belzutifan
|
|
|
|
|
|
L01XX75
|
tebentafusp
|
|
|
|
|
|
L01XX77
|
adagrasib
|
|
|
|
|
L01XY
|
|
Combinations of antineoplastic agents
|
|
|
|
|
|
L01XY01
|
cytarabine and daunorubicin
|
|
|
|
|
|
L01XY02
|
pertuzumab and trastuzumab
|
|
|
L02
|
|
|
|
Endocrine therapy
|
|
|
|
L02A
|
|
|
Hormones and related agents
|
|
|
|
|
L02AA
|
|
Estrogens
|
|
|
|
|
|
L02AA01
|
Diethylstilbestrol
|
|
|
|
|
|
L02AA02
|
Polyestradiol phosphate
|
|
|
|
|
|
L02AA03
|
Ethinylestradiol
|
|
|
|
|
|
L02AA04
|
Fosfestrol
|
|
|
|
|
L02AB
|
|
Progestogens
|
|
|
|
|
|
L02AB01
|
Megestrol
|
|
|
|
|
|
L02AB02
|
Medroxyprogesterone
|
|
|
|
|
|
L02AB03
|
Gestonorone
|
|
|
|
|
L02AE
|
|
Gonadotropin-releasing hormone analogues
|
|
|
|
|
|
L02AE01
|
Buserelin
|
|
|
|
|
|
L02AE02
|
Leuprorelin
|
|
|
|
|
|
L02AE03
|
Goserelin
|
|
|
|
|
|
L02AE04
|
Triptorelin
|
|
|
|
|
|
L02AE05
|
Histrelin
|
|
|
|
|
L02AX
|
|
Other hormones
|
|
|
|
|
|
|
empty
|
|
|
|
L02B
|
|
|
Hormone antagonists and related agents
|
|
|
|
|
L02BA
|
|
Anti-estrogens
|
|
|
|
|
|
L02BA01
|
Tamoxifen
|
|
|
|
|
|
L02BA02
|
Toremifene
|
|
|
|
|
|
L02BA03
|
Fulvestrant
|
|
|
|
|
L02BB
|
|
Anti-androgens
|
|
|
|
|
|
L02BB01
|
Flutamide
|
|
|
|
|
|
L02BB02
|
Nilutamide
|
|
|
|
|
|
L02BB03
|
Bicalutamide
|
|
|
|
|
|
L02BB04
|
enzalutamide
|
|
|
|
|
|
L02BB05
|
apalutamide
|
|
|
|
|
|
L02BB06
|
darolutamide
|
|
|
|
|
L02BG
|
|
Aromatase inhibitors
|
|
|
|
|
|
L02BG01
|
Aminogluthetimide
|
|
|
|
|
|
L02BG02
|
Formestane
|
|
|
|
|
|
L02BG03
|
Anastrozole
|
|
|
|
|
|
L02BG04
|
Letrozole
|
|
|
|
|
|
L02BG05
|
Vorozole
|
|
|
|
|
|
L02BG06
|
Exemestane
|
|
|
|
|
L02BX
|
|
Other hormone antagonists and related agents
|
|
|
|
|
|
L02BX01
|
Abarelix
|
|
|
|
|
|
L02BX02
|
Degarelix
|
|
|
|
|
|
L02BX03
|
Abiraterone
|
|
|
L03
|
|
|
|
Immunostimulants
|
|
|
|
L03A
|
|
|
Immunostimulants
|
|
|
|
|
L03AA
|
|
Colony stimulating factors
|
|
|
|
|
|
L03AA02
|
Filgrastim
|
|
|
|
|
|
L03AA03
|
Molgramostim
|
|
|
|
|
|
L03AA09
|
Sargramostim
|
|
|
|
|
|
L03AA10
|
Lenograstim
|
|
|
|
|
|
L03AA12
|
Ancestim
|
|
|
|
|
|
L03AA13
|
Pegfilgrastim
|
|
|
|
|
|
L03AA14
|
Lipegfilgrastim
|
|
|
|
|
L03AB
|
|
Interferons
|
|
|
|
|
|
L03AB01
|
Interferon alfa natural
|
|
|
|
|
|
L03AB02
|
Interferon beta natural
|
|
|
|
|
|
L03AB03
|
Interferon gamma
|
|
|
|
|
|
L03AB04
|
Interferon alfa-2a
|
|
|
|
|
|
L03AB05
|
Interferon alfa-2b
|
|
|
|
|
|
L03AB06
|
Interferon alfa-n1
|
|
|
|
|
|
L03AB07
|
Interferon beta-1a
|
|
|
|
|
|
L03AB08
|
Interferon beta-1b
|
|
|
|
|
|
L03AB09
|
Interferon alfacon-1
|
|
|
|
|
|
L03AB10
|
Peginterferon alfa-2b
|
|
|
|
|
|
L03AB11
|
Peginterferon alfa-2a
|
|
|
|
|
|
L03AB12
|
Albinterferon alfa-2b
|
|
|
|
|
|
L03AB13
|
peginterferon beta-1a
|
|
|
|
|
|
L03AB14
|
cepeginterferon alfa-2b
|
|
|
|
|
|
L03AB15
|
ropeginterferon alfa-2b
|
|
|
|
|
|
L03AB16
|
peginterferon alfacon-2
|
|
|
|
|
|
L03AB60
|
Peginterferon alfa-2b, combinations
|
|
|
|
|
|
L03AB61
|
Peginterferon alfa-2a, combinations
|
|
|
|
|
L03AC
|
|
Interleukins
|
|
|
|
|
|
L03AC01
|
Aldesleukin
|
|
|
|
|
|
L03AC02
|
Oprelvekin
|
|
|
|
|
L03AX
|
|
Other immunostimulants
|
|
|
|
|
|
L03AX01
|
Lentinan
|
|
|
|
|
|
L03AX02
|
Roquinimex
|
|
|
|
|
|
L03AX03
|
BCG vaccine
|
|
|
|
|
|
L03AX04
|
Pegademase
|
|
|
|
|
|
L03AX05
|
Pidotimod
|
|
|
|
|
|
L03AX07
|
Poly I:C
|
|
|
|
|
|
L03AX08
|
Poly ICLC
|
|
|
|
|
|
L03AX09
|
Thymopentin
|
|
|
|
|
|
L03AX10
|
Immunocyanin
|
|
|
|
|
|
L03AX11
|
Tasonermin
|
|
|
|
|
|
L03AX12
|
Melanoma vaccine
|
|
|
|
|
|
L03AX13
|
Glatiramer acetate
|
|
|
|
|
|
L03AX14
|
Histamine dihydrochloride
|
|
|
|
|
|
L03AX15
|
Mifamurtide
|
|
|
|
|
|
L03AX16
|
Plerixafor
|
|
|
|
|
|
L03AX17
|
Sipuleucel-T
|
|
|
L04
|
|
|
|
Immunosuppressants
|
|
|
|
L04A
|
|
|
Immunosuppressants
|
|
|
|
|
L04AA
|
|
Selective immunosuppressants
|
|
|
|
|
|
L04AA01
|
ciclosporin (בוטל, קוד חדש L04AD01)
|
|
|
|
|
|
L04AA02
|
Muromonab-CD3
|
|
|
|
|
|
L04AA03
|
Antilymphocyte immunoglobulin (horse)
|
|
|
|
|
|
L04AA04
|
Antithymocyte immunoglobulin (rabbit)
|
|
|
|
|
|
L04AA05
|
tacrolimus (בוטל, קוד חדש L04AD02)
|
|
|
|
|
|
L04AA06
|
Mycophenolic acid
|
|
|
|
|
|
L04AA08
|
daclizumab (בוטל, קוד חדש L04AC01)
|
|
|
|
|
|
L04AA09
|
basiliximab (בוטל, קוד חדש L04AC02)
|
|
|
|
|
|
L04AA10
|
Sirolimus
|
|
|
|
|
|
L04AA11
|
etanercept (בוטל, קוד חדש L04AB01)
|
|
|
|
|
|
L04AA12
|
infliximab (בוטל, קוד חדש L04AB02)
|
|
|
|
|
|
L04AA13
|
Leflunomide
|
|
|
|
|
|
L04AA14
|
anakinra (בוטל, קוד חדש L04AC03)
|
|
|
|
|
|
L04AA15
|
Alefacept
|
|
|
|
|
|
L04AA16
|
afelimomab (בוטל, קוד חדש L04AB03)
|
|
|
|
|
|
L04AA17
|
adalimumab (בוטל, קוד חדש L04AB04)
|
|
|
|
|
|
L04AA18
|
Everolimus
|
|
|
|
|
|
L04AA19
|
Gusperimus
|
|
|
|
|
|
L04AA21
|
Efalizumab
|
|
|
|
|
|
L04AA22
|
Abetimus
|
|
|
|
|
|
L04AA23
|
Natalizumab
|
|
|
|
|
|
L04AA24
|
Abatacept
|
|
|
|
|
|
L04AA25
|
Eculizumab
|
|
|
|
|
|
L04AA26
|
Belimumab
|
|
|
|
|
|
L04AA27
|
Fingolimod
|
|
|
|
|
|
L04AA28
|
Belatacept
|
|
|
|
|
|
L04AA29
|
Tofacitinib
|
|
|
|
|
|
L04AA31
|
teriflunomide
|
|
|
|
|
|
L04AA32
|
apremilast
|
|
|
|
|
|
L04AA33
|
vedolizumab
|
|
|
|
|
|
L04AA34
|
alemtuzumab
|
|
|
|
|
|
L04AA35
|
begelomab
|
|
|
|
|
|
L04AA36
|
ocrelizumab
|
|
|
|
|
|
L04AA37
|
baricitinib
|
|
|
|
|
|
L04AA38
|
ozanimod
|
|
|
|
|
|
L04AA39
|
emapalumab
|
|
|
|
|
|
L04AA40
|
cladribine
|
|
|
|
|
|
L04AA41
|
imlifidase
|
|
|
|
|
|
L04AA42
|
siponimod
|
|
|
|
|
|
L04AA43
|
ravulizumab
|
|
|
|
|
|
L04AA44
|
upadacitinib
|
|
|
|
|
|
L04AA45
|
filgotinib
|
|
|
|
|
|
L04AA46
|
itacitinib
|
|
|
|
|
|
L04AA47
|
inebilizumab
|
|
|
|
|
|
L04AA48
|
belumosudil
|
|
|
|
|
|
L04AA49
|
peficitinib
|
|
|
|
|
|
L04AA50
|
ponesimod
|
|
|
|
|
|
L04AA51
|
anifrolumab
|
|
|
|
|
|
L04AA52
|
ofatumumab
|
|
|
|
|
|
L04AA53
|
teprotumumab
|
|
|
|
|
|
L04AA54
|
pegcetacoplan
|
|
|
|
|
|
L04AA55
|
sutimlimab
|
|
|
|
|
|
L04AA56
|
deucravacitinib
|
|
|
|
|
|
L04AA57
|
ublituximab
|
|
|
|
|
|
L04AA58
|
efgartigimod alfa
|
|
|
|
|
|
L04AA59
|
avacopan
|
|
|
|
|
L04AB
|
|
Tumor necrosis factor alpha (TNF-α) inhibitors
|
|
|
|
|
|
L04AB01
|
Etanercept
|
|
|
|
|
|
L04AB02
|
Infliximab
|
|
|
|
|
|
L04AB03
|
Afelimomab
|
|
|
|
|
|
L04AB04
|
Adalimumab
|
|
|
|
|
|
L04AB05
|
Certolizumab pegol
|
|
|
|
|
|
L04AB06
|
Golimumab
|
|
|
|
|
|
L04AB07
|
opinercept
|
|
|
|
|
L04AC
|
|
Interleukin inhibitors
|
|
|
|
|
|
L04AC01
|
Daclizumab
|
|
|
|
|
|
L04AC02
|
Basiliximab
|
|
|
|
|
|
L04AC03
|
Anakinra
|
|
|
|
|
|
L04AC04
|
Rilonacept
|
|
|
|
|
|
L04AC05
|
Ustekinumab
|
|
|
|
|
|
L04AC06
|
Mepolizumab (בוטל, קוד חדש R03DX09)
|
|
|
|
|
|
L04AC07
|
Tocilizumab
|
|
|
|
|
|
L04AC08
|
Canakinumab
|
|
|
|
|
|
L04AC09
|
Briakinumab
|
|
|
|
|
|
L04AC10
|
Secukinumab
|
|
|
|
|
|
L04AC11
|
siltuximab
|
|
|
|
|
|
L04AC12
|
brodalumab
|
|
|
|
|
|
L04AC13
|
ixekizumab
|
|
|
|
|
|
L04AC14
|
sarilumab
|
|
|
|
|
|
L04AC15
|
sirukumab
|
|
|
|
|
|
L04AC16
|
guselkumab
|
|
|
|
|
|
L04AC17
|
tildrakizumab
|
|
|
|
|
|
L04AC18
|
risankizumab
|
|
|
|
|
|
L04AC19
|
satralizumab
|
|
|
|
|
|
L04AC20
|
netakimab
|
|
|
|
|
|
L04AC21
|
bimekizumab
|
|
|
|
|
|
L04AC22
|
spesolimab
|
|
|
|
|
|
L04AC23
|
olokizumab
|
|
|
|
|
|
L04AC24
|
mirikizumab
|
|
|
|
|
|
L04AC25
|
levilimab
|
|
|
|
|
L04AD
|
|
Calcineurin inhibitors
|
|
|
|
|
|
L04AD01
|
Ciclosporin
|
|
|
|
|
|
L04AD02
|
Tacrolimus
|
|
|
|
|
|
L04AD03
|
Voclosporin
|
|
|
|
|
L04AX
|
|
Other immunosuppressants
|
|
|
|
|
|
L04AX01
|
Azathioprine
|
|
|
|
|
|
L04AX02
|
Thalidomide
|
|
|
|
|
|
L04AX03
|
Methotrexate
|
|
|
|
|
|
L04AX04
|
Lenalidomide
|
|
|
|
|
|
L04AX05
|
Pirfenidone
|
|
|
|
|
|
L04AX06
|
pomalidomide
|
|
|
|
|
|
L04AX07
|
dimethyl fumarate
|
|
|
|
|
|
L04AX08
|
darvadstrocel
|
| M
|
|
|
|
|
Musculo-skeletal system
|
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
|
|
M01AA01
|
Phenylbutazone
|
|
|
|
|
|
M01AA02
|
Mofebutazone
|
|
|
|
|
|
M01AA03
|
Oxyphenbutazone
|
|
|
|
|
|
M01AA05
|
Clofezone
|
|
|
|
|
|
M01AA06
|
Kebuzone
|
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
|
|
M01AC01
|
Piroxicam
|
|
|
|
|
|
M01AC02
|
Tenoxicam
|
|
|
|
|
|
M01AC04
|
Droxicam
|
|
|
|
|
|
M01AC05
|
Lornoxicam
|
|
|
|
|
|
M01AC06
|
Meloxicam
|
|
|
|
|
|
M01AC56
|
Meloxicam, combinations
|
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
|
|
M01AE01
|
Ibuprofen
|
|
|
|
|
|
M01AE02
|
Naproxen
|
|
|
|
|
|
M01AE03
|
Ketoprofen
|
|
|
|
|
|
M01AE04
|
Fenoprofen
|
|
|
|
|
|
M01AE05
|
Fenbufen
|
|
|
|
|
|
M01AE06
|
Benoxaprofen
|
|
|
|
|
|
M01AE07
|
Suprofen
|
|
|
|
|
|
M01AE08
|
Pirprofen
|
|
|
|
|
|
M01AE09
|
Flurbiprofen
|
|
|
|
|
|
M01AE10
|
Indoprofen
|
|
|
|
|
|
M01AE11
|
Tiaprofenic acid
|
|
|
|
|
|
M01AE12
|
Oxaprozin
|
|
|
|
|
|
M01AE13
|
Ibuproxam
|
|
|
|
|
|
M01AE14
|
Dexibuprofen
|
|
|
|
|
|
M01AE15
|
Flunoxaprofen
|
|
|
|
|
|
M01AE16
|
Alminoprofen
|
|
|
|
|
|
M01AE17
|
Dexketoprofen
|
|
|
|
|
|
M01AE18
|
Naproxcinod
|
|
|
|
|
|
M01AE51
|
Ibuprofen, combinations (בוטל, קוד חדש N02AJ03)
|
|
|
|
|
|
M01AE52
|
Naproxen and esomeprazole
|
|
|
|
|
|
M01AE53
|
Ketoprofen, combinations
|
|
|
|
|
|
M01AE56
|
Naproxen and misoprostol
|
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
|
|
M01AG01
|
Mefenamic acid
|
|
|
|
|
|
M01AG02
|
Tolfenamic acid
|
|
|
|
|
|
M01AG03
|
Flufenamic acid
|
|
|
|
|
|
M01AG04
|
Meclofenamic acid
|
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
|
|
M01AH01
|
Celecoxib
|
|
|
|
|
|
M01AH02
|
Rofecoxib
|
|
|
|
|
|
M01AH03
|
Valdecoxib
|
|
|
|
|
|
M01AH04
|
Parecoxib
|
|
|
|
|
|
M01AH05
|
Etoricoxib
|
|
|
|
|
|
M01AH06
|
Lumiracoxib
|
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
|
|
M01BA
|
|
Anti-inflammatory/antirheumatic agents in combination with corticosteroids
|
|
|
|
|
|
M01BA01
|
Phenylbutazone and corticosteroids
|
|
|
|
|
|
M01BA02
|
Dipyrocetyl and corticosteroids
|
|
|
|
|
|
M01BA03
|
Acetylsalicylic acid and corticosteroids
|
|
|
|
|
M01BX
|
|
Other anti-inflammatory/antirheumatic agents in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
|
|
|
M01CA
|
|
Quinolines
|
|
|
|
|
|
M01CA03
|
Oxycinchophen
|
|
|
|
|
M01CB
|
|
Gold preparations
|
|
|
|
|
|
M01CB01
|
Sodium aurothiomalate
|
|
|
|
|
|
M01CB02
|
Sodium aurothiosulfate
|
|
|
|
|
|
M01CB03
|
Auranofin
|
|
|
|
|
|
M01CB04
|
Aurothioglucose
|
|
|
|
|
|
M01CB05
|
Aurotioprol
|
|
|
|
|
M01CC
|
|
Penicillamine and similar agents
|
|
|
|
|
|
M01CC01
|
Penicillamine
|
|
|
|
|
|
M01CC02
|
Bucillamine
|
|
|
|
|
M01CX
|
|
Other specific antirheumatic agents
|
|
|
|
|
|
|
empty
|
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
|
|
M02AB01
|
Capsaicin
|
|
|
|
|
|
M02AB02
|
Zucapsaicin
|
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
|
|
|
empty
|
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
|
|
|
|
M02AX02
|
Tolazoline
|
|
|
|
|
|
M02AX03
|
Dimethyl sulfoxide
|
|
|
|
|
|
M02AX05
|
Idrocilamide
|
|
|
|
|
|
M02AX10
|
Various
|
|
|
M03
|
|
|
|
Muscle relaxants
|
|
|
|
M03A
|
|
|
Muscle relaxants, peripherally acting agents
|
|
|
|
|
M03AA
|
|
Curare alkaloids
|
|
|
|
|
|
M03AA01
|
Alcuronium
|
|
|
|
|
|
M03AA02
|
Tubocurarine
|
|
|
|
|
|
M03AA04
|
Dimethyltubocurarine
|
|
|
|
|
M03AB
|
|
Choline derivatives
|
|
|
|
|
|
M03AB01
|
Suxamethonium
|
|
|
|
|
M03AC
|
|
Other quaternary ammonium compounds
|
|
|
|
|
|
M03AC01
|
Pancuronium
|
|
|
|
|
|
M03AC02
|
Gallamine
|
|
|
|
|
|
M03AC03
|
Vecuronium
|
|
|
|
|
|
M03AC04
|
Atracurium
|
|
|
|
|
|
M03AC05
|
Hexafluronium
|
|
|
|
|
|
M03AC06
|
Pipecuronium bromide
|
|
|
|
|
|
M03AC07
|
Doxacurium chloride
|
|
|
|
|
|
M03AC08
|
Fazadinium bromide
|
|
|
|
|
|
M03AC09
|
Rocuronium bromide
|
|
|
|
|
|
M03AC10
|
Mivacurium chloride
|
|
|
|
|
|
M03AC11
|
Cisatracurium
|
|
|
|
|
M03AX
|
|
Other muscle relaxants, peripherally acting agents
|
|
|
|
|
|
M03AX01
|
Botulinum toxin
|
|
|
|
M03B
|
|
|
Muscle relaxants, centrally acting agents
|
|
|
|
|
M03BA
|
|
Carbamic acid esters
|
|
|
|
|
|
M03BA01
|
Phenprobamate
|
|
|
|
|
|
M03BA02
|
Carisoprodol
|
|
|
|
|
|
M03BA03
|
Methocarbamol
|
|
|
|
|
|
M03BA04
|
Styramate
|
|
|
|
|
|
M03BA05
|
Febarbamate
|
|
|
|
|
|
M03BA51
|
Phenprobamate, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA52
|
Carisoprodol, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA53
|
Methocarbamol, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA71
|
Phenprobamate, combinations with psycholeptics
|
|
|
|
|
|
M03BA72
|
Carisoprodol, combinations with psycholeptics
|
|
|
|
|
|
M03BA73
|
Methocarbamol, combinations with psycholeptics
|
|
|
|
|
M03BB
|
|
Oxazol, thiazine, and triazine derivatives
|
|
|
|
|
|
M03BB02
|
Chlormezanone
|
|
|
|
|
|
M03BB03
|
Chlorzoxazone
|
|
|
|
|
|
M03BB52
|
Chlormezanone, combinations excluding psycholeptics
|
|
|
|
|
|
M03BB53
|
Chlorzoxazone, combinations excluding psycholeptics
|
|
|
|
|
|
M03BB72
|
Chlormezanone, combinations with psycholeptics
|
|
|
|
|
|
M03BB73
|
Chlorzoxazone, combinations with psycholeptics
|
|
|
|
|
M03BC
|
|
Ethers, chemically close to antihistamines
|
|
|
|
|
|
M03BC01
|
Orphenadrine (citrate)
|
|
|
|
|
|
M03BC51
|
Orphenadrine, combinations
|
|
|
|
|
M03BX
|
|
Other centrally acting agents
|
|
|
|
|
|
M03BX01
|
Baclofen
|
|
|
|
|
|
M03BX02
|
Tizanidine
|
|
|
|
|
|
M03BX03
|
Pridinol
|
|
|
|
|
|
M03BX04
|
Tolperisone
|
|
|
|
|
|
M03BX05
|
Thiocolchicoside
|
|
|
|
|
|
M03BX06
|
Mephenesin
|
|
|
|
|
|
M03BX07
|
Tetrazepam
|
|
|
|
|
|
M03BX08
|
Cyclobenzaprine
|
|
|
|
|
|
M03BX09
|
Eperisone
|
|
|
|
|
|
M03BX30
|
Phenyramidol
|
|
|
|
M03C
|
|
|
Muscle relaxants, directly acting agents
|
|
|
|
|
M03CA
|
|
Dantrolene and derivatives
|
|
|
|
|
|
M03CA01
|
Dantrolene
|
|
|
M04
|
|
|
|
Antigout preparations
|
|
|
|
M04A
|
|
|
Antigout preparations
|
|
|
|
|
M04AA
|
|
Preparations inhibiting uric acid production
|
|
|
|
|
|
M04AA01
|
Allopurinol
|
|
|
|
|
|
M04AA02
|
Tisopurine
|
|
|
|
|
|
M04AA03
|
Febuxostat
|
|
|
|
|
|
M04AA51
|
Allopurinol, combinations
|
|
|
|
|
M04AB
|
|
Preparations increasing uric acid excretion
|
|
|
|
|
|
M04AB01
|
Probenecid
|
|
|
|
|
|
M04AB02
|
Sulfinpyrazone
|
|
|
|
|
|
M04AB03
|
Benzbromarone
|
|
|
|
|
|
M04AB04
|
Isobromindione
|
|
|
|
|
M04AC
|
|
Preparations with no effect on uric acid metabolism
|
|
|
|
|
|
M04AC01
|
Colchicine
|
|
|
|
|
|
M04AC02
|
Cinchophen
|
|
|
|
|
M04AX
|
|
Other antigout preparations
|
|
|
|
|
|
M04AX01
|
Urate oxidase
|
|
|
|
|
|
M04AX02
|
Pegloticase
|
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
|
|
M05B
|
|
|
Drugs affecting bone structure and mineralization
|
|
|
|
|
M05BA
|
|
Bisphosphonates
|
|
|
|
|
|
M05BA01
|
Etidronic acid
|
|
|
|
|
|
M05BA02
|
Clodronic acid
|
|
|
|
|
|
M05BA03
|
Pamidronic acid
|
|
|
|
|
|
M05BA04
|
Alendronic acid
|
|
|
|
|
|
M05BA05
|
Tiludronic acid
|
|
|
|
|
|
M05BA06
|
Ibandronic acid
|
|
|
|
|
|
M05BA07
|
Risedronic acid
|
|
|
|
|
|
M05BA08
|
Zoledronic acid
|
|
|
|
|
M05BB
|
|
Bisphosphonates, combinations
|
|
|
|
|
|
M05BB01
|
Etidronic acid and calcium, sequential
|
|
|
|
|
|
M05BB02
|
Risedronic acid and calcium, sequential
|
|
|
|
|
|
M05BB03
|
Alendronic acid and colecalciferol
|
|
|
|
|
|
M05BB04
|
Risedronic acid, calcium and colecalciferol, sequential
|
|
|
|
|
|
M05BB05
|
Alendronic acid, calcium and colecalciferol, sequential
|
|
|
|
|
|
M05BB06
|
Alendronic acid and alfacalcidol, sequential
|
|
|
|
|
M05BC
|
|
Bone morphogenetic proteins
|
|
|
|
|
|
M05BC01
|
Dibotermin alfa
|
|
|
|
|
|
M05BC02
|
Eptotermin alfa
|
|
|
|
|
M05BX
|
|
Other drugs affecting bone structure and mineralization
|
|
|
|
|
|
M05BX01
|
Ipriflavone
|
|
|
|
|
|
M05BX02
|
aluminium chlorohydrate
|
|
|
|
|
|
M05BX03
|
Strontium ranelate
|
|
|
|
|
|
M05BX04
|
Denosumab
|
|
|
|
|
|
M05BX05
|
burosumab
|
|
|
|
|
|
M05BX06
|
romosozumab
|
|
|
|
|
|
M05BX07
|
vosoritide
|
|
|
|
|
|
M05BX08
|
menatetrenone
|
|
|
|
|
|
M05BX53
|
strontium ranelate and colecalciferol
|
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
M09A
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
|
M09AA
|
|
Quinine and derivatives
|
|
|
|
|
|
M09AA01
|
Hydroquinine
|
|
|
|
|
|
M09AA72
|
Quinine, combinations with psycholeptics
|
|
|
|
|
M09AB
|
|
Enzymes
|
|
|
|
|
|
M09AB01
|
Chymopapain
|
|
|
|
|
|
M09AB02
|
Collagenase clostridium histolyticum
|
|
|
|
|
|
M09AB52
|
Trypsin, combinations
|
|
|
|
|
M09AX
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
|
|
M09AX01
|
Hyaluronic acid
|
|
|
|
|
|
M09AX02
|
Chondrocytes, autologous
|
|
|
|
|
|
M09AX03
|
ataluren
|
|
|
|
|
|
M09AX04
|
drisapersen
|
|
|
|
|
|
M09AX05
|
aceneuramic acid
|
|
|
|
|
|
M09AX06
|
eteplirsen
|
|
|
|
|
|
M09AX07
|
nusinersen
|
|
|
|
|
|
M09AX08
|
golodirsen
|
|
|
|
|
|
M09AX09
|
onasemnogene abeparvovec
|
|
|
|
|
|
M09AX10
|
risdiplam
|
|
|
|
|
|
M09AX11
|
palovarotene
|
|
|
|
|
|
M09AX12
|
viltolarsen
|
|
|
|
|
|
M09AX13
|
casimersen
|
| N
|
|
|
|
|
Nervous system
|
|
|
N01
|
|
|
|
Anesthetics
|
|
|
|
N01A
|
|
|
Anesthetics, general
|
|
|
|
|
N01AA
|
|
Ethers
|
|
|
|
|
|
N01AA01
|
Diethyl ether
|
|
|
|
|
|
N01AA02
|
Vinyl ether
|
|
|
|
|
N01AB
|
|
Halogenated hydrocarbons
|
|
|
|
|
|
N01AB01
|
Halothane
|
|
|
|
|
|
N01AB02
|
Chloroform
|
|
|
|
|
|
N01AB03
|
methoxyflurane (בוטל, קוד חדש N02BG09)
|
|
|
|
|
|
N01AB04
|
Enflurane
|
|
|
|
|
|
N01AB05
|
Trichloroethylene
|
|
|
|
|
|
N01AB06
|
Isoflurane
|
|
|
|
|
|
N01AB07
|
Desflurane
|
|
|
|
|
|
N01AB08
|
Sevoflurane
|
|
|
|
|
N01AF
|
|
Barbiturates, plain
|
|
|
|
|
|
N01AF01
|
Methohexital
|
|
|
|
|
|
N01AF02
|
Hexobarbital
|
|
|
|
|
|
N01AF03
|
Thiopental
|
|
|
|
|
N01AG
|
|
Barbiturates in combination with other drugs
|
|
|
|
|
|
N01AG01
|
Narcobarbital
|
|
|
|
|
N01AH
|
|
Opioid anesthetics
|
|
|
|
|
|
N01AH01
|
Fentanyl
|
|
|
|
|
|
N01AH02
|
Alfentanil
|
|
|
|
|
|
N01AH03
|
Sufentanil
|
|
|
|
|
|
N01AH04
|
Phenoperidine
|
|
|
|
|
|
N01AH05
|
Anileridine
|
|
|
|
|
|
N01AH06
|
Remifentanil
|
|
|
|
|
|
N01AH51
|
Fentanyl, combinations
|
|
|
|
|
N01AX
|
|
Other general anesthetics
|
|
|
|
|
|
N01AX01
|
droperidol (בוטל, קוד חדש N05AD08)
|
|
|
|
|
|
N01AX03
|
Ketamine
|
|
|
|
|
|
N01AX04
|
Propanidid
|
|
|
|
|
|
N01AX05
|
Alfaxalone
|
|
|
|
|
|
N01AX07
|
Etomidate
|
|
|
|
|
|
N01AX10
|
Propofol
|
|
|
|
|
|
N01AX11
|
Sodium oxybate
|
|
|
|
|
|
N01AX13
|
Nitrous oxide
|
|
|
|
|
|
N01AX14
|
Esketamine
|
|
|
|
|
|
N01AX15
|
Xenon
|
|
|
|
|
|
N01AX63
|
Nitrous oxide, combinations
|
|
|
|
N01B
|
|
|
Anesthetics, local
|
|
|
|
|
N01BA
|
|
Esters of aminobenzoic acid
|
|
|
|
|
|
N01BA01
|
Metabutethamine
|
|
|
|
|
|
N01BA02
|
Procaine
|
|
|
|
|
|
N01BA03
|
Tetracaine
|
|
|
|
|
|
N01BA04
|
Chloroprocaine
|
|
|
|
|
|
N01BA05
|
Benzocaine
|
|
|
|
|
|
N01BA52
|
Procaine, combinations
|
|
|
|
|
N01BB
|
|
Amides
|
|
|
|
|
|
N01BB01
|
Bupivacaine
|
|
|
|
|
|
N01BB02
|
Lidocaine
|
|
|
|
|
|
N01BB03
|
Mepivacaine
|
|
|
|
|
|
N01BB04
|
Prilocaine
|
|
|
|
|
|
N01BB05
|
Butanilicaine
|
|
|
|
|
|
N01BB06
|
Cinchocaine
|
|
|
|
|
|
N01BB07
|
Etidocaine
|
|
|
|
|
|
N01BB08
|
Articaine
|
|
|
|
|
|
N01BB09
|
Ropivacaine
|
|
|
|
|
|
N01BB10
|
Levobupivacaine
|
|
|
|
|
|
N01BB20
|
Combinations
|
|
|
|
|
|
N01BB51
|
Bupivacaine, combinations
|
|
|
|
|
|
N01BB52
|
Lidocaine, combinations
|
|
|
|
|
|
N01BB53
|
Mepivacaine, combinations
|
|
|
|
|
|
N01BB54
|
Prilocaine, combinations
|
|
|
|
|
|
N01BB57
|
Etidocaine, combinations
|
|
|
|
|
|
N01BB58
|
Articaine, combinations
|
|
|
|
|
N01BC
|
|
Esters of benzoic acid
|
|
|
|
|
|
N01BC01
|
Cocaine
|
|
|
|
|
N01BX
|
|
Other local anesthetics
|
|
|
|
|
|
N01BX01
|
Ethyl chloride
|
|
|
|
|
|
N01BX02
|
Dyclonine
|
|
|
|
|
|
N01BX03
|
Phenol
|
|
|
|
|
|
N01BX04
|
Capsaicin
|
|
|
N02
|
|
|
|
Analgesics
|
|
|
|
N02A
|
|
|
Opioids
|
|
|
|
|
N02AA
|
|
Natural opium alkaloids
|
|
|
|
|
|
N02AA01
|
Morphine
|
|
|
|
|
|
N02AA02
|
Opium
|
|
|
|
|
|
N02AA03
|
Hydromorphone
|
|
|
|
|
|
N02AA04
|
Nicomorphine
|
|
|
|
|
|
N02AA05
|
Oxycodone
|
|
|
|
|
|
N02AA08
|
Dihydrocodeine
|
|
|
|
|
|
N02AA09
|
diamorphine (בוטל, קוד חדש N07BC06)
|
|
|
|
|
|
N02AA10
|
Papaveretum
|
|
|
|
|
|
N02AA51
|
Morphine, combinations
|
|
|
|
|
|
N02AA55
|
Oxycodone, combinations (בוטל, קוד חדש N02AJ17 - N02AJ19)
|
|
|
|
|
|
N02AA58
|
Dihydrocodeine, combinations (בוטל, קוד חדש N02AJ01 - N02AJ03)
|
|
|
|
|
|
N02AA59
|
Codeine, combinations excluding psycholeptics (בוטל, קוד חדש N02AJ06 - N02AJ09)
|
|
|
|
|
|
N02AA79
|
Codeine, combinations with psycholeptics
|
|
|
|
|
N02AB
|
|
Phenylpiperidine derivatives
|
|
|
|
|
|
N02AB01
|
Ketobemidone
|
|
|
|
|
|
N02AB02
|
Pethidine
|
|
|
|
|
|
N02AB03
|
Fentanyl
|
|
|
|
|
|
N02AB52
|
Pethidine, combinations excluding psycholeptics
|
|
|
|
|
|
N02AB72
|
Pethidine, combinations with psycholeptics
|
|
|
|
|
N02AC
|
|
Diphenylpropylamine derivatives
|
|
|
|
|
|
N02AC01
|
Dextromoramide
|
|
|
|
|
|
N02AC03
|
Piritramide
|
|
|
|
|
|
N02AC04
|
Dextropropoxyphene
|
|
|
|
|
|
N02AC05
|
Bezitramide
|
|
|
|
|
|
N02AC52
|
Methadone, combinations excluding psycholeptics
|
|
|
|
|
|
N02AC54
|
Dextropropoxyphene, combinations excluding psycholeptics
|
|
|
|
|
|
N02AC74
|
Dextropropoxyphene, combinations with psycholeptics
|
|
|
|
|
N02AD
|
|
Benzomorphan derivatives
|
|
|
|
|
|
N02AD01
|
Pentazocine
|
|
|
|
|
|
N02AD02
|
Phenazocine
|
|
|
|
|
N02AE
|
|
Oripavine derivatives
|
|
|
|
|
|
N02AE01
|
Buprenorphine
|
|
|
|
|
N02AF
|
|
Morphinan derivatives
|
|
|
|
|
|
N02AF01
|
Butorphanol
|
|
|
|
|
|
N02AF02
|
Nalbuphine
|
|
|
|
|
N02AG
|
|
Opioids in combination with antispasmodics
|
|
|
|
|
|
N02AG01
|
Morphine and antispasmodics
|
|
|
|
|
|
N02AG02
|
Ketobemidone and antispasmodics
|
|
|
|
|
|
N02AG03
|
Pethidine and antispasmodics
|
|
|
|
|
|
N02AG04
|
Hydromorphone and antispasmodics
|
|
|
|
|
N02AJ
|
|
Opioids in combination with non-opioid analgesics
|
|
|
|
|
|
N02AJ01
|
dihydrocodeine and paracetamol
|
|
|
|
|
|
N02AJ02
|
dihydrocodeine and acetylsalicylic acid
|
|
|
|
|
|
N02AJ03
|
dihydrocodeine and other non-opioid analgesics
|
|
|
|
|
|
N02AJ06
|
codeine and paracetamol
|
|
|
|
|
|
N02AJ07
|
codeine and acetylsalicylic acid
|
|
|
|
|
|
N02AJ08
|
codeine and ibuprofen
|
|
|
|
|
|
N02AJ09
|
codeine and other non-opioid analgesics
|
|
|
|
|
|
N02AJ13
|
tramadol and paracetamol
|
|
|
|
|
|
N02AJ14
|
tramadol and dexketoprofen
|
|
|
|
|
|
N02AJ15
|
tramadol and other non-opioid analgesics
|
|
|
|
|
|
N02AJ17
|
oxycodone and paracetamol
|
|
|
|
|
|
N02AJ18
|
oxycodone and acetylsalicylic acid
|
|
|
|
|
|
N02AJ19
|
oxycodone and ibuprofen
|
|
|
|
|
N02AX
|
|
Other opioids
|
|
|
|
|
|
N02AX01
|
Tilidine
|
|
|
|
|
|
N02AX02
|
Tramadol
|
|
|
|
|
|
N02AX03
|
Dezocine
|
|
|
|
|
|
N02AX05
|
Meptazinol
|
|
|
|
|
|
N02AX06
|
Tapentadol
|
|
|
|
|
|
N02AX52
|
Tramadol, combinations (בוטל, קוד חדש N02AJ13)
|
|
|
|
N02B
|
|
|
Other analgesics and antipyretics
|
|
|
|
|
N02BA
|
|
Salicylic acid and derivatives
|
|
|
|
|
|
N02BA01
|
Acetylsalicylic acid
|
|
|
|
|
|
N02BA02
|
Aloxiprin
|
|
|
|
|
|
N02BA03
|
Choline salicylate
|
|
|
|
|
|
N02BA04
|
Sodium salicylate
|
|
|
|
|
|
N02BA05
|
Salicylamide
|
|
|
|
|
|
N02BA06
|
Salsalate
|
|
|
|
|
|
N02BA07
|
Ethenzamide
|
|
|
|
|
|
N02BA08
|
Morpholine salicylate
|
|
|
|
|
|
N02BA09
|
Dipyrocetyl
|
|
|
|
|
|
N02BA10
|
Benorilate
|
|
|
|
|
|
N02BA11
|
Diflunisal
|
|
|
|
|
|
N02BA12
|
Potassium salicylate
|
|
|
|
|
|
N02BA14
|
Guacetisal
|
|
|
|
|
|
N02BA15
|
Carbasalate calcium
|
|
|
|
|
|
N02BA16
|
Imidazole salicylate
|
|
|
|
|
|
N02BA51
|
Acetylsalicylic acid, combinations excluding psycholeptics (בוטל, קוד חדש N02AJ02 - N02AJ17)
|
|
|
|
|
|
N02BA55
|
Salicylamide, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA57
|
Ethenzamide, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA59
|
Dipyrocetyl, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA65
|
Carbasalate calcium combinations excluding psycholeptics
|
|
|
|
|
|
N02BA71
|
Acetylsalicylic acid, combinations with psycholeptics
|
|
|
|
|
|
N02BA75
|
Salicylamide, combinations with psycholeptics
|
|
|
|
|
|
N02BA77
|
Ethenzamide, combinations with psycholeptics
|
|
|
|
|
|
N02BA79
|
Dipyrocetyl, combinations with psycholeptics
|
|
|
|
|
N02BB
|
|
Pyrazolones
|
|
|
|
|
|
N02BB01
|
Phenazone
|
|
|
|
|
|
N02BB02
|
Metamizole
|
|
|
|
|
|
N02BB03
|
Aminophenazone
|
|
|
|
|
|
N02BB04
|
Propyphenazone
|
|
|
|
|
|
N02BB05
|
Nifenazone
|
|
|
|
|
|
N02BB51
|
Phenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB52
|
Metamizole sodium, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB53
|
Aminophenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB54
|
Propyphenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB71
|
Phenazone, combinations with psycholeptics
|
|
|
|
|
|
N02BB72
|
Metamizole sodium, combinations with psycholeptics
|
|
|
|
|
|
N02BB73
|
Aminophenazone, combinations with psycholeptics
|
|
|
|
|
|
N02BB74
|
Propyphenazone, combinations with psycholeptics
|
|
|
|
|
N02BE
|
|
Anilides
|
|
|
|
|
|
N02BE01
|
Paracetamol
|
|
|
|
|
|
N02BE03
|
Phenacetin
|
|
|
|
|
|
N02BE04
|
Bucetin
|
|
|
|
|
|
N02BE05
|
Propacetamol
|
|
|
|
|
|
N02BE51
|
Paracetamol, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE53
|
Phenacetin, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE54
|
Bucetin, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE71
|
Paracetamol, combinations with psycholeptics
|
|
|
|
|
|
N02BE73
|
Phenacetin, combinations with psycholeptics
|
|
|
|
|
|
N02BE74
|
Bucetin, combinations with psycholeptics
|
|
|
|
|
N02BF
|
|
Gabapentinoids
|
|
|
|
|
|
N02BF01
|
gabapentin
|
|
|
|
|
|
N02BF02
|
pregabalin
|
|
|
|
|
|
N02BF03
|
mirogabalin
|
|
|
|
|
N02BG
|
|
Other analgesics and antipyretics
|
|
|
|
|
|
N02BG02
|
Rimazolium
|
|
|
|
|
|
N02BG03
|
Glafenine
|
|
|
|
|
|
N02BG04
|
Floctafenine
|
|
|
|
|
|
N02BG05
|
Viminol
|
|
|
|
|
|
N02BG06
|
Nefopam
|
|
|
|
|
|
N02BG07
|
Flupirtine
|
|
|
|
|
|
N02BG08
|
Ziconotide
|
|
|
|
|
|
N02BG09
|
Methoxyflurane
|
|
|
|
|
|
N02BG10
|
Nabiximols
|
|
|
|
N02C
|
|
|
Antimigraine preparations
|
|
|
|
|
N02CA
|
|
Ergot alkaloids
|
|
|
|
|
|
N02CA01
|
Dihydroergotamine
|
|
|
|
|
|
N02CA02
|
Ergotamine
|
|
|
|
|
|
N02CA04
|
Methysergide
|
|
|
|
|
|
N02CA07
|
Lisuride
|
|
|
|
|
|
N02CA51
|
Dihydroergotamine, combinations
|
|
|
|
|
|
N02CA52
|
Ergotamine, combinations excluding psycholeptics
|
|
|
|
|
|
N02CA72
|
Ergotamine, combinations with psycholeptics
|
|
|
|
|
N02CB
|
|
Corticosteroid derivatives
|
|
|
|
|
|
N02CB01
|
Flumedroxone
|
|
|
|
|
N02CC
|
|
Selective serotonin (5-HT1) agonists
|
|
|
|
|
|
N02CC01
|
Sumatriptan
|
|
|
|
|
|
N02CC02
|
Naratriptan
|
|
|
|
|
|
N02CC03
|
Zolmitriptan
|
|
|
|
|
|
N02CC04
|
Rizatriptan
|
|
|
|
|
|
N02CC05
|
Almotriptan
|
|
|
|
|
|
N02CC06
|
Eletriptan
|
|
|
|
|
|
N02CC07
|
Frovatriptan
|
|
|
|
|
N02CD
|
|
Calcitonin gene-related peptide (CGRP) antagonists
|
|
|
|
|
|
N02CD01
|
erenumab
|
|
|
|
|
|
N02CD02
|
galcanezumab
|
|
|
|
|
|
N02CD03
|
fremanezumab
|
|
|
|
|
|
N02CD04
|
ubrogepant
|
|
|
|
|
|
N02CD05
|
eptinezumab
|
|
|
|
|
|
N02CD06
|
rimegepant
|
|
|
|
|
|
N02CD07
|
atogepant
|
|
|
|
|
N02CX
|
|
Other antimigraine preparations
|
|
|
|
|
|
N02CX01
|
Pizotifen
|
|
|
|
|
|
N02CX02
|
Clonidine
|
|
|
|
|
|
N02CX03
|
Iprazochrome
|
|
|
|
|
|
N02CX05
|
Dimetotiazine
|
|
|
|
|
|
N02CX06
|
Oxetorone
|
|
|
|
|
|
N02CX07
|
erenumab (בוטל, קוד חדש N02CD01)
|
|
|
|
|
|
N02CX08
|
galcanezumab (בוטל, קוד חדש N02CD02)
|
|
|
N03
|
|
|
|
Antiepileptics
|
|
|
|
N03A
|
|
|
Antiepileptics
|
|
|
|
|
N03AA
|
|
Barbiturates and derivatives
|
|
|
|
|
|
N03AA01
|
Methylphenobarbital
|
|
|
|
|
|
N03AA02
|
Phenobarbital
|
|
|
|
|
|
N03AA03
|
Primidone
|
|
|
|
|
|
N03AA04
|
Barbexaclone
|
|
|
|
|
|
N03AA30
|
Metharbital
|
|
|
|
|
N03AB
|
|
Hydantoin derivatives
|
|
|
|
|
|
N03AB01
|
Ethotoin
|
|
|
|
|
|
N03AB02
|
Phenytoin
|
|
|
|
|
|
03AB03
|
Amino(diphenylhydantoin) valeric acid
|
|
|
|
|
|
N03AB04
|
Mephenytoin
|
|
|
|
|
|
N03AB05
|
Fosphenytoin
|
|
|
|
|
|
N03AB52
|
Phenytoin, combinations
|
|
|
|
|
|
N03AB54
|
Mephenytoin, combinations
|
|
|
|
|
N03AC
|
|
Oxazolidine derivatives
|
|
|
|
|
|
N03AC01
|
Paramethadione
|
|
|
|
|
|
N03AC02
|
Trimethadione
|
|
|
|
|
|
N03AC03
|
Ethadione
|
|
|
|
|
N03AD
|
|
Succinimide derivatives
|
|
|
|
|
|
N03AD01
|
Ethosuximide
|
|
|
|
|
|
N03AD02
|
Phensuximide
|
|
|
|
|
|
N03AD03
|
Mesuximide
|
|
|
|
|
|
N03AD51
|
Ethosuximide, combinations
|
|
|
|
|
N03AE
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N03AE01
|
Clonazepam
|
|
|
|
|
N03AF
|
|
Carboxamide derivatives
|
|
|
|
|
|
N03AF01
|
Carbamazepine
|
|
|
|
|
|
N03AF02
|
Oxcarbazepine
|
|
|
|
|
|
N03AF03
|
Rufinamide
|
|
|
|
|
|
N03AF04
|
Eslicarbazepine
|
|
|
|
|
N03AG
|
|
Fatty acid derivatives
|
|
|
|
|
|
N03AG01
|
Valproic acid
|
|
|
|
|
|
N03AG02
|
Valpromide
|
|
|
|
|
|
N03AG03
|
Aminobutyric acid
|
|
|
|
|
|
N03AG04
|
Vigabatrin
|
|
|
|
|
|
N03AG05
|
Progabide
|
|
|
|
|
|
N03AG06
|
Tiagabine
|
|
|
|
|
N03AX
|
|
Other antiepileptics
|
|
|
|
|
|
N03AX03
|
Sultiame
|
|
|
|
|
|
N03AX07
|
Phenacemide
|
|
|
|
|
|
N03AX09
|
Lamotrigine
|
|
|
|
|
|
N03AX10
|
Felbamate
|
|
|
|
|
|
N03AX11
|
Topiramate
|
|
|
|
|
|
N03AX12
|
Gabapentin (בוטל)
|
|
|
|
|
|
N03AX13
|
Pheneturide
|
|
|
|
|
|
N03AX14
|
Levetiracetam
|
|
|
|
|
|
N03AX15
|
Zonisamide
|
|
|
|
|
|
N03AX16
|
Pregabalin (בוטל)
|
|
|
|
|
|
N03AX17
|
Stiripentol
|
|
|
|
|
|
N03AX18
|
Lacosamide
|
|
|
|
|
|
N03AX19
|
Carisbamate
|
|
|
|
|
|
N03AX21
|
Retigabine
|
|
|
|
|
|
N03AX22
|
Perampanel
|
|
|
|
|
|
N03AX23
|
brivaracetam
|
|
|
|
|
|
N03AX24
|
cannabidiol
|
|
|
|
|
|
N03AX25
|
cenobamate
|
|
|
|
|
|
N03AX26
|
fenfluramine
|
|
|
|
|
|
N03AX27
|
ganaxolone
|
|
|
|
|
|
N03AX30
|
Beclamide
|
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
|
|
N04A
|
|
|
Anticholinergic agents
|
|
|
|
|
N04AA
|
|
Tertiary amines
|
|
|
|
|
|
N04AA01
|
Trihexyphenidyl
|
|
|
|
|
|
N04AA02
|
Biperiden
|
|
|
|
|
|
N04AA03
|
Metixene
|
|
|
|
|
|
N04AA04
|
Procyclidine
|
|
|
|
|
|
N04AA05
|
Profenamine
|
|
|
|
|
|
N04AA08
|
Dexetimide
|
|
|
|
|
|
N04AA09
|
Phenglutarimide
|
|
|
|
|
|
N04AA10
|
Mazaticol
|
|
|
|
|
|
N04AA11
|
Bornaprine
|
|
|
|
|
|
N04AA12
|
Tropatepine
|
|
|
|
|
N04AB
|
|
Ethers chemically close to antihistamines
|
|
|
|
|
|
N04AB01
|
Etanautine
|
|
|
|
|
|
N04AB02
|
Orphenadrine (chloride)
|
|
|
|
|
N04AC
|
|
Ethers of tropine or tropine derivatives
|
|
|
|
|
|
N04AC01
|
Benzatropine
|
|
|
|
|
|
N04AC30
|
Etybenzatropine
|
|
|
|
N04B
|
|
|
Dopaminergic agents
|
|
|
|
|
N04BA
|
|
Dopa and dopa derivatives
|
|
|
|
|
|
N04BA01
|
Levodopa
|
|
|
|
|
|
N04BA02
|
Levodopa and decarboxylase inhibitor
|
|
|
|
|
|
N04BA03
|
Levodopa, decarboxylase inhibitor and COMT inhibitor
|
|
|
|
|
|
N04BA04
|
Melevodopa
|
|
|
|
|
|
N04BA05
|
Melevodopa and decarboxylase inhibitor
|
|
|
|
|
|
N04BA06
|
Etilevodopa and decarboxylase inhibitor
|
|
|
|
|
|
N04BA07
|
foslevodopa and decarboxylase inhibitor
|
|
|
|
|
N04BB
|
|
Adamantane derivatives
|
|
|
|
|
|
N04BB01
|
Amantadine
|
|
|
|
|
N04BC
|
|
Dopamine agonists
|
|
|
|
|
|
N04BC01
|
Bromocriptine
|
|
|
|
|
|
N04BC02
|
Pergolide
|
|
|
|
|
|
N04BC03
|
Dihydroergocryptine mesylate
|
|
|
|
|
|
N04BC04
|
Ropinirole
|
|
|
|
|
|
N04BC05
|
Pramipexole
|
|
|
|
|
|
N04BC06
|
Cabergoline
|
|
|
|
|
|
N04BC07
|
Apomorphine
|
|
|
|
|
|
N04BC08
|
Piribedil
|
|
|
|
|
|
N04BC09
|
Rotigotine
|
|
|
|
|
N04BD
|
|
Monoamine oxidase B inhibitors
|
|
|
|
|
|
N04BD01
|
Selegiline
|
|
|
|
|
|
N04BD02
|
Rasagiline
|
|
|
|
|
N04BX
|
|
Other dopaminergic agents
|
|
|
|
|
|
N04BX01
|
Tolcapone
|
|
|
|
|
|
N04BX02
|
Entacapone
|
|
|
|
|
|
N04BX03
|
Budipine
|
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
|
|
|
|
|
|
N05AA01
|
Chlorpromazine
|
|
|
|
|
|
N05AA02
|
Levomepromazine
|
|
|
|
|
|
N05AA03
|
Promazine
|
|
|
|
|
|
N05AA04
|
Acepromazine
|
|
|
|
|
|
N05AA05
|
Triflupromazine
|
|
|
|
|
|
N05AA06
|
Cyamemazine
|
|
|
|
|
|
N05AA07
|
Chlorproethazine
|
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
|
|
|
|
|
|
N05AB01
|
Dixyrazine
|
|
|
|
|
|
N05AB02
|
Fluphenazine
|
|
|
|
|
|
N05AB03
|
Perphenazine
|
|
|
|
|
|
N05AB04
|
Prochlorperazine
|
|
|
|
|
|
N05AB05
|
Thiopropazate
|
|
|
|
|
|
N05AB06
|
Trifluoperazine
|
|
|
|
|
|
N05AB07
|
Acetophenazine
|
|
|
|
|
|
N05AB08
|
Thioproperazine
|
|
|
|
|
|
N05AB09
|
Butaperazine
|
|
|
|
|
|
N05AB10
|
Perazine
|
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
|
|
|
|
|
|
N05AC01
|
Periciazine
|
|
|
|
|
|
N05AC02
|
Thioridazine
|
|
|
|
|
|
N05AC03
|
Mesoridazine
|
|
|
|
|
|
N05AC04
|
Pipotiazine
|
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
|
|
|
|
|
|
N05AD01
|
Haloperidol
|
|
|
|
|
|
N05AD02
|
Trifluperidol
|
|
|
|
|
|
N05AD03
|
Melperone
|
|
|
|
|
|
N05AD04
|
Moperone
|
|
|
|
|
|
N05AD05
|
Pipamperone
|
|
|
|
|
|
N05AD06
|
Bromperidol
|
|
|
|
|
|
N05AD07
|
Benperidol
|
|
|
|
|
|
N05AD08
|
Droperidol
|
|
|
|
|
|
N05AD09
|
Fluanisone
|
|
|
|
|
N05AE
|
|
Indole derivatives
|
|
|
|
|
|
N05AE01
|
Oxypertine
|
|
|
|
|
|
N05AE02
|
Molindone
|
|
|
|
|
|
N05AE03
|
Sertindole
|
|
|
|
|
|
N05AE04
|
Ziprasidone
|
|
|
|
|
|
N05AE05
|
Lurasidone
|
|
|
|
|
N05AF
|
|
Thioxanthene derivative
|
|
|
|
|
|
N05AF01
|
Flupentixol
|
|
|
|
|
|
N05AF02
|
Clopenthixol
|
|
|
|
|
|
N05AF03
|
Chlorprothixene
|
|
|
|
|
|
N05AF04
|
Thiothixene
|
|
|
|
|
|
N05AF05
|
Zuclopenthixol
|
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
|
|
|
|
|
|
N05AG01
|
Fluspirilene
|
|
|
|
|
|
N05AG02
|
Pimozide
|
|
|
|
|
|
N05AG03
|
Penfluridol
|
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
|
|
|
|
|
|
N05AH01
|
Loxapine
|
|
|
|
|
|
N05AH02
|
Clozapine
|
|
|
|
|
|
N05AH03
|
Olanzapine
|
|
|
|
|
|
N05AH04
|
Quetiapine
|
|
|
|
|
|
N05AH05
|
Asenapine
|
|
|
|
|
|
N05AH06
|
Clotiapine
|
|
|
|
|
N05AK
|
|
Neuroleptics, in tardive dyskinesia
|
|
|
|
|
|
N05AK01
|
tetrabenazine (בוטל, קוד חדש N07XX06)
|
|
|
|
|
N05AL
|
|
Benzamides
|
|
|
|
|
|
N05AL01
|
Sulpiride
|
|
|
|
|
|
N05AL02
|
Sultopride
|
|
|
|
|
|
N05AL03
|
Tiapride
|
|
|
|
|
|
N05AL04
|
Remoxipride
|
|
|
|
|
|
N05AL05
|
Amisulpride
|
|
|
|
|
|
N05AL06
|
Veralipride
|
|
|
|
|
|
N05AL07
|
Levosulpiride
|
|
|
|
|
N05AN
|
|
Lithium
|
|
|
|
|
|
N05AN01
|
Lithium
|
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
|
N05AX09
|
clotiapine (בוטל, קוד חדש N05AH06)
|
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
|
|
|
N05AX15
|
cariprazine
|
|
|
|
|
|
N05AX16
|
brexpiprazole
|
|
|
|
|
|
N05AX17
|
pimavanserin
|
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
|
|
N05BA
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N05BA01
|
Diazepam
|
|
|
|
|
|
N05BA02
|
Chlordiazepoxide
|
|
|
|
|
|
N05BA03
|
Medazepam
|
|
|
|
|
|
N05BA04
|
Oxazepam
|
|
|
|
|
|
N05BA05
|
Potassium clorazepate
|
|
|
|
|
|
N05BA06
|
Lorazepam
|
|
|
|
|
|
N05BA07
|
Adinazolam
|
|
|
|
|
|
N05BA08
|
Bromazepam
|
|
|
|
|
|
N05BA09
|
Clobazam
|
|
|
|
|
|
N05BA10
|
Ketazolam
|
|
|
|
|
|
N05BA11
|
Prazepam
|
|
|
|
|
|
N05BA12
|
Alprazolam
|
|
|
|
|
|
N05BA13
|
Halazepam
|
|
|
|
|
|
N05BA14
|
Pinazepam
|
|
|
|
|
|
N05BA15
|
Camazepam
|
|
|
|
|
|
N05BA16
|
Nordazepam
|
|
|
|
|
|
N05BA17
|
Fludiazepam
|
|
|
|
|
|
N05BA18
|
Ethyl loflazepate
|
|
|
|
|
|
N05BA19
|
Etizolam
|
|
|
|
|
|
N05BA21
|
Clotiazepam
|
|
|
|
|
|
N05BA22
|
Cloxazolam
|
|
|
|
|
|
N05BA23
|
Tofisopam
|
|
|
|
|
|
N05BA56
|
Lorazepam, combinations
|
|
|
|
|
N05BB
|
|
Diphenylmethane derivatives
|
|
|
|
|
|
N05BB01
|
Hydroxyzine
|
|
|
|
|
|
N05BB02
|
Captodiame
|
|
|
|
|
|
N05BB51
|
Hydroxyzine, combinations
|
|
|
|
|
N05BC
|
|
Carbamates
|
|
|
|
|
|
N05BC01
|
Meprobamate
|
|
|
|
|
|
N05BC03
|
Emylcamate
|
|
|
|
|
|
N05BC04
|
Mebutamate
|
|
|
|
|
|
N05BC51
|
Meprobamate, combinations
|
|
|
|
|
N05BD
|
|
Dibenzo-bicyclo-octadiene derivatives
|
|
|
|
|
|
N05BD01
|
Benzoctamine
|
|
|
|
|
N05BE
|
|
Azaspirodecanedione derivatives
|
|
|
|
|
|
N05BE01
|
Buspirone
|
|
|
|
|
N05BX
|
|
Other anxiolytics
|
|
|
|
|
|
N05BX01
|
Mephenoxalone
|
|
|
|
|
|
N05BX02
|
Gedocarnil
|
|
|
|
|
|
N05BX03
|
Etifoxine
|
|
|
|
N05C
|
|
|
Hypnotics and sedatives
|
|
|
|
|
N05CA
|
|
Barbiturates, plain
|
|
|
|
|
|
N05CA01
|
Pentobarbital
|
|
|
|
|
|
N05CA02
|
Amobarbital
|
|
|
|
|
|
N05CA03
|
Butobarbital
|
|
|
|
|
|
N05CA04
|
Barbital
|
|
|
|
|
|
N05CA05
|
Aprobarbital
|
|
|
|
|
|
N05CA06
|
Secobarbital
|
|
|
|
|
|
N05CA07
|
Talbutal
|
|
|
|
|
|
N05CA08
|
Vinylbital
|
|
|
|
|
|
N05CA09
|
Vinbarbital
|
|
|
|
|
|
N05CA10
|
Cyclobarbital
|
|
|
|
|
|
N05CA11
|
Heptabarbital
|
|
|
|
|
|
N05CA12
|
Reposal
|
|
|
|
|
|
N05CA15
|
Methohexital
|
|
|
|
|
|
N05CA16
|
Hexobarbital
|
|
|
|
|
|
N05CA19
|
Thiopental
|
|
|
|
|
|
N05CA20
|
Ethallobarbital
|
|
|
|
|
|
N05CA21
|
Allobarbital
|
|
|
|
|
|
N05CA22
|
Proxibarbal
|
|
|
|
|
N05CB
|
|
Barbiturates, combinations
|
|
|
|
|
|
N05CB01
|
Combinations of barbiturates
|
|
|
|
|
|
N05CB02
|
Barbiturates in combination with other drugs
|
|
|
|
|
N05CC
|
|
Aldehydes and derivatives
|
|
|
|
|
|
N05CC01
|
Chloral hydrate
|
|
|
|
|
|
N05CC02
|
Chloralodol
|
|
|
|
|
|
N05CC03
|
Acetylglycinamide chloral hydrate
|
|
|
|
|
|
N05CC04
|
Dichloralphenazone
|
|
|
|
|
|
N05CC05
|
Paraldehyde
|
|
|
|
|
N05CD
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N05CD01
|
Flurazepam
|
|
|
|
|
|
N05CD02
|
Nitrazepam
|
|
|
|
|
|
N05CD03
|
Flunitrazepam
|
|
|
|
|
|
N05CD04
|
Estazolam
|
|
|
|
|
|
N05CD05
|
Triazolam
|
|
|
|
|
|
N05CD06
|
Lormetazepam
|
|
|
|
|
|
N05CD07
|
Temazepam
|
|
|
|
|
|
N05CD08
|
Midazolam
|
|
|
|
|
|
N05CD09
|
Brotizolam
|
|
|
|
|
|
N05CD10
|
Quazepam
|
|
|
|
|
|
N05CD11
|
Loprazolam
|
|
|
|
|
|
N05CD12
|
Doxefazepam
|
|
|
|
|
|
N05CD13
|
Cinolazepam
|
|
|
|
|
|
N05CD14
|
remimazolam
|
|
|
|
|
|
N05CD15
|
nimetazepam
|
|
|
|
|
N05CE
|
|
Piperidinedione derivatives
|
|
|
|
|
|
N05CE01
|
Glutethimide
|
|
|
|
|
|
N05CE02
|
Methyprylon
|
|
|
|
|
|
N05CE03
|
Pyrithyldione
|
|
|
|
|
N05CF
|
|
Benzodiazepine related drugs
|
|
|
|
|
|
N05CF01
|
Zopiclone
|
|
|
|
|
|
N05CF02
|
Zolpidem
|
|
|
|
|
|
N05CF03
|
Zaleplon
|
|
|
|
|
|
N05CF04
|
Eszopiclone
|
|
|
|
|
N05CH
|
|
Melatonin receptor agonists
|
|
|
|
|
|
N05CH01
|
Melatonin
|
|
|
|
|
|
N05CH02
|
Ramelteon
|
|
|
|
|
|
N05CH03
|
tasimelteon
|
|
|
|
|
N05CJ
|
|
Orexin receptor antagonists
|
|
|
|
|
|
N05CJ01
|
suvorexant
|
|
|
|
|
|
N05CJ02
|
lemborexant
|
|
|
|
|
|
N05CJ03
|
daridorexant
|
|
|
|
|
N05CM
|
|
Other hypnotics and sedatives
|
|
|
|
|
|
N05CM01
|
Methaqualone
|
|
|
|
|
|
N05CM02
|
Clomethiazole
|
|
|
|
|
|
N05CM03
|
Bromisoval
|
|
|
|
|
|
N05CM04
|
Carbromal
|
|
|
|
|
|
N05CM05
|
Scopolamine
|
|
|
|
|
|
N05CM06
|
Propiomazine
|
|
|
|
|
|
N05CM07
|
Triclofos
|
|
|
|
|
|
N05CM08
|
Ethchlorvynol
|
|
|
|
|
|
N05CM09
|
Valerianae radix
|
|
|
|
|
|
N05CM10
|
Hexapropymate
|
|
|
|
|
|
N05CM11
|
Bromides
|
|
|
|
|
|
N05CM12
|
Apronal
|
|
|
|
|
|
N05CM13
|
Valnoctamide
|
|
|
|
|
|
N05CM15
|
Methylpentynol
|
|
|
|
|
|
N05CM16
|
Niaprazine
|
|
|
|
|
|
N05CM17
|
melatonin (בוטל, קוד חדש N05CH01)
|
|
|
|
|
|
N05CM18
|
Dexmedetomidine
|
|
|
|
|
N05CX
|
|
Hypnotics and sedatives in combination, excluding barbiturates
|
|
|
|
|
|
N05CX01
|
Meprobamate, combinations
|
|
|
|
|
|
N05CX02
|
Methaqualone, combinations
|
|
|
|
|
|
N05CX03
|
Methylpentynol, combinations
|
|
|
|
|
|
N05CX04
|
Clomethiazole, combinations
|
|
|
|
|
|
N05CX05
|
Emepronium, combinations
|
|
|
|
|
|
N05CX06
|
Dipiperonylaminoethanol, combinations
|
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
|
|
N06A
|
|
|
Antidepressants
|
|
|
|
|
N06AA
|
|
Non-selective monoamine reuptake inhibitors
|
|
|
|
|
|
N06AA01
|
Desipramine
|
|
|
|
|
|
N06AA02
|
Imipramine
|
|
|
|
|
|
N06AA03
|
Imipramine oxide
|
|
|
|
|
|
N06AA04
|
Clomipramine
|
|
|
|
|
|
N06AA05
|
Opipramol
|
|
|
|
|
|
N06AA06
|
Trimipramine
|
|
|
|
|
|
N06AA07
|
Lofepramine
|
|
|
|
|
|
N06AA08
|
Dibenzepin
|
|
|
|
|
|
N06AA09
|
Amitriptyline
|
|
|
|
|
|
N06AA10
|
Nortriptyline
|
|
|
|
|
|
N06AA11
|
Protriptyline
|
|
|
|
|
|
N06AA12
|
Doxepin
|
|
|
|
|
|
N06AA13
|
Iprindole
|
|
|
|
|
|
N06AA14
|
Melitracen
|
|
|
|
|
|
N06AA15
|
Butriptyline
|
|
|
|
|
|
N06AA16
|
Dosulepin
|
|
|
|
|
|
N06AA17
|
Amoxapine
|
|
|
|
|
|
N06AA18
|
Dimetacrine
|
|
|
|
|
|
N06AA19
|
Amineptine
|
|
|
|
|
|
N06AA21
|
Maprotiline
|
|
|
|
|
|
N06AA23
|
Quinupramine
|
|
|
|
|
N06AB
|
|
Selective serotonin reuptake inhibitors
|
|
|
|
|
|
N06AB02
|
Zimelidine
|
|
|
|
|
|
N06AB03
|
Fluoxetine
|
|
|
|
|
|
N06AB04
|
Citalopram
|
|
|
|
|
|
N06AB05
|
Paroxetine
|
|
|
|
|
|
N06AB06
|
Sertraline
|
|
|
|
|
|
N06AB07
|
Alaproclate
|
|
|
|
|
|
N06AB08
|
Fluvoxamine
|
|
|
|
|
|
N06AB09
|
Etoperidone
|
|
|
|
|
|
N06AB10
|
Escitalopram
|
|
|
|
|
N06AF
|
|
Monoamine oxidase inhibitors, non-selective
|
|
|
|
|
|
N06AF01
|
Isocarboxazid
|
|
|
|
|
|
N06AF02
|
Nialamide
|
|
|
|
|
|
N06AF03
|
Phenelzine
|
|
|
|
|
|
N06AF04
|
Tranylcypromine
|
|
|
|
|
|
N06AF05
|
Iproniazide
|
|
|
|
|
|
N06AF06
|
Iproclozide
|
|
|
|
|
N06AG
|
|
Monoamine oxidase A inhibitors
|
|
|
|
|
|
N06AG02
|
Moclobemide
|
|
|
|
|
|
N06AG03
|
Toloxatone
|
|
|
|
|
N06AX
|
|
Other antidepressants
|
|
|
|
|
|
N06AX01
|
Oxitriptan
|
|
|
|
|
|
N06AX02
|
Tryptophan
|
|
|
|
|
|
N06AX03
|
Mianserin
|
|
|
|
|
|
N06AX04
|
Nomifensine
|
|
|
|
|
|
N06AX05
|
Trazodone
|
|
|
|
|
|
N06AX06
|
Nefazodone
|
|
|
|
|
|
N06AX07
|
Minaprine
|
|
|
|
|
|
N06AX08
|
Bifemelane
|
|
|
|
|
|
N06AX09
|
Viloxazine
|
|
|
|
|
|
N06AX10
|
Oxaflozane
|
|
|
|
|
|
N06AX11
|
Mirtazapine
|
|
|
|
|
|
N06AX12
|
Bupropion
|
|
|
|
|
|
N06AX13
|
Medifoxamine
|
|
|
|
|
|
N06AX14
|
Tianeptine
|
|
|
|
|
|
N06AX15
|
Pivagabine
|
|
|
|
|
|
N06AX16
|
Venlafaxine
|
|
|
|
|
|
N06AX17
|
Milnacipran
|
|
|
|
|
|
N06AX18
|
Reboxetine
|
|
|
|
|
|
N06AX19
|
Gepirone
|
|
|
|
|
|
N06AX21
|
Duloxetine
|
|
|
|
|
|
N06AX22
|
Agomelatine
|
|
|
|
|
|
N06AX23
|
Desvenlafaxine
|
|
|
|
|
|
N06AX24
|
Vilazodone
|
|
|
|
|
|
N06AX25
|
Hyperici herba
|
|
|
|
|
|
N06AX26
|
Vortioxetine (proposed code)
|
|
|
|
N06B
|
|
|
Psychostimulants, agents used for ADHD and nootropics
|
|
|
|
|
N06BA
|
|
Centrally acting sympathomimetics
|
|
|
|
|
|
N06BA01
|
Amphetamine
|
|
|
|
|
|
N06BA02
|
Dexamphetamine
|
|
|
|
|
|
N06BA03
|
Dextromethamphetamine
|
|
|
|
|
|
N06BA04
|
Methylphenidate
|
|
|
|
|
|
N06BA05
|
Pemoline
|
|
|
|
|
|
N06BA06
|
Fencamfamin
|
|
|
|
|
|
N06BA07
|
Modafinil
|
|
|
|
|
|
N06BA08
|
Fenozolone
|
|
|
|
|
|
N06BA09
|
Atomoxetine
|
|
|
|
|
|
N06BA10
|
Fenetylline
|
|
|
|
|
|
N06BA11
|
Dexmethylphenidate
|
|
|
|
|
|
N06BA12
|
Lisdexamfetamine
|
|
|
|
|
|
N06BA13
|
armodafinil
|
|
|
|
|
|
N06BA14
|
solriamfetol
|
|
|
|
|
N06BC
|
|
Xanthine derivatives
|
|
|
|
|
|
N06BC01
|
Caffeine
|
|
|
|
|
|
N06BC02
|
Propentofylline
|
|
|
|
|
N06BX
|
|
Other psychostimulants and nootropics
|
|
|
|
|
|
N06BX01
|
Meclofenoxate
|
|
|
|
|
|
N06BX02
|
Pyritinol
|
|
|
|
|
|
N06BX03
|
Piracetam
|
|
|
|
|
|
N06BX04
|
Deanol
|
|
|
|
|
|
N06BX05
|
Fipexide
|
|
|
|
|
|
N06BX06
|
Citicoline
|
|
|
|
|
|
N06BX07
|
Oxiracetam
|
|
|
|
|
|
N06BX08
|
Pirisudanol
|
|
|
|
|
|
N06BX09
|
Linopirdine
|
|
|
|
|
|
N06BX10
|
Nizofenone
|
|
|
|
|
|
N06BX11
|
Aniracetam
|
|
|
|
|
|
N06BX12
|
Acetylcarnitine
|
|
|
|
|
|
N06BX13
|
Idebenone
|
|
|
|
|
|
N06BX14
|
Prolintane
|
|
|
|
|
|
N06BX15
|
Pipradrol
|
|
|
|
|
|
N06BX16
|
Pramiracetam
|
|
|
|
|
|
N06BX17
|
Adrafinil
|
|
|
|
|
|
N06BX18
|
Vinpocetine
|
|
|
|
N06C
|
|
|
Psycholeptics and psychoanaleptics in combination
|
|
|
|
|
N06CA
|
|
Antidepressants in combination with psycholeptics
|
|
|
|
|
|
N06CA01
|
Amitriptyline and psycholeptics
|
|
|
|
|
|
N06CA02
|
Melitracen and psycholeptics
|
|
|
|
|
|
N06CA03
|
Fluoxetine and psycholeptics
|
|
|
|
|
N06CB
|
|
Psychostimulants in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
N06D
|
|
|
Anti-dementia drugs
|
|
|
|
|
N06DA
|
|
Anticholinesterases
|
|
|
|
|
|
N06DA01
|
Tacrine
|
|
|
|
|
|
N06DA02
|
Donepezil
|
|
|
|
|
|
N06DA03
|
Rivastigmine
|
|
|
|
|
|
N06DA04
|
Galantamine
|
|
|
|
|
|
N06DA52
|
Donepezil and memantine
|
|
|
|
|
N06DX
|
|
Other anti-dementia drugs
|
|
|
|
|
|
N06DX01
|
Memantine
|
|
|
|
|
|
N06DX02
|
Ginkgo folium
|
|
|
|
|
|
N06DX03
|
aducanumab
|
|
|
|
|
|
N06DX30
|
combinations
|
|
|
N07
|
|
|
|
Other nervous system drugs
|
|
|
|
N07A
|
|
|
Parasympathomimetics
|
|
|
|
|
N07AA
|
|
Anticholinesterases
|
|
|
|
|
|
N07AA01
|
Neostigmine
|
|
|
|
|
|
N07AA02
|
Pyridostigmine
|
|
|
|
|
|
N07AA03
|
Distigmine
|
|
|
|
|
|
N07AA30
|
Ambenonium
|
|
|
|
|
|
N07AA51
|
Neostigmine, combinations
|
|
|
|
|
N07AB
|
|
Choline esters
|
|
|
|
|
|
N07AB01
|
Carbachol
|
|
|
|
|
|
N07AB02
|
Bethanechol
|
|
|
|
|
N07AX
|
|
Other parasympathomimetics
|
|
|
|
|
|
N07AX01
|
Pilocarpine
|
|
|
|
|
|
N07AX02
|
Choline alfoscerate
|
|
|
|
|
|
N07AX03
|
Cevimeline
|
|
|
|
N07B
|
|
|
Drugs used in addictive disorders
|
|
|
|
|
N07BA
|
|
Drugs used in nicotine dependence
|
|
|
|
|
|
N07BA01
|
Nicotine
|
|
|
|
|
|
N07BA02
|
bupropion (בוטל, קוד חדש N06AX12)
|
|
|
|
|
|
N07BA03
|
Varenicline
|
|
|
|
|
N07BB
|
|
Drugs used in alcohol dependence
|
|
|
|
|
|
N07BB01
|
Disulfiram
|
|
|
|
|
|
N07BB02
|
Calcium carbimide
|
|
|
|
|
|
N07BB03
|
Acamprosate
|
|
|
|
|
|
N07BB04
|
Naltrexone
|
|
|
|
|
|
N07BB05
|
nalmefene
|
|
|
|
|
N07BC
|
|
Drugs used in opioid dependence
|
|
|
|
|
|
N07BC01
|
Buprenorphine
|
|
|
|
|
|
N07BC02
|
Methadone
|
|
|
|
|
|
N07BC03
|
Levacetylmethadol
|
|
|
|
|
|
N07BC04
|
Lofexidine
|
|
|
|
|
|
N07BC05
|
Levomethadone
|
|
|
|
|
|
N07BC06
|
Diamorphine
|
|
|
|
|
|
N07BC51
|
Buprenorphine, combinations
|
|
|
|
N07C
|
|
|
Antivertigo preparations
|
|
|
|
|
N07CA
|
|
Antivertigo preparations
|
|
|
|
|
|
N07CA01
|
Betahistine
|
|
|
|
|
|
N07CA02
|
Cinnarizine
|
|
|
|
|
|
N07CA03
|
Flunarizine
|
|
|
|
|
|
N07CA04
|
Acetylleucine
|
|
|
|
|
|
N07CA52
|
Cinnarizine, combinations
|
|
|
|
N07X
|
|
|
Other nervous system drugs
|
|
|
|
|
N07XA
|
|
Gangliosides and ganglioside derivatives
|
|
|
|
|
|
|
empty
|
|
|
|
|
N07XX
|
|
Other nervous system drugs
|
|
|
|
|
|
N07XX01
|
Tirilazad
|
|
|
|
|
|
N07XX02
|
Riluzole
|
|
|
|
|
|
N07XX03
|
Xaliproden
|
|
|
|
|
|
N07XX04
|
Sodium oxybate
|
|
|
|
|
|
N07XX05
|
Amifampridine
|
|
|
|
|
|
N07XX06
|
Tetrabenazine
|
|
|
|
|
|
N07XX07
|
Fampridine
|
|
|
|
|
|
N07XX08
|
Tafamidis
|
|
|
|
|
|
N07XX09
|
dimethyl fumarate (בוטל, קוד חדש L04AX07)
|
|
|
|
|
|
N07XX10
|
laquinimod
|
|
|
|
|
|
N07XX11
|
pitolisant
|
|
|
|
|
|
N07XX12
|
patisiran
|
|
|
|
|
|
N07XX13
|
valbenazine
|
|
|
|
|
|
N07XX14
|
edaravone
|
|
|
|
|
|
N07XX15
|
inotersen
|
|
|
|
|
|
N07XX16
|
deutetrabenazine
|
|
|
|
|
|
N07XX17
|
arimoclomol
|
|
|
|
|
|
N07XX59
|
Dextromethorphan, combinations
|
| P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
|
P01
|
|
|
|
Antiprotozoals
|
|
|
|
P01A
|
|
|
Agents against amoebiasis and other protozoal diseases
|
|
|
|
|
P01AA
|
|
Hydroxyquinoline derivatives
|
|
|
|
|
|
P01AA01
|
Broxyquinoline
|
|
|
|
|
|
P01AA02
|
Clioquinol
|
|
|
|
|
|
P01AA04
|
Chlorquinaldol
|
|
|
|
|
|
P01AA05
|
Tilbroquinol
|
|
|
|
|
|
P01AA52
|
Clioquinol, combinations
|
|
|
|
|
P01AB
|
|
Nitroimidazole derivatives
|
|
|
|
|
|
P01AB01
|
Metronidazole
|
|
|
|
|
|
P01AB02
|
Tinidazole
|
|
|
|
|
|
P01AB03
|
Ornidazole
|
|
|
|
|
|
P01AB04
|
Azanidazole
|
|
|
|
|
|
P01AB05
|
Propenidazole
|
|
|
|
|
|
P01AB06
|
Nimorazole
|
|
|
|
|
|
P01AB07
|
Secnidazole
|
|
|
|
|
P01AC
|
|
Dichloroacetamide derivatives
|
|
|
|
|
|
P01AC01
|
Diloxanide
|
|
|
|
|
|
P01AC02
|
Clefamide
|
|
|
|
|
|
P01AC03
|
Etofamide
|
|
|
|
|
|
P01AC04
|
Teclozan
|
|
|
|
|
P01AR
|
|
Arsenic compounds
|
|
|
|
|
|
P01AR01
|
Arsthinol
|
|
|
|
|
|
P01AR02
|
Difetarsone
|
|
|
|
|
|
P01AR03
|
Glycobiarsol
|
|
|
|
|
|
P01AR53
|
Glycobiarsol, combinations
|
|
|
|
|
P01AX
|
|
Other agents against amoebiasis and other protozoal diseases
|
|
|
|
|
|
P01AX01
|
Chiniofon
|
|
|
|
|
|
P01AX02
|
Emetine
|
|
|
|
|
|
P01AX04
|
Phanquinone
|
|
|
|
|
|
P01AX05
|
Mepacrine
|
|
|
|
|
|
P01AX06
|
Atovaquone
|
|
|
|
|
|
P01AX07
|
Trimetrexate
|
|
|
|
|
|
P01AX08
|
Tenonitrozole
|
|
|
|
|
|
P01AX09
|
Dehydroemetine
|
|
|
|
|
|
P01AX10
|
Fumagillin
|
|
|
|
|
|
P01AX52
|
Emetine, combinations
|
|
|
|
P01B
|
|
|
Antimalarials
|
|
|
|
|
P01BA
|
|
Aminoquinolines
|
|
|
|
|
|
P01BA01
|
Chloroquine
|
|
|
|
|
|
P01BA02
|
Hydroxychloroquine
|
|
|
|
|
|
P01BA03
|
Primaquine
|
|
|
|
|
|
P01BA06
|
Amodiaquine
|
|
|
|
|
P01BB
|
|
Biguanides
|
|
|
|
|
|
P01BB01
|
Proguanil
|
|
|
|
|
|
P01BB02
|
Cycloguanil embonate
|
|
|
|
|
|
P01BB51
|
Proguanil, combinations
|
|
|
|
|
P01BC
|
|
Methanolquinolines
|
|
|
|
|
|
P01BC01
|
Quinine
|
|
|
|
|
|
P01BC02
|
Mefloquine
|
|
|
|
|
P01BD
|
|
Diaminopyrimidines
|
|
|
|
|
|
P01BD01
|
Pyrimethamine
|
|
|
|
|
|
P01BD51
|
Pyrimethamine, combinations
|
|
|
|
|
P01BE
|
|
Artemisinin and derivatives, plain
|
|
|
|
|
|
P01BE01
|
Artemisinin
|
|
|
|
|
|
P01BE02
|
Artemether
|
|
|
|
|
|
P01BE03
|
Artesunate
|
|
|
|
|
|
P01BE04
|
Artemotil
|
|
|
|
|
|
P01BE05
|
Artenimol
|
|
|
|
|
|
P01BE52
|
artemether and lumefantrine (בוטל, קוד חדש P01BF01)
|
|
|
|
|
P01BF
|
|
Artemisinin and derivatives, combinations
|
|
|
|
|
|
P01BF01
|
Artemether and lumefantrine
|
|
|
|
|
|
P01BF02
|
Artesunate and mefloquine
|
|
|
|
|
|
P01BF03
|
Artesunate and amodiaquine
|
|
|
|
|
|
P01BF04
|
Artesunate, sulphamethopyrazine and pyrimethamine
|
|
|
|
|
|
P01BF05
|
Artenimol and piperaquine
|
|
|
|
|
|
P01BF06
|
Artesunate and pyronaridine
|
|
|
|
|
P01BX
|
|
Other antimalarials
|
|
|
|
|
|
P01BX01
|
Halofantrine
|
|
|
|
P01C
|
|
|
Agents against leishmaniasis and trypanosomiasis
|
|
|
|
|
P01CA
|
|
Nitroimidazole derivatives
|
|
|
|
|
|
P01CA02
|
Benznidazole
|
|
|
|
|
P01CB
|
|
Antimony compounds
|
|
|
|
|
|
P01CB01
|
Meglumine antimonate
|
|
|
|
|
|
P01CB02
|
Sodium stibogluconate
|
|
|
|
|
P01CC
|
|
Nitrofuran derivatives
|
|
|
|
|
|
P01CC01
|
Nifurtimox
|
|
|
|
|
|
P01CC02
|
Nitrofural
|
|
|
|
|
P01CD
|
|
Arsenic compounds
|
|
|
|
|
|
P01CD01
|
Melarsoprol
|
|
|
|
|
|
P01CD02
|
Acetarsol
|
|
|
|
|
P01CX
|
|
Other agents against leishmaniasis and trypanosomiasis
|
|
|
|
|
|
P01CX01
|
Pentamidine isethionate
|
|
|
|
|
|
P01CX02
|
Suramin sodium
|
|
|
|
|
|
P01CX03
|
Eflornithine
|
|
|
|
|
|
P01CX04
|
miltefosine
|
|
|
P02
|
|
|
|
Anthelmintics
|
|
|
|
P02B
|
|
|
Antitrematodals
|
|
|
|
|
P02BA
|
|
Quinoline derivatives and related substances
|
|
|
|
|
|
P02BA01
|
Praziquantel
|
|
|
|
|
|
P02BA02
|
Oxamniquine
|
|
|
|
|
P02BB
|
|
Organophosphorous compounds
|
|
|
|
|
|
P02BB01
|
Metrifonate
|
|
|
|
|
P02BX
|
|
Other antitrematodal agents
|
|
|
|
|
|
P02BX01
|
Bithionol
|
|
|
|
|
|
P02BX02
|
Niridazole
|
|
|
|
|
|
P02BX03
|
Stibophen
|
|
|
|
|
|
P02BX04
|
Triclabendazole
|
|
|
|
P02C
|
|
|
Antinematodal agents
|
|
|
|
|
P02CA
|
|
Benzimidazole derivatives
|
|
|
|
|
|
P02CA01
|
Mebendazole
|
|
|
|
|
|
P02CA02
|
Tiabendazole
|
|
|
|
|
|
P02CA03
|
Albendazole
|
|
|
|
|
|
P02CA04
|
Ciclobendazole
|
|
|
|
|
|
P02CA05
|
Flubendazole
|
|
|
|
|
|
P02CA06
|
Fenbendazole
|
|
|
|
|
|
P02CA51
|
Mebendazole, combinations
|
|
|
|
|
P02CB
|
|
Piperazine and derivatives
|
|
|
|
|
|
P02CB01
|
Piperazine
|
|
|
|
|
|
P02CB02
|
Diethylcarbamazine
|
|
|
|
|
P02CC
|
|
Tetrahydropyrimidine derivatives
|
|
|
|
|
|
P02CC01
|
Pyrantel
|
|
|
|
|
|
P02CC02
|
Oxantel
|
|
|
|
|
P02CE
|
|
Imidazothiazole derivatives
|
|
|
|
|
|
P02CE01
|
Levamisole
|
|
|
|
|
P02CF
|
|
Avermectines
|
|
|
|
|
|
P02CF01
|
Ivermectin
|
|
|
|
|
P02CX
|
|
Other antinematodals
|
|
|
|
|
|
P02CX01
|
Pyrvinium
|
|
|
|
|
|
P02CX02
|
Bephenium
|
|
|
|
P02D
|
|
|
Anticestodals
|
|
|
|
|
P02DA
|
|
Salicylic acid derivatives
|
|
|
|
|
|
P02DA01
|
Niclosamide
|
|
|
|
|
P02DX
|
|
Other anticestodals
|
|
|
|
|
|
P02DX01
|
Desaspidin
|
|
|
|
|
|
P02DX02
|
Dichlorophen
|
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
|
|
|
P03A
|
|
|
Ectoparasiticides, including scabicides
|
|
|
|
|
P03AA
|
|
Sulfur containing products
|
|
|
|
|
|
P03AA01
|
Dixanthogen
|
|
|
|
|
|
P03AA02
|
Potassium polysulfide
|
|
|
|
|
|
P03AA03
|
Mesulfen
|
|
|
|
|
|
P03AA04
|
Disulfiram
|
|
|
|
|
|
P03AA05
|
Thiram
|
|
|
|
|
|
P03AA54
|
Disulfiram, combinations
|
|
|
|
|
P03AB
|
|
Chlorine containing products
|
|
|
|
|
|
P03AB01
|
Clofenotane
|
|
|
|
|
|
P03AB02
|
Lindane
|
|
|
|
|
|
P03AB51
|
Clofenotane, combinations
|
|
|
|
|
P03AC
|
|
Pyrethrines, including synthetic compounds
|
|
|
|
|
|
P03AC01
|
Pyrethrum
|
|
|
|
|
|
P03AC02
|
Bioallethrin
|
|
|
|
|
|
P03AC03
|
Phenothrin
|
|
|
|
|
|
P03AC04
|
Permethrin
|
|
|
|
|
|
P03AC51
|
Pyrethrum, combinations
|
|
|
|
|
|
P03AC52
|
Bioallethrin, combinations
|
|
|
|
|
|
P03AC53
|
Phenothrin, combinations
|
|
|
|
|
|
P03AC54
|
Permethrin, combinations
|
|
|
|
|
P03AX
|
|
Other ectoparasiticides, including scabicides
|
|
|
|
|
|
P03AX01
|
Benzyl benzoate
|
|
|
|
|
|
P03AX02
|
Copper oleinate
|
|
|
|
|
|
P03AX03
|
Malathion
|
|
|
|
|
|
P03AX04
|
Quassia
|
|
|
|
|
|
P03AX05
|
Dimeticone
|
|
|
|
P03B
|
|
|
Insecticides and repellents
|
|
|
|
|
P03BA
|
|
Pyrethrines
|
|
|
|
|
|
P03BA01
|
Cyfluthrin
|
|
|
|
|
|
P03BA02
|
Cypermethrin
|
|
|
|
|
|
P03BA03
|
Decamethrin
|
|
|
|
|
|
P03BA04
|
Tetramethrin
|
|
|
|
|
P03BX
|
|
Other insecticides and repellents
|
|
|
|
|
|
P03BX01
|
Diethyltoluamide
|
|
|
|
|
|
P03BX02
|
Dimethylphthalate
|
|
|
|
|
|
P03BX03
|
Dibutylphthalate
|
|
|
|
|
|
P03BX04
|
Dibutylsuccinate
|
|
|
|
|
|
P03BX05
|
Dimethylcarbate
|
|
|
|
|
|
P03BX06
|
Etohexadiol
|
| R
|
|
|
|
|
Respiratory system
|
|
|
R01
|
|
|
|
Nasal preparations
|
|
|
|
R01A
|
|
|
Decongestants and other nasal preparations for topical use
|
|
|
|
|
R01AA
|
|
Sympathomimetics, plain
|
|
|
|
|
|
R01AA02
|
Cyclopentamine
|
|
|
|
|
|
R01AA03
|
Ephedrine
|
|
|
|
|
|
R01AA04
|
Phenylephrine
|
|
|
|
|
|
R01AA05
|
Oxymetazoline
|
|
|
|
|
|
R01AA06
|
Tetryzoline
|
|
|
|
|
|
R01AA07
|
Xylometazoline
|
|
|
|
|
|
R01AA08
|
Naphazoline
|
|
|
|
|
|
R01AA09
|
Tramazoline
|
|
|
|
|
|
R01AA10
|
Metizoline
|
|
|
|
|
|
R01AA11
|
Tuaminoheptane
|
|
|
|
|
|
R01AA12
|
Fenoxazoline
|
|
|
|
|
|
R01AA13
|
Tymazoline
|
|
|
|
|
|
R01AA14
|
Epinephrine
|
|
|
|
|
R01AB
|
|
Sympathomimetics, combinations excluding corticosteroids
|
|
|
|
|
|
R01AB01
|
Phenylephrine
|
|
|
|
|
|
R01AB02
|
Naphazoline
|
|
|
|
|
|
R01AB03
|
Tetryzoline
|
|
|
|
|
|
R01AB05
|
Ephedrine
|
|
|
|
|
|
R01AB06
|
Xylometazoline
|
|
|
|
|
|
R01AB07
|
Oxymetazoline
|
|
|
|
|
|
R01AB08
|
Tuaminoheptane
|
|
|
|
|
R01AC
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
R01AC01
|
Cromoglicic acid
|
|
|
|
|
|
R01AC02
|
Levocabastine
|
|
|
|
|
|
R01AC03
|
Azelastine
|
|
|
|
|
|
R01AC04
|
Antazoline
|
|
|
|
|
|
R01AC05
|
Spaglumic acid
|
|
|
|
|
|
R01AC06
|
Thonzylamine
|
|
|
|
|
|
R01AC07
|
Nedocromil
|
|
|
|
|
|
R01AC08
|
Olopatadine
|
|
|
|
|
|
R01AC51
|
Cromoglicic acid, combinations
|
|
|
|
|
R01AD
|
|
Corticosteroids
|
|
|
|
|
|
R01AD01
|
Beclometasone
|
|
|
|
|
|
R01AD02
|
Prednisolone
|
|
|
|
|
|
R01AD03
|
Dexamethasone
|
|
|
|
|
|
R01AD04
|
Flunisolide
|
|
|
|
|
|
R01AD05
|
Budesonide
|
|
|
|
|
|
R01AD06
|
Betamethasone
|
|
|
|
|
|
R01AD07
|
Tixocortol
|
|
|
|
|
|
R01AD08
|
Fluticasone
|
|
|
|
|
|
R01AD09
|
Mometasone furoate
|
|
|
|
|
|
R01AD11
|
Triamcinolone
|
|
|
|
|
|
R01AD12
|
Fluticasone furoate
|
|
|
|
|
|
R01AD13
|
Ciclesonide
|
|
|
|
|
|
R01AD52
|
Prednisolone, combinations
|
|
|
|
|
|
R01AD53
|
Dexamethasone, combinations
|
|
|
|
|
|
R01AD57
|
Tixocortol, combinations
|
|
|
|
|
|
R01AD58
|
Fluticasone, combinations
|
|
|
|
|
|
R01AD60
|
Hydrocortisone, combinations
|
|
|
|
|
R01AX
|
|
Other nasal preparations
|
|
|
|
|
|
R01AX01
|
Calcium hexamine thiocyanate
|
|
|
|
|
|
R01AX02
|
Retinol
|
|
|
|
|
|
R01AX03
|
Ipratropium bromide
|
|
|
|
|
|
R01AX05
|
Ritiometan
|
|
|
|
|
|
R01AX06
|
Mupirocin
|
|
|
|
|
|
R01AX07
|
Hexamidine
|
|
|
|
|
|
R01AX08
|
Framycetin
|
|
|
|
|
|
R01AX09
|
Hyaluronic acid
|
|
|
|
|
|
R01AX10
|
Various
|
|
|
|
|
|
R01AX30
|
Combinations
|
|
|
|
R01B
|
|
|
Nasal decongestants for systemic use
|
|
|
|
|
R01BA
|
|
Sympathomimetics
|
|
|
|
|
|
R01BA01
|
Phenylpropanolamine
|
|
|
|
|
|
R01BA02
|
Pseudoephedrine
|
|
|
|
|
|
R01BA03
|
Phenylephrine
|
|
|
|
|
|
R01BA51
|
Phenylpropanolamine, combinations
|
|
|
|
|
|
R01BA52
|
Pseudoephedrine, combinations
|
|
|
|
|
|
R01BA53
|
Phenylephrine, combinations
|
|
|
R02
|
|
|
|
Throat preparations
|
|
|
|
R02A
|
|
|
Throat preparations
|
|
|
|
|
R02AA
|
|
Antiseptics
|
|
|
|
|
|
R02AA01
|
Ambazone
|
|
|
|
|
|
R02AA02
|
Dequalinium
|
|
|
|
|
|
R02AA03
|
Dichlorobenzyl alcohol
|
|
|
|
|
|
R02AA05
|
Chlorhexidine
|
|
|
|
|
|
R02AA06
|
Cetylpyridinium
|
|
|
|
|
|
R02AA09
|
Benzethonium
|
|
|
|
|
|
R02AA10
|
Myristyl-benzalkonium
|
|
|
|
|
|
R02AA11
|
Chlorquinaldol
|
|
|
|
|
|
R02AA12
|
Hexylresorcinol
|
|
|
|
|
|
R02AA13
|
Acriflavinium chloride
|
|
|
|
|
|
R02AA14
|
Oxyquinoline
|
|
|
|
|
|
R02AA15
|
Povidone-iodine
|
|
|
|
|
|
R02AA16
|
Benzalkonium
|
|
|
|
|
|
R02AA17
|
Cetrimonium
|
|
|
|
|
|
R02AA18
|
Hexamidine
|
|
|
|
|
|
R02AA19
|
Phenol
|
|
|
|
|
|
R02AA20
|
Various
|
|
|
|
|
R02AB
|
|
Antibiotics
|
|
|
|
|
|
R02AB01
|
Neomycin
|
|
|
|
|
|
R02AB02
|
Tyrothricin
|
|
|
|
|
|
R02AB03
|
Fusafungine
|
|
|
|
|
|
R02AB04
|
Bacitracin
|
|
|
|
|
|
R02AB30
|
Gramicidin
|
|
|
|
|
R02AD
|
|
Anesthetics, local
|
|
|
|
|
|
R02AD01
|
Benzocaine
|
|
|
|
|
|
R02AD02
|
Lidocaine
|
|
|
|
|
|
R02AD03
|
Cocaine
|
|
|
|
|
|
R02AD04
|
Dyclonine
|
|
|
|
|
R02AX
|
|
Other throat preparations
|
|
|
|
|
|
R02AX01
|
Flurbiprofen
|
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
|
|
R03A
|
|
|
Adrenergics, inhalants
|
|
|
|
|
R03AA
|
|
Alpha- and beta-adrenoreceptor agonists
|
|
|
|
|
|
R03AA01
|
Epinephrine
|
|
|
|
|
R03AB
|
|
Non-selective beta-adrenoreceptor agonists
|
|
|
|
|
|
R03AB02
|
Isoprenaline
|
|
|
|
|
|
R03AB03
|
Orciprenaline
|
|
|
|
|
R03AC
|
|
Selective beta-2-adrenoreceptor agonists
|
|
|
|
|
|
R03AC02
|
Salbutamol
|
|
|
|
|
|
R03AC03
|
Terbutaline
|
|
|
|
|
|
R03AC04
|
Fenoterol
|
|
|
|
|
|
R03AC05
|
Rimiterol
|
|
|
|
|
|
R03AC06
|
Hexoprenaline
|
|
|
|
|
|
R03AC07
|
Isoetarine
|
|
|
|
|
|
R03AC08
|
Pirbuterol
|
|
|
|
|
|
R03AC09
|
Tretoquinol
|
|
|
|
|
|
R03AC10
|
Carbuterol
|
|
|
|
|
|
R03AC11
|
Tulobuterol
|
|
|
|
|
|
R03AC12
|
Salmeterol
|
|
|
|
|
|
R03AC13
|
Formoterol
|
|
|
|
|
|
R03AC14
|
Clenbuterol
|
|
|
|
|
|
R03AC15
|
Reproterol
|
|
|
|
|
|
R03AC16
|
Procaterol
|
|
|
|
|
|
R03AC17
|
Bitolterol
|
|
|
|
|
|
R03AC18
|
Indacaterol
|
|
|
|
|
R03AH
|
|
Combinations of adrenergics
|
|
|
|
|
|
|
empty
|
|
|
|
|
R03AK
|
|
Adrenergics and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK01
|
Epinephrine and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK02
|
Isoprenaline and other drugs for obstructive airway diseases
|
|
|
|
|
|
R03AK03
|
Fenoterol and other drugs for obstructive airway diseases (בוטל, קוד חדש R03AL01)
|
|
|
|
|
|
R03AK04
|
Salbutamol and other drugs for obstructive airway diseases (בוטל, קוד חדש R03AL02)
|
|
|
|
|
|
R03AK05
|
reproterol and sodium cromoglicate
|
|
|
|
|
|
R03AK06
|
salmeterol and fluticasone
|
|
|
|
|
|
R03AK07
|
formoterol and budesonide (חלק מהסיווג הישן עבר לקוד חדש R03AK08, R03AK09)
|
|
|
|
|
|
R03AK08
|
formoterol and beclometasone
|
|
|
|
|
|
R03AK09
|
formoterol and mometasone
|
|
|
|
|
|
R03AK10
|
vilanterol and fluticasone furoate
|
|
|
|
|
|
R03AK11
|
formoterol and fluticasone
|
|
|
|
|
|
R03AK12
|
salmeterol and budesonide
|
|
|
|
|
|
R03AK13
|
salbutamol and beclometasone
|
|
|
|
|
|
R03AK14
|
indacaterol and mometasone
|
|
|
|
|
R03AL
|
|
Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
|
|
|
|
|
|
R03AL01
|
fenoterol and ipratropium bromide
|
|
|
|
|
|
R03AL02
|
salbutamol and ipratropium bromide
|
|
|
|
|
|
R03AL03
|
vilanterol and umeclidinium bromide
|
|
|
|
|
|
R03AL04
|
indacaterol and glycopyrronium bromide
|
|
|
|
|
|
R03AL05
|
formoterol and aclidinium bromide
|
|
|
|
|
|
R03AL06
|
olodaterol and tiotropium bromide
|
|
|
|
|
|
R03AL07
|
formoterol and glycopyrronium bromide
|
|
|
|
|
|
R03AL08
|
vilanterol, umeclidinium bromide and fluticasone furoate
|
|
|
|
|
|
R03AL09
|
formoterol, glycopyrronium bromide and beclometasone
|
|
|
|
|
|
R03AL10
|
formoterol and tiotropium bromide
|
|
|
|
|
|
R03AL11
|
formoterol, glycopyrronium bromide and budesonide
|
|
|
|
|
|
R03AL12
|
indacaterol, glycopyrronium bromide and mometasone
|
|
|
|
R03B
|
|
|
Other drugs for obstructive airway diseases, inhalants
|
|
|
|
|
R03BA
|
|
Glucocorticoids
|
|
|
|
|
|
R03BA01
|
Beclometasone
|
|
|
|
|
|
R03BA02
|
Budesonide
|
|
|
|
|
|
R03BA03
|
Flunisolide
|
|
|
|
|
|
R03BA04
|
Betamethasone
|
|
|
|
|
|
R03BA05
|
Fluticasone
|
|
|
|
|
|
R03BA06
|
Triamcinolone
|
|
|
|
|
|
R03BA07
|
Mometasone
|
|
|
|
|
|
R03BA08
|
Ciclesonide
|
|
|
|
|
R03BB
|
|
Anticholinergics
|
|
|
|
|
|
R03BB01
|
Ipratropium bromide
|
|
|
|
|
|
R03BB02
|
Oxitropium bromide
|
|
|
|
|
|
R03BB03
|
Stramoni preparations
|
|
|
|
|
|
R03BB04
|
Tiotropium bromide
|
|
|
|
|
|
R03BB05
|
Aclidinium bromide
|
|
|
|
|
|
R03BB06
|
Glycopyrronium bromide
|
|
|
|
|
R03BC
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
R03BC01
|
Cromoglicic acid
|
|
|
|
|
|
R03BC03
|
Nedocromil
|
|
|
|
|
R03BX
|
|
Other drugs for obstructive airway diseases, inhalants
|
|
|
|
|
|
R03BX01
|
Fenspiride
|
|
|
|
R03C
|
|
|
Adrenergics for systemic use
|
|
|
|
|
R03CA
|
|
Alpha- and beta-adrenoreceptor agonists
|
|
|
|
|
|
R03CA02
|
Ephedrine (בוטל, קוד חדש C01CA26)
|
|
|
|
|
R03CB
|
|
Non-selective beta-adrenoreceptor agonists
|
|
|
|
|
|
R03CB01
|
Isoprenaline
|
|
|
|
|
|
R03CB02
|
Methoxyphenamine
|
|
|
|
|
|
R03CB03
|
Orciprenaline
|
|
|
|
|
|
R03CB51
|
Isoprenaline, combinations
|
|
|
|
|
|
R03CB53
|
Orciprenaline, combinations
|
|
|
|
|
R03CC
|
|
Selective beta-2-adrenoreceptor agonists
|
|
|
|
|
|
R03CC02
|
Salbutamol
|
|
|
|
|
|
R03CC03
|
Terbutaline
|
|
|
|
|
|
R03CC04
|
Fenoterol
|
|
|
|
|
|
R03CC05
|
Hexoprenaline
|
|
|
|
|
|
R03CC06
|
Isoetarine
|
|
|
|
|
|
R03CC07
|
Pirbuterol
|
|
|
|
|
|
R03CC08
|
Procaterol
|
|
|
|
|
|
R03CC09
|
Tretoquinol
|
|
|
|
|
|
R03CC10
|
Carbuterol
|
|
|
|
|
|
R03CC11
|
Tulobuterol
|
|
|
|
|
|
R03CC12
|
Bambuterol
|
|
|
|
|
|
R03CC13
|
Clenbuterol
|
|
|
|
|
|
R03CC14
|
Reproterol
|
|
|
|
|
|
R03CC53
|
Terbutaline, combinations
|
|
|
|
|
R03CK
|
|
Adrenergics and other drugs for obstructive airway diseases
|
|
|
|
|
|
|
empty
|
|
|
|
R03D
|
|
|
Other systemic drugs for obstructive airway diseases
|
|
|
|
|
R03DA
|
|
Xanthines
|
|
|
|
|
|
R03DA01
|
Diprophylline
|
|
|
|
|
|
R03DA02
|
Choline theophyllinate
|
|
|
|
|
|
R03DA03
|
Proxyphylline
|
|
|
|
|
|
R03DA04
|
Theophylline
|
|
|
|
|
|
R03DA05
|
Aminophylline
|
|
|
|
|
|
R03DA06
|
Etamiphylline
|
|
|
|
|
|
R03DA07
|
Theobromine
|
|
|
|
|
|
R03DA08
|
Bamifylline
|
|
|
|
|
|
R03DA09
|
Acefylline piperazine
|
|
|
|
|
|
R03DA10
|
Bufylline
|
|
|
|
|
|
R03DA11
|
Doxofylline
|
|
|
|
|
|
R03DA20
|
Combinations of xanthines
|
|
|
|
|
|
R03DA51
|
Diprophylline, combinations
|
|
|
|
|
|
R03DA54
|
Theophylline, combinations excluding psycholeptics
|
|
|
|
|
|
R03DA55
|
Aminophylline, combinations
|
|
|
|
|
|
R03DA57
|
Theobromine, combinations
|
|
|
|
|
|
R03DA74
|
Theophylline, combinations with psycholeptics
|
|
|
|
|
R03DB
|
|
Xanthines and adrenergics
|
|
|
|
|
|
R03DB01
|
Diprophylline and adrenergics
|
|
|
|
|
|
R03DB02
|
Choline theophyllinate and adrenergics
|
|
|
|
|
|
R03DB03
|
Proxyphylline and adrenergics
|
|
|
|
|
|
R03DB04
|
Theophylline and adrenergics
|
|
|
|
|
|
R03DB05
|
Aminophylline and adrenergics
|
|
|
|
|
|
R03DB06
|
Etamiphylline and adrenergics
|
|
|
|
|
R03DC
|
|
Leukotriene receptor antagonists
|
|
|
|
|
|
R03DC01
|
Zafirlukast
|
|
|
|
|
|
R03DC02
|
Pranlukast
|
|
|
|
|
|
R03DC03
|
Montelukast
|
|
|
|
|
|
R03DC04
|
Ibudilast
|
|
|
|
|
R03DX
|
|
Other systemic drugs for obstructive airway diseases
|
|
|
|
|
|
R03DX01
|
Amlexanox
|
|
|
|
|
|
R03DX02
|
Eprozinol
|
|
|
|
|
|
R03DX03
|
Fenspiride
|
|
|
|
|
|
R03DX05
|
Omalizumab
|
|
|
|
|
|
R03DX06
|
Seratrodast
|
|
|
|
|
|
R03DX07
|
Roflumilast
|
|
|
|
|
|
R03DX08
|
Reslizumab
|
|
|
|
|
|
R03DX09
|
Mepolizumab
|
|
|
|
|
|
R03DX10
|
Benralizumab
|
|
|
|
|
|
R03DX11
|
tezepelumab
|
|
|
R05
|
|
|
|
Cough and cold preparations
|
|
|
|
R05C
|
|
|
Expectorants, excluding combinations with cough suppressants
|
|
|
|
|
R05CA
|
|
Expectorants
|
|
|
|
|
|
R05CA01
|
Tyloxapol
|
|
|
|
|
|
R05CA02
|
Potassium iodide
|
|
|
|
|
|
R05CA03
|
Guaifenesin
|
|
|
|
|
|
R05CA04
|
Ipecacuanha
|
|
|
|
|
|
R05CA05
|
Althea root
|
|
|
|
|
|
R05CA06
|
Senega
|
|
|
|
|
|
R05CA07
|
Antimony pentasulfide
|
|
|
|
|
|
R05CA08
|
Creosote
|
|
|
|
|
|
R05CA09
|
Guaiacolsulfonate
|
|
|
|
|
|
R05CA10
|
Combinations
|
|
|
|
|
|
R05CA11
|
Levoverbenone
|
|
|
|
|
|
R05CA12
|
Hederae helicis folium
|
|
|
|
|
R05CB
|
|
Mucolytics
|
|
|
|
|
|
R05CB01
|
Acetylcysteine
|
|
|
|
|
|
R05CB02
|
Bromhexine
|
|
|
|
|
|
R05CB03
|
Carbocisteine
|
|
|
|
|
|
R05CB04
|
Eprazinone
|
|
|
|
|
|
R05CB05
|
Mesna
|
|
|
|
|
|
R05CB06
|
Ambroxol
|
|
|
|
|
|
R05CB07
|
Sobrerol
|
|
|
|
|
|
R05CB08
|
Domiodol
|
|
|
|
|
|
R05CB09
|
Letosteine
|
|
|
|
|
|
R05CB10
|
Combinations
|
|
|
|
|
|
R05CB11
|
Stepronin
|
|
|
|
|
|
R05CB12
|
Tiopronin (בוטל, קוד חדש G04BX16)
|
|
|
|
|
|
R05CB13
|
Dornase alfa (desoxyribonuclease)
|
|
|
|
|
|
R05CB14
|
Neltenexine
|
|
|
|
|
|
R05CB15
|
Erdosteine
|
|
|
|
|
|
R05CB16
|
Mannitol
|
|
|
|
R05D
|
|
|
Cough suppressants, excluding combinations with expectorants
|
|
|
|
|
R05DA
|
|
Opium alkaloids and derivatives
|
|
|
|
|
|
R05DA01
|
Ethylmorphine
|
|
|
|
|
|
R05DA03
|
Hydrocodone
|
|
|
|
|
|
R05DA04
|
Codeine
|
|
|
|
|
|
R05DA05
|
Opium alkaloids with morphine
|
|
|
|
|
|
R05DA06
|
Normethadone
|
|
|
|
|
|
R05DA07
|
Noscapine
|
|
|
|
|
|
R05DA08
|
Pholcodine
|
|
|
|
|
|
R05DA09
|
Dextromethorphan
|
|
|
|
|
|
R05DA10
|
Thebacon
|
|
|
|
|
|
R05DA11
|
Dimemorfan
|
|
|
|
|
|
R05DA12
|
Acetyldihydrocodeine
|
|
|
|
|
|
R05DA20
|
Combinations
|
|
|
|
|
R05DB
|
|
Other cough suppressants
|
|
|
|
|
|
R05DB01
|
Benzonatate
|
|
|
|
|
|
R05DB02
|
Benproperine
|
|
|
|
|
|
R05DB03
|
Clobutinol
|
|
|
|
|
|
R05DB04
|
Isoaminile
|
|
|
|
|
|
R05DB05
|
Pentoxyverine
|
|
|
|
|
|
R05DB07
|
Oxolamine
|
|
|
|
|
|
R05DB09
|
Oxeladin
|
|
|
|
|
|
R05DB10
|
Clofedanol
|
|
|
|
|
|
R05DB11
|
Pipazetate
|
|
|
|
|
|
R05DB12
|
Bibenzonium bromide
|
|
|
|
|
|
R05DB13
|
Butamirate
|
|
|
|
|
|
R05DB14
|
Fedrilate
|
|
|
|
|
|
R05DB15
|
Zipeprol
|
|
|
|
|
|
R05DB16
|
Dibunate
|
|
|
|
|
|
R05DB17
|
Droxypropine
|
|
|
|
|
|
R05DB18
|
Prenoxdiazine
|
|
|
|
|
|
R05DB19
|
Dropropizine
|
|
|
|
|
|
R05DB20
|
Combinations
|
|
|
|
|
|
R05DB21
|
Cloperastine
|
|
|
|
|
|
R05DB22
|
Meprotixol
|
|
|
|
|
|
R05DB23
|
Piperidione
|
|
|
|
|
|
R05DB24
|
Tipepidine
|
|
|
|
|
|
R05DB25
|
Morclofone
|
|
|
|
|
|
R05DB26
|
Nepinalone
|
|
|
|
|
|
R05DB27
|
Levodropropizine
|
|
|
|
|
|
R05DB28
|
Dimethoxanate
|
|
|
|
R05F
|
|
|
Cough suppressants and expectorants, combinations
|
|
|
|
|
R05FA
|
|
Opium derivatives and expectorants
|
|
|
|
|
|
R05FA01
|
Opium derivatives and mucolytics
|
|
|
|
|
|
R05FA02
|
Opium derivatives and expectorants
|
|
|
|
|
R05FB
|
|
Other cough suppressants and expectorants
|
|
|
|
|
|
R05FB01
|
Cough suppressants and mucolytics
|
|
|
|
|
|
R05FB02
|
Cough suppressants and expectorants
|
|
|
|
R05X
|
|
|
Other cold preparations
|
|
|
|
|
|
|
Empty group
|
|
|
R06
|
|
|
|
Antihistamines for systemic use
|
|
|
|
R06A
|
|
|
Antihistamines for systemic use
|
|
|
|
|
R06AA
|
|
Aminoalkyl ethers
|
|
|
|
|
|
R06AA01
|
Bromazine
|
|
|
|
|
|
R06AA02
|
Diphenhydramine
|
|
|
|
|
|
R06AA04
|
Clemastine
|
|
|
|
|
|
R06AA06
|
Chlorphenoxamine
|
|
|
|
|
|
R06AA07
|
Diphenylpyraline
|
|
|
|
|
|
R06AA08
|
Carbinoxamine
|
|
|
|
|
|
R06AA09
|
Doxylamine
|
|
|
|
|
|
R06AA10
|
trimethobenzamide
|
|
|
|
|
|
R06AA11
|
dimenhydrinate
|
|
|
|
|
|
R06AA52
|
Diphenhydramine, combinations
|
|
|
|
|
|
R06AA54
|
Clemastine, combinations
|
|
|
|
|
|
R06AA56
|
Chlorphenoxamine, combinations
|
|
|
|
|
|
R06AA57
|
Diphenylpyraline, combinations
|
|
|
|
|
|
R06AA59
|
Doxylamine, combinations
|
|
|
|
|
|
R06AA61
|
dimenhydrinate, combinations
|
|
|
|
|
R06AB
|
|
Substituted alkylamines
|
|
|
|
|
|
R06AB01
|
Brompheniramine
|
|
|
|
|
|
R06AB02
|
Dexchlorpheniramine
|
|
|
|
|
|
R06AB03
|
Dimetindene
|
|
|
|
|
|
R06AB04
|
Chlorphenamine
|
|
|
|
|
|
R06AB05
|
Pheniramine
|
|
|
|
|
|
R06AB06
|
Dexbrompheniramine
|
|
|
|
|
|
R06AB07
|
Talastine
|
|
|
|
|
|
R06AB51
|
Brompheniramine, combinations
|
|
|
|
|
|
R06AB52
|
Dexchlorpheniramine, combinations
|
|
|
|
|
|
R06AB54
|
Chlorphenamine, combinations
|
|
|
|
|
|
R06AB56
|
Dexbrompheniramine, combinations
|
|
|
|
|
R06AC
|
|
Substituted ethylene diamines
|
|
|
|
|
|
R06AC01
|
Mepyramine
|
|
|
|
|
|
R06AC02
|
Histapyrrodine
|
|
|
|
|
|
R06AC03
|
Chloropyramine
|
|
|
|
|
|
R06AC04
|
Tripelennamine
|
|
|
|
|
|
R06AC05
|
Methapyrilene
|
|
|
|
|
|
R06AC06
|
Thonzylamine
|
|
|
|
|
|
R06AC52
|
Histapyrrodine, combinations
|
|
|
|
|
|
R06AC53
|
Chloropyramine, combinations
|
|
|
|
|
R06AD
|
|
Phenothiazine derivatives
|
|
|
|
|
|
R06AD01
|
Alimemazine
|
|
|
|
|
|
R06AD02
|
Promethazine
|
|
|
|
|
|
R06AD03
|
Thiethylperazine
|
|
|
|
|
|
R06AD04
|
Methdilazine
|
|
|
|
|
|
R06AD05
|
Hydroxyethylpromethazine
|
|
|
|
|
|
R06AD06
|
Thiazinam
|
|
|
|
|
|
R06AD07
|
Mequitazine
|
|
|
|
|
|
R06AD08
|
Oxomemazine
|
|
|
|
|
|
R06AD09
|
Isothipendyl
|
|
|
|
|
|
R06AD52
|
Promethazine, combinations
|
|
|
|
|
|
R06AD55
|
Hydroxyethylpromethazine, combinations
|
|
|
|
|
R06AE
|
|
Piperazine derivatives
|
|
|
|
|
|
R06AE01
|
Buclizine
|
|
|
|
|
|
R06AE03
|
Cyclizine
|
|
|
|
|
|
R06AE04
|
Chlorcyclizine
|
|
|
|
|
|
R06AE05
|
Meclozine
|
|
|
|
|
|
R06AE06
|
Oxatomide
|
|
|
|
|
|
R06AE07
|
Cetirizine
|
|
|
|
|
|
R06AE09
|
Levocetirizine
|
|
|
|
|
|
R06AE51
|
Buclizine, combinations
|
|
|
|
|
|
R06AE53
|
Cyclizine, combinations
|
|
|
|
|
|
R06AE55
|
Meclozine, combinations
|
|
|
|
|
R06AK
|
|
Combinations of antihistamines
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
R06AX
|
|
Other antihistamines for systemic use
|
|
|
|
|
|
R06AX01
|
Bamipine
|
|
|
|
|
|
R06AX02
|
Cyproheptadine
|
|
|
|
|
|
R06AX03
|
Thenalidine
|
|
|
|
|
|
R06AX04
|
Phenindamine
|
|
|
|
|
|
R06AX05
|
Antazoline
|
|
|
|
|
|
R06AX07
|
Triprolidine
|
|
|
|
|
|
R06AX08
|
Pyrrobutamine
|
|
|
|
|
|
R06AX09
|
Azatadine
|
|
|
|
|
|
R06AX11
|
Astemizole
|
|
|
|
|
|
R06AX12
|
Terfenadine
|
|
|
|
|
|
R06AX13
|
Loratadine
|
|
|
|
|
|
R06AX15
|
Mebhydrolin
|
|
|
|
|
|
R06AX16
|
Deptropine
|
|
|
|
|
|
R06AX17
|
Ketotifen
|
|
|
|
|
|
R06AX18
|
Acrivastine
|
|
|
|
|
|
R06AX19
|
Azelastine
|
|
|
|
|
|
R06AX21
|
Tritoqualine
|
|
|
|
|
|
R06AX22
|
Ebastine
|
|
|
|
|
|
R06AX23
|
Pimethixene
|
|
|
|
|
|
R06AX24
|
Epinastine
|
|
|
|
|
|
R06AX25
|
Mizolastine
|
|
|
|
|
|
R06AX26
|
Fexofenadine
|
|
|
|
|
|
R06AX27
|
Desloratadine
|
|
|
|
|
|
R06AX28
|
Rupatadine
|
|
|
|
|
|
R06AX29
|
Bilastine
|
|
|
|
|
|
R06AX31
|
Quifenadine
|
|
|
|
|
|
R06AX53
|
Thenalidine, combinations
|
|
|
|
|
|
R06AX58
|
Pyrrobutamine, combinations
|
|
|
R07
|
|
|
|
Other respiratory system products
|
|
|
|
R07A
|
|
|
Other respiratory system products
|
|
|
|
|
R07AA
|
|
Lung surfactants
|
|
|
|
|
|
R07AA01
|
Colfosceril palmitate
|
|
|
|
|
|
R07AA02
|
Natural phospholipids
|
|
|
|
|
|
R07AA30
|
Combinations
|
|
|
|
|
R07AB
|
|
Respiratory stimulants
|
|
|
|
|
|
R07AB01
|
Doxapram
|
|
|
|
|
|
R07AB02
|
Nikethamide
|
|
|
|
|
|
R07AB03
|
Pentetrazol
|
|
|
|
|
|
R07AB04
|
Etamivan
|
|
|
|
|
|
R07AB05
|
Bemegride
|
|
|
|
|
|
R07AB06
|
Prethcamide
|
|
|
|
|
|
R07AB07
|
Almitrine
|
|
|
|
|
|
R07AB08
|
Dimefline
|
|
|
|
|
|
R07AB09
|
Mepixanox
|
|
|
|
|
|
R07AB52
|
Nikethamide, combinations
|
|
|
|
|
|
R07AB53
|
Pentetrazol, combinations
|
|
|
|
|
R07AX
|
|
Other respiratory system products
|
|
|
|
|
|
R07AX01
|
Nitric oxide
|
|
|
|
|
|
R07AX02
|
Ivacaftor
|
|
|
|
|
|
R07AX30
|
ivacaftor and lumacaftor
|
|
|
|
|
|
R07AX31
|
ivacaftor and tezacaftor
|
|
|
|
|
|
R07AX32
|
ivacaftor, tezacaftor and elexacaftor
|
| S
|
|
|
|
|
Sensory organs
|
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
|
|
S01A
|
|
|
Anti-infectives
|
|
|
|
|
S01AA
|
|
Antibiotics
|
|
|
|
|
|
S01AA01
|
Chloramphenicol
|
|
|
|
|
|
S01AA02
|
Chlortetracycline
|
|
|
|
|
|
S01AA03
|
Neomycin
|
|
|
|
|
|
S01AA04
|
Oxytetracycline
|
|
|
|
|
|
S01AA05
|
Tyrothricin
|
|
|
|
|
|
S01AA07
|
Framycetin
|
|
|
|
|
|
S01AA09
|
Tetracycline
|
|
|
|
|
|
S01AA10
|
Natamycin
|
|
|
|
|
|
S01AA11
|
Gentamicin
|
|
|
|
|
|
S01AA12
|
Tobramycin
|
|
|
|
|
|
S01AA13
|
Fusidic acid
|
|
|
|
|
|
S01AA14
|
Benzylpenicillin
|
|
|
|
|
|
S01AA15
|
Dihydrostreptomycin
|
|
|
|
|
|
S01AA16
|
Rifamycin
|
|
|
|
|
|
S01AA17
|
Erythromycin
|
|
|
|
|
|
S01AA18
|
Polymyxin B
|
|
|
|
|
|
S01AA19
|
Ampicillin
|
|
|
|
|
|
S01AA20
|
Antibiotics in combination with other drugs
|
|
|
|
|
|
S01AA21
|
Amikacin
|
|
|
|
|
|
S01AA22
|
Micronomicin
|
|
|
|
|
|
S01AA23
|
Netilmicin
|
|
|
|
|
|
S01AA24
|
Kanamycin
|
|
|
|
|
|
S01AA25
|
Azidamfenicol
|
|
|
|
|
|
S01AA26
|
Azithromycin
|
|
|
|
|
|
S01AA27
|
Cefuroxime
|
|
|
|
|
|
S01AA30
|
Combinations of different antibiotics
|
|
|
|
|
S01AB
|
|
Sulfonamides
|
|
|
|
|
|
S01AB01
|
Sulfamethizole
|
|
|
|
|
|
S01AB02
|
Sulfafurazole
|
|
|
|
|
|
S01AB03
|
Sulfadicramide
|
|
|
|
|
|
S01AB04
|
Sulfacetamide
|
|
|
|
|
|
S01AB05
|
Sulfafenazol
|
|
|
|
|
S01AD
|
|
Antivirals
|
|
|
|
|
|
S01AD01
|
Idoxuridine
|
|
|
|
|
|
S01AD02
|
Trifluridine
|
|
|
|
|
|
S01AD03
|
Aciclovir
|
|
|
|
|
|
S01AD05
|
Interferon
|
|
|
|
|
|
S01AD06
|
Vidarabine
|
|
|
|
|
|
S01AD07
|
Famciclovir
|
|
|
|
|
|
S01AD08
|
Fomivirsen
|
|
|
|
|
|
S01AD09
|
Ganciclovir
|
|
|
|
|
S01AE
|
|
Fluoroquinolones
|
|
|
|
|
|
S01AE01
|
Ofloxacin
|
|
|
|
|
|
S01AE02
|
Norfloxacin
|
|
|
|
|
|
S01AE03
|
Ciprofloxacin
|
|
|
|
|
|
S01AE04
|
Lomefloxacin
|
|
|
|
|
|
S01AE05
|
Levofloxacin
|
|
|
|
|
|
S01AE06
|
Gatifloxacin
|
|
|
|
|
|
S01AE07
|
Moxifloxacin
|
|
|
|
|
|
S01AE08
|
Besifloxacin
|
|
|
|
|
S01AX
|
|
Other anti-infectives
|
|
|
|
|
|
S01AX01
|
Mercury compounds
|
|
|
|
|
|
S01AX02
|
Silver compounds
|
|
|
|
|
|
S01AX03
|
Zinc compounds
|
|
|
|
|
|
S01AX04
|
Nitrofural
|
|
|
|
|
|
S01AX05
|
Bibrocathol
|
|
|
|
|
|
S01AX06
|
Resorcinol
|
|
|
|
|
|
S01AX07
|
Sodium borate
|
|
|
|
|
|
S01AX08
|
Hexamidine
|
|
|
|
|
|
S01AX09
|
Chlorhexidine
|
|
|
|
|
|
S01AX10
|
Sodium propionate
|
|
|
|
|
|
S01AX11
|
ofloxacin (בוטל, קוד חדש S01AE01)
|
|
|
|
|
|
S01AX12
|
norfloxacin (בוטל, קוד חדש S01AE02)
|
|
|
|
|
|
S01AX13
|
ciprofloxacin (בוטל, קוד חדש S01AE03)
|
|
|
|
|
|
S01AX14
|
Dibrompropamidine
|
|
|
|
|
|
S01AX15
|
Propamidine
|
|
|
|
|
|
S01AX16
|
Picloxydine
|
|
|
|
|
|
S01AX17
|
lomefloxacin (בוטל, קוד חדש S01AE04)
|
|
|
|
|
|
S01AX18
|
Povidone-iodine
|
|
|
|
|
|
S01AX19
|
levofloxacin (בוטל, קוד חדש S01AE05)
|
|
|
|
|
|
S01AX21
|
levofloxacin (בוטל, קוד חדש S01AE06)
|
|
|
|
|
|
S01AX22
|
moxifloxacin (בוטל, קוד חדש S01AE07)
|
|
|
|
|
|
S01AX23
|
besifloxacin (בוטל, קוד חדש S01AE08)
|
|
|
|
S01B
|
|
|
Anti-inflammatory agents
|
|
|
|
|
S01BA
|
|
Corticosteroids, plain
|
|
|
|
|
|
S01BA01
|
Dexamethasone
|
|
|
|
|
|
S01BA02
|
Hydrocortisone
|
|
|
|
|
|
S01BA03
|
Cortisone
|
|
|
|
|
|
S01BA04
|
Prednisolone
|
|
|
|
|
|
S01BA05
|
Triamcinolone
|
|
|
|
|
|
S01BA06
|
Betamethasone
|
|
|
|
|
|
S01BA07
|
Fluorometholone
|
|
|
|
|
|
S01BA08
|
Medrysone
|
|
|
|
|
|
S01BA09
|
Clobetasone
|
|
|
|
|
|
S01BA10
|
Alclometasone
|
|
|
|
|
|
S01BA11
|
Desonide
|
|
|
|
|
|
S01BA12
|
Formocortal
|
|
|
|
|
|
S01BA13
|
Rimexolone
|
|
|
|
|
|
S01BA14
|
Loteprednol
|
|
|
|
|
|
S01BA15
|
Fluocinolone acetonide
|
|
|
|
|
S01BB
|
|
Corticosteroids and mydriatics in combination
|
|
|
|
|
|
S01BB01
|
Hydrocortisone and mydriatics
|
|
|
|
|
|
S01BB02
|
Prednisolone and mydriatics
|
|
|
|
|
|
S01BB03
|
Fluorometholone and mydriatics
|
|
|
|
|
|
S01BB04
|
Betamethasone and mydriatics
|
|
|
|
|
S01BC
|
|
Anti-inflammatory agents, non-steroids
|
|
|
|
|
|
S01BC01
|
Indometacin
|
|
|
|
|
|
S01BC02
|
Oxyphenbutazone
|
|
|
|
|
|
S01BC03
|
Diclofenac
|
|
|
|
|
|
S01BC04
|
Flurbiprofen
|
|
|
|
|
|
S01BC05
|
Ketorolac
|
|
|
|
|
|
S01BC06
|
Piroxicam
|
|
|
|
|
|
S01BC07
|
Bendazac
|
|
|
|
|
|
S01BC08
|
Salicylic acid
|
|
|
|
|
|
S01BC09
|
Pranoprofen
|
|
|
|
|
|
S01BC10
|
Nepafenac
|
|
|
|
|
|
S01BC11
|
Bromfenac
|
|
|
|
S01C
|
|
|
Anti-inflammatory agents and anti-infectives in combination
|
|
|
|
|
S01CA
|
|
Corticosteroids and anti-infectives in combination
|
|
|
|
|
|
S01CA01
|
Dexamethasone and antiinfectives
|
|
|
|
|
|
S01CA02
|
Prednisolone and antiinfectives
|
|
|
|
|
|
S01CA03
|
Hydrocortisone and antiinfectives
|
|
|
|
|
|
S01CA04
|
Fluocortolone and antiinfectives
|
|
|
|
|
|
S01CA05
|
Betamethasone and antiinfectives
|
|
|
|
|
|
S01CA06
|
Fludrocortisone and antiinfectives
|
|
|
|
|
|
S01CA07
|
Fluorometholone and antiinfectives
|
|
|
|
|
|
S01CA08
|
Methylprednisolone and antiinfectives
|
|
|
|
|
|
S01CA09
|
Chloroprednisone and antiinfectives
|
|
|
|
|
|
S01CA10
|
Fluocinolone acetonide and antiinfectives
|
|
|
|
|
|
S01CA11
|
Clobetasone and antiinfectives
|
|
|
|
|
S01CB
|
|
Corticosteroids/anti-infectives/mydriatics in combination
|
|
|
|
|
|
S01CB01
|
Dexamethasone
|
|
|
|
|
|
S01CB02
|
Prednisolone
|
|
|
|
|
|
S01CB03
|
Hydrocortisone
|
|
|
|
|
|
S01CB04
|
Betamethasone
|
|
|
|
|
|
S01CB05
|
Fluorometholone
|
|
|
|
|
S01CC
|
|
Anti-inflammatory agents, non-steroids and anti-infectives in combination
|
|
|
|
|
|
S01CC01
|
Diclofenac and antiinfectives
|
|
|
|
S01E
|
|
|
Antiglaucoma preparations and miotics
|
|
|
|
|
S01EA
|
|
Sympathomimetics in glaucoma therapy
|
|
|
|
|
|
S01EA01
|
Epinephrine
|
|
|
|
|
|
S01EA02
|
Dipivefrine
|
|
|
|
|
|
S01EA03
|
Apraclonidine
|
|
|
|
|
|
S01EA04
|
Clonidine
|
|
|
|
|
|
S01EA05
|
Brimonidine
|
|
|
|
|
|
S01EA51
|
Epinephrine, combinations
|
|
|
|
|
S01EB
|
|
Parasympathomimetics
|
|
|
|
|
|
S01EB01
|
Pilocarpine
|
|
|
|
|
|
S01EB02
|
Carbachol
|
|
|
|
|
|
S01EB03
|
Ecothiopate
|
|
|
|
|
|
S01EB04
|
Demecarium
|
|
|
|
|
|
S01EB05
|
Physostigmine
|
|
|
|
|
|
S01EB06
|
Neostigmine
|
|
|
|
|
|
S01EB07
|
Fluostigmine
|
|
|
|
|
|
S01EB08
|
Aceclidine
|
|
|
|
|
|
S01EB09
|
Acetylcholine
|
|
|
|
|
|
S01EB10
|
Paraoxon
|
|
|
|
|
|
S01EB51
|
Pilocarpine, combinations
|
|
|
|
|
|
S01EB58
|
Aceclidine, combinations
|
|
|
|
|
S01EC
|
|
Carbonic anhydrase inhibitors
|
|
|
|
|
|
S01EC01
|
Acetazolamide
|
|
|
|
|
|
S01EC02
|
Diclofenamide
|
|
|
|
|
|
S01EC03
|
Dorzolamide
|
|
|
|
|
|
S01EC04
|
Brinzolamide
|
|
|
|
|
|
S01EC05
|
Methazolamide
|
|
|
|
|
S01ED
|
|
Beta blocking agents
|
|
|
|
|
|
S01ED01
|
Timolol
|
|
|
|
|
|
S01ED02
|
Betaxolol
|
|
|
|
|
|
S01ED03
|
Levobunolol
|
|
|
|
|
|
S01ED04
|
Metipranolol
|
|
|
|
|
|
S01ED05
|
Carteolol
|
|
|
|
|
|
S01ED06
|
Befunolol
|
|
|
|
|
|
S01ED51
|
Timolol, combinations
|
|
|
|
|
|
S01ED52
|
Betaxolol, combinations
|
|
|
|
|
|
S01ED54
|
Metipranolol, combinations
|
|
|
|
|
|
S01ED55
|
Carteolol, combinations
|
|
|
|
|
S01EE
|
|
Prostaglandin analogues
|
|
|
|
|
|
S01EE01
|
Latanoprost
|
|
|
|
|
|
S01EE02
|
Unoprostone
|
|
|
|
|
|
S01EE03
|
Bimatoprost
|
|
|
|
|
|
S01EE04
|
Travoprost
|
|
|
|
|
|
S01EE05
|
Tafluprost
|
|
|
|
|
S01EX
|
|
Other antiglaucoma preparations
|
|
|
|
|
|
S01EX01
|
Guanethidine
|
|
|
|
|
|
S01EX02
|
Dapiprazole
|
|
|
|
S01F
|
|
|
Mydriatics and cycloplegics
|
|
|
|
|
S01FA
|
|
Anticholinergics
|
|
|
|
|
|
S01FA01
|
Atropine
|
|
|
|
|
|
S01FA02
|
Scopolamine
|
|
|
|
|
|
S01FA03
|
Methylscopolamine
|
|
|
|
|
|
S01FA04
|
Cyclopentolate
|
|
|
|
|
|
S01FA05
|
Homatropine
|
|
|
|
|
|
S01FA06
|
Tropicamide
|
|
|
|
|
|
S01FA56
|
Tropicamide, combinations
|
|
|
|
|
S01FB
|
|
Sympathomimetics excluding antiglaucoma preparations
|
|
|
|
|
|
S01FB01
|
Phenylephrine
|
|
|
|
|
|
S01FB02
|
Ephedrine
|
|
|
|
|
|
S01FB03
|
Ibopamine
|
|
|
|
S01G
|
|
|
Decongestants and antiallergics
|
|
|
|
|
S01GA
|
|
Sympathomimetics used as decongestants
|
|
|
|
|
|
S01GA01
|
Naphazoline
|
|
|
|
|
|
S01GA02
|
Tetryzoline
|
|
|
|
|
|
S01GA03
|
Xylometazoline
|
|
|
|
|
|
S01GA04
|
Oxymetazoline
|
|
|
|
|
|
S01GA05
|
Phenylephrine
|
|
|
|
|
|
S01GA06
|
Oxedrine
|
|
|
|
|
|
S01GA51
|
Naphazoline, combinations
|
|
|
|
|
|
S01GA52
|
Tetryzoline, combinations
|
|
|
|
|
|
S01GA53
|
Xylometazoline, combinations
|
|
|
|
|
|
S01GA55
|
Phenylephrine, combinations
|
|
|
|
|
|
S01GA56
|
Oxedrine, combinations
|
|
|
|
|
S01GX
|
|
Other antiallergics
|
|
|
|
|
|
S01GX01
|
Cromoglicic acid
|
|
|
|
|
|
S01GX02
|
Levocabastine
|
|
|
|
|
|
S01GX03
|
Spaglumic acid
|
|
|
|
|
|
S01GX04
|
Nedocromil
|
|
|
|
|
|
S01GX05
|
Lodoxamide
|
|
|
|
|
|
S01GX06
|
Emedastine
|
|
|
|
|
|
S01GX07
|
Azelastine
|
|
|
|
|
|
S01GX08
|
Ketotifen
|
|
|
|
|
|
S01GX09
|
Olopatadine
|
|
|
|
|
|
S01GX10
|
Epinastine
|
|
|
|
|
|
S01GX11
|
Alcaftadine
|
|
|
|
|
|
S01GX51
|
Cromoglicic acid, combinations
|
|
|
|
S01H
|
|
|
Local anesthetics
|
|
|
|
|
S01HA
|
|
Local anesthetics
|
|
|
|
|
|
S01HA01
|
Cocaine
|
|
|
|
|
|
S01HA02
|
Oxybuprocaine
|
|
|
|
|
|
S01HA03
|
Tetracaine
|
|
|
|
|
|
S01HA04
|
Proxymetacaine
|
|
|
|
|
|
S01HA05
|
Procaine
|
|
|
|
|
|
S01HA06
|
Cinchocaine
|
|
|
|
|
|
S01HA07
|
Lidocaine
|
|
|
|
|
|
S01HA30
|
Combinations
|
|
|
|
S01J
|
|
|
Diagnostic agents
|
|
|
|
|
S01JA
|
|
Colouring agents
|
|
|
|
|
|
S01JA01
|
Fluorescein
|
|
|
|
|
|
S01JA02
|
Rose bengal sodium
|
|
|
|
|
|
S01JA51
|
Fluorescein, combinations
|
|
|
|
|
S01JX
|
|
Other ophthalmological diagnostic agents
|
|
|
|
|
|
|
empty
|
|
|
|
S01K
|
|
|
Surgical aids
|
|
|
|
|
S01KA
|
|
Viscoelastic substances
|
|
|
|
|
|
S01KA01
|
Hyaluronic acid
|
|
|
|
|
|
S01KA02
|
Hypromellose
|
|
|
|
|
|
S01KA51
|
Hyaluronic acid, combinations
|
|
|
|
|
S01KX
|
|
Other surgical aids
|
|
|
|
|
|
S01KX01
|
Chymotrypsin
|
|
|
|
S01L
|
|
|
Ocular vascular disorder agents
|
|
|
|
|
S01LA
|
|
Antineovascularisation agents
|
|
|
|
|
|
S01LA01
|
Verteporfin
|
|
|
|
|
|
S01LA02
|
Anecortave
|
|
|
|
|
|
S01LA03
|
Pegaptanib
|
|
|
|
|
|
S01LA04
|
Ranibizumab
|
|
|
|
|
|
S01LA05
|
Aflibercept
|
|
|
|
|
|
S01LA06
|
brolucizumab
|
|
|
|
|
|
S01LA07
|
abicipar pegol
|
|
|
|
|
|
S01LA08
|
bevacizumab
|
|
|
|
|
|
S01LA09
|
faricimab
|
|
|
|
S01X
|
|
|
Other ophthalmologicals
|
|
|
|
|
S01XA
|
|
Other ophthalmologicals
|
|
|
|
|
|
S01XA01
|
Guaiazulene
|
|
|
|
|
|
S01XA02
|
Retinol
|
|
|
|
|
|
S01XA03
|
Sodium chloride, hypertonic
|
|
|
|
|
|
S01XA04
|
Potassium iodide
|
|
|
|
|
|
S01XA05
|
Sodium edetate
|
|
|
|
|
|
S01XA06
|
Ethylmorphine
|
|
|
|
|
|
S01XA07
|
Alum
|
|
|
|
|
|
S01XA08
|
Acetylcysteine
|
|
|
|
|
|
S01XA09
|
Iodoheparinate
|
|
|
|
|
|
S01XA10
|
Inosine
|
|
|
|
|
|
S01XA11
|
Nandrolone
|
|
|
|
|
|
S01XA12
|
Dexpanthenol
|
|
|
|
|
|
S01XA13
|
Alteplase
|
|
|
|
|
|
S01XA14
|
Heparin
|
|
|
|
|
|
S01XA15
|
Ascorbic acid
|
|
|
|
|
|
S01XA16
|
anecortave (בוטל, קוד חדש S01LA02)
|
|
|
|
|
|
S01XA17
|
pegaptanib (בוטל, קוד חדש S01LA03)
|
|
|
|
|
|
S01XA18
|
Ciclosporin
|
|
|
|
|
|
S01XA19
|
Limbal stem cells, autologous
|
|
|
|
|
|
S01XA20
|
Artificial tears and other indifferent preparations
|
|
|
S02
|
|
|
|
Otologicals
|
|
|
|
S02A
|
|
|
Anti-infectives
|
|
|
|
|
S02AA
|
|
Anti-infectives
|
|
|
|
|
|
S02AA01
|
Chloramphenicol
|
|
|
|
|
|
S02AA02
|
Nitrofural
|
|
|
|
|
|
S02AA03
|
Boric acid
|
|
|
|
|
|
S02AA04
|
Aluminium acetotartrate
|
|
|
|
|
|
S02AA05
|
Clioquinol
|
|
|
|
|
|
S02AA06
|
Hydrogen peroxide
|
|
|
|
|
|
S02AA07
|
Neomycin
|
|
|
|
|
|
S02AA08
|
Tetracycline
|
|
|
|
|
|
S02AA09
|
Chlorhexidine
|
|
|
|
|
|
S02AA10
|
Acetic acid
|
|
|
|
|
|
S02AA11
|
Polymyxin B
|
|
|
|
|
|
S02AA12
|
Rifamycin
|
|
|
|
|
|
S02AA13
|
Miconazole
|
|
|
|
|
|
S02AA14
|
Gentamicin
|
|
|
|
|
|
S02AA15
|
Ciprofloxacin
|
|
|
|
|
|
S02AA16
|
Ofloxacin
|
|
|
|
|
|
S02AA30
|
Antiinfectives, combinations
|
|
|
|
S02B
|
|
|
Corticosteroids
|
|
|
|
|
S02BA
|
|
Corticosteroids
|
|
|
|
|
|
S02BA01
|
Hydrocortisone
|
|
|
|
|
|
S02BA03
|
Prednisolone
|
|
|
|
|
|
S02BA06
|
Dexamethasone
|
|
|
|
|
|
S02BA07
|
Betamethasone
|
|
|
|
|
|
S02BA08
|
Fluocinolone acetonide
|
|
|
|
S02C
|
|
|
Corticosteroids and anti-infectives in combination
|
|
|
|
|
S02CA
|
|
Corticosteroids and anti-infectives in combination
|
|
|
|
|
|
S02CA01
|
Prednisolone and antiinfectives
|
|
|
|
|
|
S02CA02
|
Flumetasone and antiinfectives
|
|
|
|
|
|
S02CA03
|
Hydrocortisone and antiinfectives
|
|
|
|
|
|
S02CA04
|
Triamcinolone and antiinfectives
|
|
|
|
|
|
S02CA05
|
Fluocinolone acetonide and antiinfectives
|
|
|
|
|
|
S02CA06
|
Dexamethasone and antiinfectives
|
|
|
|
|
|
S02CA07
|
Fludrocortisone and antiinfectives
|
|
|
|
S02D
|
|
|
Other otologicals
|
|
|
|
|
S02DA
|
|
Analgesics and anesthetics
|
|
|
|
|
|
S02DA01
|
Lidocaine
|
|
|
|
|
|
S02DA02
|
Cocaine
|
|
|
|
|
|
S02DA03
|
Phenazone
|
|
|
|
|
|
S02DA04
|
Cinchocaine
|
|
|
|
|
|
S02DA30
|
Combinations
|
|
|
|
|
S02DC
|
|
Indifferent preparations
|
|
|
|
|
|
|
Empty group
|
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
|
|
|
S03A
|
|
|
Anti-infectives
|
|
|
|
|
S03AA
|
|
Anti-infectives
|
|
|
|
|
|
S03AA01
|
Neomycin
|
|
|
|
|
|
S03AA02
|
Tetracycline
|
|
|
|
|
|
S03AA03
|
Polymyxin B
|
|
|
|
|
|
S03AA04
|
Chlorhexidine
|
|
|
|
|
|
S03AA05
|
Hexamidine
|
|
|
|
|
|
S03AA06
|
Gentamicin
|
|
|
|
|
|
S03AA07
|
Ciprofloxacin
|
|
|
|
|
|
S03AA08
|
Chloramphenicol
|
|
|
|
|
|
S03AA30
|
Antiinfectives, combinations
|
|
|
|
S03B
|
|
|
Corticosteroids
|
|
|
|
|
S03BA
|
|
Corticosteroids
|
|
|
|
|
|
S03BA01
|
Dexamethasone
|
|
|
|
|
|
S03BA02
|
Prednisolone
|
|
|
|
|
|
S03BA03
|
Betamethasone
|
|
|
|
S03C
|
|
|
Corticosteroids and anti-infectives in combination
|
|
|
|
|
S03CA
|
|
Corticosteroids and anti-infectives in combination
|
|
|
|
|
|
S03CA01
|
Dexamethasone and antiinfectives
|
|
|
|
|
|
S03CA02
|
Prednisolone and antiinfectives
|
|
|
|
|
|
S03CA04
|
Hydrocortisone and antiinfectives
|
|
|
|
|
|
S03CA05
|
Fludrocortisone and antiinfectives
|
|
|
|
|
|
S03CA06
|
Betamethasone and antiinfectives
|
|
|
|
S03D
|
|
|
Other ophthalmological and otological preparations
|
|
|
|
|
|
|
Empty group
|
| V
|
|
|
|
|
Various
|
|
|
V01
|
|
|
|
Allergens
|
|
|
|
V01A
|
|
|
Allergens
|
|
|
|
|
V01AA
|
|
Allergen extracts
|
|
|
|
|
|
V01AA01
|
Feather
|
|
|
|
|
|
V01AA02
|
Grass pollen
|
|
|
|
|
|
V01AA03
|
House dust mites
|
|
|
|
|
|
V01AA04
|
Mould fungus and yeast fungus
|
|
|
|
|
|
V01AA05
|
Tree pollen
|
|
|
|
|
|
V01AA07
|
Insects
|
|
|
|
|
|
V01AA08
|
Food
|
|
|
|
|
|
V01AA09
|
Textiles
|
|
|
|
|
|
V01AA10
|
Flowers
|
|
|
|
|
|
V01AA11
|
Animals
|
|
|
|
|
|
V01AA20
|
Various
|
|
|
V03
|
|
|
|
All other therapeutic products
|
|
|
|
V03A
|
|
|
All other therapeutic products
|
|
|
|
|
V03AB
|
|
Antidotes
|
|
|
|
|
|
V03AB01
|
Ipecacuanha
|
|
|
|
|
|
V03AB02
|
Nalorphine
|
|
|
|
|
|
V03AB03
|
Edetates
|
|
|
|
|
|
V03AB04
|
Pralidoxime
|
|
|
|
|
|
V03AB05
|
Prednisolone and promethazine
|
|
|
|
|
|
V03AB06
|
Thiosulfate
|
|
|
|
|
|
V03AB08
|
Sodium nitrite
|
|
|
|
|
|
V03AB09
|
Dimercaprol
|
|
|
|
|
|
V03AB13
|
Obidoxime
|
|
|
|
|
|
V03AB14
|
Protamine
|
|
|
|
|
|
V03AB15
|
Naloxone
|
|
|
|
|
|
V03AB16
|
Ethanol
|
|
|
|
|
|
V03AB17
|
Methylthioninium chloride
|
|
|
|
|
|
V03AB18
|
Potassium permanganate
|
|
|
|
|
|
V03AB19
|
Physostigmine
|
|
|
|
|
|
V03AB20
|
Copper sulfate
|
|
|
|
|
|
V03AB21
|
Potassium iodide
|
|
|
|
|
|
V03AB22
|
Amyl nitrite
|
|
|
|
|
|
V03AB23
|
Acetylcysteine
|
|
|
|
|
|
V03AB24
|
Digitalis antitoxin
|
|
|
|
|
|
V03AB25
|
Flumazenil
|
|
|
|
|
|
V03AB26
|
Methionine
|
|
|
|
|
|
V03AB27
|
4-dimethylaminophenol
|
|
|
|
|
|
V03AB29
|
Cholinesterase
|
|
|
|
|
|
V03AB31
|
Prussian blue
|
|
|
|
|
|
V03AB32
|
Glutathione
|
|
|
|
|
|
V03AB33
|
Hydroxocobalamin
|
|
|
|
|
|
V03AB34
|
Fomepizole
|
|
|
|
|
|
V03AB35
|
Sugammadex
|
|
|
|
|
|
V03AB36
|
Phentolamine
|
|
|
|
|
|
V03AB37
|
idarucizumab
|
|
|
|
|
|
V03AB38
|
andexanet alfa
|
|
|
|
|
V03AC
|
|
Iron chelating agents
|
|
|
|
|
|
V03AC01
|
Deferoxamine
|
|
|
|
|
|
V03AC02
|
Deferiprone
|
|
|
|
|
|
V03AC03
|
Deferasirox
|
|
|
|
|
V03AE
|
|
Drugs for treatment of hyperkalemia and hyperphosphatemia
|
|
|
|
|
|
V03AE01
|
Polystyrene sulfonate
|
|
|
|
|
|
V03AE02
|
Sevelamer
|
|
|
|
|
|
V03AE03
|
Lanthanum carbonate
|
|
|
|
|
|
V03AE04
|
Calcium acetate and magnesium carbonate
|
|
|
|
|
|
V03AE05
|
sucroferric oxyhydroxide
|
|
|
|
|
|
V03AE06
|
colestilan
|
|
|
|
|
|
V03AE07
|
calcium acetate
|
|
|
|
|
|
V03AE08
|
ferric citrate
|
|
|
|
|
|
V03AE09
|
patiromer calcium
|
|
|
|
|
|
V03AE10
|
patiromer calcium
|
|
|
|
|
V03AF
|
|
Detoxifying agents for antineoplastic treatment
|
|
|
|
|
|
V03AF01
|
Mesna
|
|
|
|
|
|
V03AF02
|
Dexrazoxane
|
|
|
|
|
|
V03AF03
|
Calcium folinate
|
|
|
|
|
|
V03AF04
|
Calcium levofolinate
|
|
|
|
|
|
V03AF05
|
Amifostine
|
|
|
|
|
|
V03AF06
|
Sodium folinate
|
|
|
|
|
|
V03AF07
|
Rasburicase
|
|
|
|
|
|
V03AF08
|
Palifermin
|
|
|
|
|
|
V03AF09
|
Glucarpidase
|
|
|
|
|
|
V03AF10
|
Sodium levofolinate
|
|
|
|
|
|
V03AF11
|
arginine and lysine
|
|
|
|
|
V03AG
|
|
Drugs for treatment of hypercalcemia
|
|
|
|
|
|
V03AG01
|
Sodium cellulose phosphate
|
|
|
|
|
V03AH
|
|
Drugs for treatment of hypoglycaemia
|
|
|
|
|
|
V03AH01
|
Diazoxide
|
|
|
|
|
V03AK
|
|
Tissue adhesives
|
|
|
|
|
|
|
empty
|
|
|
|
|
V03AM
|
|
Drugs for embolisation
|
|
|
|
|
|
|
empty
|
|
|
|
|
V03AN
|
|
Medical gases
|
|
|
|
|
|
V03AN01
|
Oxygen
|
|
|
|
|
|
V03AN02
|
Carbon dioxide
|
|
|
|
|
|
V03AN03
|
Helium
|
|
|
|
|
|
V03AN04
|
Nitrogen
|
|
|
|
|
|
V03AN05
|
Medical air
|
|
|
|
|
V03AX
|
|
Other therapeutic products
|
|
|
|
|
|
V03AX02
|
Nalfurafine
|
|
|
|
|
|
V03AX03
|
Cobicistat
|
|
|
|
|
V03AZ
|
|
Nerve depressants
|
|
|
|
|
|
V03AZ01
|
Ethanol
|
|
|
V04
|
|
|
|
Diagnostic agents
|
|
|
|
V04B
|
|
|
Urine tests
|
|
|
|
|
|
|
Empty group
|
|
|
|
V04C
|
|
|
Other diagnostic agents
|
|
|
|
|
V04CA
|
|
Tests for diabetes
|
|
|
|
|
|
V04CA01
|
Tolbutamide
|
|
|
|
|
|
V04CA02
|
Glucose
|
|
|
|
|
V04CB
|
|
Tests for fat absorption
|
|
|
|
|
|
V04CB01
|
Vitamin A concentrates
|
|
|
|
|
V04CC
|
|
Tests for bile duct patency
|
|
|
|
|
|
V04CC01
|
Sorbitol
|
|
|
|
|
|
V04CC02
|
Magnesium sulfate
|
|
|
|
|
|
V04CC03
|
Sincalide
|
|
|
|
|
|
V04CC04
|
Ceruletide
|
|
|
|
|
V04CD
|
|
Tests for pituitary function
|
|
|
|
|
|
V04CD01
|
Metyrapone
|
|
|
|
|
|
V04CD03
|
Sermorelin
|
|
|
|
|
|
V04CD04
|
Corticorelin
|
|
|
|
|
|
V04CD05
|
Somatorelin
|
|
|
|
|
V04CE
|
|
Tests for liver functional capacity
|
|
|
|
|
|
V04CE01
|
Galactose
|
|
|
|
|
|
V04CE02
|
Sulfobromophthalein
|
|
|
|
|
V04CF
|
|
Tuberculosis diagnostics
|
|
|
|
|
|
V04CF01
|
Tuberculin
|
|
|
|
|
V04CG
|
|
Tests for gastric secretion
|
|
|
|
|
|
V04CG01
|
Cation exchange resins
|
|
|
|
|
|
V04CG02
|
Betazole
|
|
|
|
|
|
V04CG03
|
Histamine phosphate
|
|
|
|
|
|
V04CG04
|
Pentagastrin
|
|
|
|
|
|
V04CG05
|
Methylthioninium chloride
|
|
|
|
|
|
V04CG30
|
Caffeine and sodium benzoate
|
|
|
|
|
V04CH
|
|
Tests for renal function and ureteral injuries
|
|
|
|
|
|
V04CH01
|
Inulin and other polyfructosans
|
|
|
|
|
|
V04CH02
|
Indigo carmine
|
|
|
|
|
|
V04CH03
|
Phenolsulfonphthalein
|
|
|
|
|
|
V04CH04
|
Alsactide
|
|
|
|
|
|
V04CH30
|
Aminohippuric acid
|
|
|
|
|
V04CJ
|
|
Tests for thyreoidea function
|
|
|
|
|
|
V04CJ01
|
Thyrotropin
|
|
|
|
|
|
V04CJ02
|
Protirelin
|
|
|
|
|
V04CK
|
|
Tests for pancreatic function
|
|
|
|
|
|
V04CK01
|
Secretin
|
|
|
|
|
|
V04CK02
|
Pancreozymin (cholecystokinin)
|
|
|
|
|
|
V04CK03
|
Bentiromide
|
|
|
|
|
V04CL
|
|
Tests for allergic diseases
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V04CM
|
|
Tests for fertility disturbances
|
|
|
|
|
|
V04CM01
|
Gonadorelin
|
|
|
|
|
V04CX
|
|
Other diagnostic agents
|
|
|
|
|
|
V04CX01
|
indocyanine green
|
|
|
|
|
|
V04CX02
|
folic acid
|
|
|
|
|
|
V04CX03
|
methacholine
|
|
|
|
|
|
V04CX04
|
mannitol
|
|
|
|
|
|
V04CX05
|
13C-urea
|
|
|
|
|
|
V04CX06
|
hexaminolevulinate
|
|
|
|
|
|
V04CX07
|
edrophonium
|
|
|
|
|
|
V04CX08
|
carbon monoxide
|
|
|
|
|
|
V04CX09
|
patent blue
|
|
|
|
|
|
V04CX10
|
pafolacianine
|
|
|
|
|
|
V04CX11
|
lithium chloride
|
|
|
V06
|
|
|
|
General nutrients
|
|
|
|
V06A
|
|
|
Diet formulations for treatment of obesity
|
|
|
|
|
V06AA
|
|
Low-energy diets
|
|
|
|
|
|
|
Empty group
|
|
|
|
V06B
|
|
|
Protein supplements
|
|
|
|
|
|
|
Empty group
|
|
|
|
V06C
|
|
|
Infant formulas
|
|
|
|
|
V06CA
|
|
Nutrients without phenylalanine
|
|
|
|
|
|
|
Empty group
|
|
|
|
V06D
|
|
|
Other nutrients
|
|
|
|
|
V06DA
|
|
Carbohydrates/proteins/minerals/vitamins, combinations
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V06DB
|
|
Fat/carbohydrates/proteins/minerals/vitamins, combinations
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V06DC
|
|
Carbohydrates
|
|
|
|
|
|
V06DC01
|
Glucose
|
|
|
|
|
|
V06DC02
|
Fructose
|
|
|
|
|
V06DD
|
|
Amino acids, including combinations with polypeptides
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V06DE
|
|
Amino acids/carbohydrates/minerals/vitamins, combinations
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V06DF
|
|
Milk substitutes
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V06DX
|
|
Other combinations of nutrients
|
|
|
|
|
|
|
Empty group
|
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
|
|
V07A
|
|
|
All other non-therapeutic products
|
|
|
|
|
V07AA
|
|
Plasters
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AB
|
|
Solvents and diluting agents, including irrigating solutions
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AC
|
|
Blood transfusion, auxiliary products
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AD
|
|
Blood tests, auxiliary products
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AN
|
|
Incontinence equipment
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AR
|
|
Sensitivity tests, discs and tablets
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AS
|
|
Stoma equipment
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AT
|
|
Cosmetics
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AV
|
|
Technical disinfectants
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AX
|
|
Washing agents etc.
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AY
|
|
Other non-therapeutic auxiliary products
|
|
|
|
|
|
|
Empty group
|
|
|
|
|
V07AZ
|
|
Chemicals and reagents for analysis
|
|
|
V08
|
|
|
|
Contrast media
|
|
|
|
V08A
|
|
|
X-ray contrast media, iodinated
|
|
|
|
|
V08AA
|
|
Water-soluble, nephrotropic, high osmolar X-ray contrast media
|
|
|
|
|
|
V08AA01
|
Diatrizoic acid
|
|
|
|
|
|
V08AA02
|
Metrizoic acid
|
|
|
|
|
|
V08AA03
|
Iodamide
|
|
|
|
|
|
V08AA04
|
Iotalamic acid
|
|
|
|
|
|
V08AA05
|
Ioxitalamic acid
|
|
|
|
|
|
V08AA06
|
Ioglicic acid
|
|
|
|
|
|
V08AA07
|
Acetrizoic acid
|
|
|
|
|
|
V08AA08
|
Iocarmic acid
|
|
|
|
|
|
V08AA09
|
Methiodal
|
|
|
|
|
|
V08AA10
|
Diodone
|
|
|
|
|
V08AB
|
|
Water-soluble, nephrotropic, low osmolar X-ray contrast media
|
|
|
|
|
|
V08AB01
|
Metrizamide
|
|
|
|
|
|
V08AB02
|
Iohexol
|
|
|
|
|
|
V08AB03
|
Ioxaglic acid
|
|
|
|
|
|
V08AB04
|
Iopamidol
|
|
|
|
|
|
V08AB05
|
Iopromide
|
|
|
|
|
|
V08AB06
|
Iotrolan
|
|
|
|
|
|
V08AB07
|
Ioversol
|
|
|
|
|
|
V08AB08
|
Iopentol
|
|
|
|
|
|
V08AB09
|
Iodixanol
|
|
|
|
|
|
V08AB10
|
Iomeprol
|
|
|
|
|
|
V08AB11
|
Iobitridol
|
|
|
|
|
|
V08AB12
|
Ioxilan
|
|
|
|
|
V08AC
|
|
Water-soluble, hepatotropic X-ray contrast media
|
|
|
|
|
|
V08AC01
|
Iodoxamic acid
|
|
|
|
|
|
V08AC02
|
Iotroxic acid
|
|
|
|
|
|
V08AC03
|
Ioglycamic acid
|
|
|
|
|
|
V08AC04
|
Adipiodone
|
|
|
|
|
|
V08AC05
|
Iobenzamic acid
|
|
|
|
|
|
V08AC06
|
Iopanoic acid
|
|
|
|
|
|
V08AC07
|
Iocetamic acid
|
|
|
|
|
|
V08AC08
|
Sodium iopodate
|
|
|
|
|
|
V08AC09
|
Tyropanoic acid
|
|
|
|
|
|
V08AC10
|
Calcium iopodate
|
|
|
|
|
V08AD
|
|
Non-watersoluble X-ray contrast media
|
|
|
|
|
|
V08AD01
|
Ethyl esters of iodised fatty acids
|
|
|
|
|
|
V08AD02
|
Iopydol
|
|
|
|
|
|
V08AD03
|
Propyliodone
|
|
|
|
|
|
V08AD04
|
Iofendylate
|
|
|
|
V08B
|
|
|
X-ray contrast media, non-iodinated
|
|
|
|
|
V08BA
|
|
Barium sulfate containing X-ray contrast media
|
|
|
|
|
|
V08BA01
|
Barium sulfate with suspending agents
|
|
|
|
|
|
V08BA02
|
Barium sulfate without suspending agents
|
|
|
|
V08C
|
|
|
Magnetic resonance imaging contrast media
|
|
|
|
|
V08CA
|
|
Paramagnetic contrast media
|
|
|
|
|
|
V08CA01
|
Gadopentetic acid
|
|
|
|
|
|
V08CA02
|
Gadoteric acid
|
|
|
|
|
|
V08CA03
|
Gadodiamide
|
|
|
|
|
|
V08CA04
|
Gadoteridol
|
|
|
|
|
|
V08CA05
|
Mangafodipir
|
|
|
|
|
|
V08CA06
|
Gadoversetamide
|
|
|
|
|
|
V08CA07
|
Ferric ammonium citrate
|
|
|
|
|
|
V08CA08
|
Gadobenic acid
|
|
|
|
|
|
V08CA09
|
Gadobutrol
|
|
|
|
|
|
V08CA10
|
Gadoxetic acid
|
|
|
|
|
|
V08CA11
|
Gadofosveset
|
|
|
|
|
V08CB
|
|
Superparamagnetic contrast media
|
|
|
|
|
|
V08CB01
|
Ferumoxsil
|
|
|
|
|
|
V08CB02
|
Ferristene
|
|
|
|
|
|
V08CB03
|
Iron oxide, nanoparticles
|
|
|
|
|
V08CX
|
|
Other magnetic resonance imaging contrast media
|
|
|
|
|
|
V08CX01
|
Perflubron
|
|
|
|
V08D
|
|
|
Ultrasound contrast media
|
|
|
|
|
V08DA
|
|
Ultrasound contrast media
|
|
|
|
|
|
V08DA01
|
perflutren, human albumin microspheres
|
|
|
|
|
|
V08DA02
|
microparticles of galactose
|
|
|
|
|
|
V08DA03
|
Perflenapent
|
|
|
|
|
|
V08DA04
|
perflutren, phospholipid microspheres
|
|
|
|
|
|
V08DA05
|
sulfur hexafluoride, phospholipid microspheres
|
|
|
|
|
|
V08DA06
|
perflubutane, phospholipid microspheres
|
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
|
|
V09A
|
|
|
Central nervous system
|
|
|
|
|
V09AA
|
|
Technetium (99mTc) compounds
|
|
|
|
|
|
V09AA01
|
Technetium (99mTc) exametazime
|
|
|
|
|
|
V09AA02
|
Technetium (99mTc) bicisate
|
|
|
|
|
V09AB
|
|
Iodine (123I) compounds
|
|
|
|
|
|
V09AB01
|
Iodine iofetamine (123I)
|
|
|
|
|
|
V09AB02
|
Iodine iolopride (123I)
|
|
|
|
|
|
V09AB03
|
Iodine ioflupane (123I)
|
|
|
|
|
V09AX
|
|
Other central nervous system diagnostic radiopharmaceuticals
|
|
|
|
|
|
V09AX01
|
Indium (111In) pentetic acid
|
|
|
|
|
|
V09AX02
|
fludeoxyglucose (בוטל, קוד חדש V09IX04)
|
|
|
|
|
|
V09AX03
|
Iodine (124I) 2β-carbomethoxy-3β-(4-iodophenyl)-tropane
|
|
|
|
|
|
V09AX04
|
Flutemetamol (18F)
|
|
|
|
|
|
V09AX05
|
Florbetapir (18F)
|
|
|
|
V09B
|
|
|
Skeleton
|
|
|
|
|
V09BA
|
|
Technetium (99mTc) compounds
|
|
|
|
|
|
V09BA01
|
Technetium (99mTc) oxidronic acid
|
|
|
|
|
|
V09BA02
|
Technetium (99mTc) medronic acid
|
|
|
|
|
|
V09BA03
|
Technetium (99mTc) pyrophosphate
|
|
|
|
|
|
V09BA04
|
Technetium (99mTc) butedronic acid
|
|
|
|
V09C
|
|
|
Renal system
|
|
|
|
|
V09CA
|
|
Technetium (99mTc) compounds
|
|
|
|
|
|
V09CA01
|
Technetium (99mTc) pentetic acid
|
|
|
|
|
|
V09CA02
|
Technetium (99mTc) succimer
|
|
|
|
|
|
V09CA03
|
Technetium (99mTc) mertiatide
|
|
|
|
|
|
V09CA04
|
Technetium (99mTc) gluceptate
|
|
|
|
|
|
V09CA05
|
Technetium (99mTc) gluconate
|
|
|
|
|
|
V09CA06
|
Technetium (99mTc) ethylenedicysteine
|
|
|
|
|
V09CX
|
|
Other renal system diagnostic radiopharmaceuticals
|
|
|
|
|
|
V09CX01
|
Sodium iodohippurate (123I)
|
|
|
|
|
|
V09CX02
|
Sodium iodohippurate (131I)
|
|
|
|
|
|
V09CX03
|
Sodium iothalamate (125I)
|
|
|
|
|
|
V09CX04
|
Chromium (51Cr) edetate
|
|
|
|
V09D
|
|
|
Hepatic and reticulo endothelial system
|
|
|
|
|
V09DA
|
|
Technetium (99mTc) compounds
|
|
|
|
|
|
V09DA01
|
Technetium (99mTc) disofenin
|
|
|
|
|
|
V09DA02
|
Technetium (99mTc) etifenin
|
|
|
|
|
|
V09DA03
|
Technetium (99mTc) lidofenin
|
|
|
|
|
|
V09DA04
|
Technetium (99mTc) mebrofenin
|
|
|
|
|
|
V09DA05
|
Technetium (99mTc) galtifenin
|
|
|
|
|
V09DB
|
|
Technetium (99mTc), particles and colloids
|
|
|
|
|
|
V09DB01
|
Technetium (99mTc) nanocolloid
|
|
|
|
|
|
V09DB02
|
Technetium (99mTc) microcolloid
|
|
|
|
|
|
V09DB03
|
Technetium (99mTc) millimicrospheres
|
|
|
|
|
|
V09DB04
|
Technetium (99mTc) tin colloid
|
|
|
|
|
|
V09DB05
|
Technetium (99mTc) sulfur colloid
|
|
|
|
|
|
V09DB06
|
Technetium (99mTc) rheniumsulfide colloid
|
|
|
|
|
|
V09DB07
|
Technetium (99mTc) phytate
|
|
|
|
|
V09DX
|
|
Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals
|
|
|
|
|
|
V09DX01
|
Selenium (75Se) tauroselcholic acid
|
|
|
|
V09E
|
|
|
Respiratory system
|
|
|
|
|
V09EA
|
|
Technetium (99mTc) inhalants
|
|
|
|
|
|
V09EA01
|
Technetium (99mTc) pentetic acid
|
|
|
|
|
|
V09EA02
|
Technetium (99mTc) technegas
|
|
|
|
|
|
V09EA03
|
Technetium (99mTc) nanocolloid
|
|
|
|
|
V09EB
|
|
Technetium (99mTc) particles for injection
|
|
|
|
|
|
V09EB01
|
Technetium (99mTc) macrosalb
|
|
|
|
|
|
V09EB02
|
Technetium (99mTc) microspheres
|
|
|
|
|
V09EX
|
|
Other respiratory system diagnostic radiopharmaceuticals
|
|
|
|
|
|
V09EX01
|
Krypton (81mKr) gas
|
|
|
|
|
|
V09EX02
|
Xenon (127Xe) gas
|
|
|
|
|
|
V09EX03
|
Xenon (133Xe) gas
|
|
|
|
V09F
|
|
|
Thyroid
|
|
|
|
|
V09FX
|
|
Various thyroid diagnostic radiopharmaceuticals
|
|
|
|
|
|
V09FX01
|
Technetium (99mTc) pertechnetate
|
|
|
|
|
|
V09FX02
|
Sodium iodide (123I)
|
|
|
|
|
|
V09FX03
|
Sodium iodide (131I)
|
|
|
|
|
|
V09FX04
|
Sodium iodide (124I)
|
|
|
|
V09G
|
|
|
Cardiovascular system
|
|
|
|
|
V09GA
|
|
Technetium (99mTc) compounds
|
|
|
|
|
|
V09GA01
|
Technetium (99mTc) sestamibi
|
|
|
|
|
|
V09GA02
|
Technetium (99mTc) tetrofosmin
|
|
|
|
|
|
V09GA03
|
Technetium (99mTc) teboroxime
|
|
|
|
|
|
V09GA04
|
Technetium (99mTc) human albumin
|
|
|
|
|
|
V09GA05
|
Technetium (99mTc) furifosmin
|
|
|
|
|
|
V09GA06
|
Technetium (99mTc) stannous agent labelled cells
|
|
|
|
|
|
V09GA07
|
Technetium (99mTc) apcitide
|
|
|
|
|
V09GB
|
|
Iodine (125I) compounds
|
|
|
|
|
|
V09GB01
|
Fibrinogen (125I)
|
|
|
|
|
|
V09GB02
|
Iodine (125I) human albumin
|
|
|
|
|
V09GX
|
|
Other cardiovascular system diagnostic radiopharmaceuticals
|
|
|
|
|
|
V09GX01
|
Thallium (201Tl) chloride
|
|
|
|
|
|
V09GX02
|
Indium (111In) imciromab
|
|
|
|
|
|
V09GX03
|
Chromium (51Cr) chromate labelled cells
|
|
|
|
|
|
V09GX04
|
Rubidium (82Rb) chloride
|
|
|
|
V09H
|
|
|
Inflammation and infection detection
|
|
|
|
|
V09HA
|
|
Technetium (99mTc) compounds
|
|
|
|
|
|
V09HA01
|
Technetium (99mTc) human immunoglobulin
|
|
|
|
|
|
V09HA02
|
Technetium (99mTc) exametazime labelled cells
|
|
|
|
|
|
V09HA03
|
Technetium (99mTc) antigranulocyte antibody
|
|
|
|
|
|
V09HA04
|
Technetium (99mTc) sulesomab
|
|
|
|
|
V09HB
|
|
Indium (111In) compounds
|
|
|
|
|
|
V09HB01
|
Indium (111In) oxinate labelled cells
|
|
|
|
|
|
V09HB02
|
Indium (111In) tropolonate labelled cells
|
|
|
|
|
V09HX
|
|
Other diagnostic radiopharmaceuticals for inflammation and infection detection
|
|
|
|
|
|
V09HX01
|
Gallium (67Ga) citrate
|
|
|
|
V09I
|
|
|
Tumour detection
|
|
|
|
|
V09IA
|
|
Technetium (99mTc) compounds
|
|
|
|
|
|
V09IA01
|
Technetium (99mTc) antiCarcinoEmbryonicAntigen antibody
|
|
|
|
|
|
V09IA02
|
Technetium (99mTc) antimelanoma antibody
|
|
|
|
|
|
V09IA03
|
Technetium (99mTc) pentavalent succimer
|
|
|
|
|
|
V09IA04
|
Technetium (99mTc) votumumab
|
|
|
|
|
|
V09IA05
|
Technetium (99mTc) depreotide
|
|
|
|
|
|
V09IA06
|
Technetium (99mTc) arcitumomab
|
|
|
|
|
|
V09IA07
|
Technetium (99mTc) hynic-octreotide
|
|
|
|
|
V09IB
|
|
Indium (111In) compounds
|
|
|
|
|
|
V09IB01
|
Indium (111In) pentetreotide
|
|
|
|
|
|
V09IB02
|
Indium (111In) satumomab pendetide
|
|
|
|
|
|
V09IB03
|
Indium (111In) antiovariumcarcinoma antibody
|
|
|
|
|
|
V09IB04
|
Indium (111In) capromab pendetide
|
|
|
|
|
V09IX
|
|
Other diagnostic radiopharmaceuticals for tumour detection
|
|
|
|
|
|
V09IX01
|
Iobenguane (123I)
|
|
|
|
|
|
V09IX02
|
Iobenguane (131I)
|
|
|
|
|
|
V09IX03
|
Iodine (125I) CC49-monoclonal antibody
|
|
|
|
|
|
V09IX04
|
Fludeoxyglucose (18F)
|
|
|
|
|
|
V09IX05
|
Fluorodopa (18F)
|
|
|
|
|
|
V09IX06
|
Sodium fluoride (18F)
|
|
|
|
|
|
V09IX07
|
Fluoromethylcholine (18F)
|
|
|
|
|
|
V09IX08
|
Fluoroethylcholine (18F)
|
|
|
|
V09X
|
|
|
Other diagnostic radiopharmaceuticals
|
|
|
|
|
V09XA
|
|
Iodine (131I) compounds
|
|
|
|
|
|
V09XA01
|
Iodine (131I) norcholesterol
|
|
|
|
|
|
V09XA02
|
Iodocholesterol (131I)
|
|
|
|
|
|
V09XA03
|
Iodine (131I) human albumin
|
|
|
|
|
V09XX
|
|
Various diagnostic radiopharmaceuticals
|
|
|
|
|
|
V09XX01
|
Cobalt (57Co) cyanocobalamine
|
|
|
|
|
|
V09XX02
|
Cobalt (58Co) cyanocobalamine
|
|
|
|
|
|
V09XX03
|
Selenium (75Se) norcholesterol
|
|
|
|
|
|
V09XX04
|
Ferric (59Fe) citrate
|
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
|
|
V10A
|
|
|
Anti-inflammatory agents
|
|
|
|
|
V10AA
|
|
Yttrium (90Y) compounds
|
|
|
|
|
|
V10AA01
|
Yttrium (90Y) citrate colloid
|
|
|
|
|
|
V10AA02
|
Yttrium (90Y) ferrihydroxide colloid
|
|
|
|
|
|
V10AA03
|
Yttrium (90Y) silicate colloid
|
|
|
|
|
V10AX
|
|
Other anti-inflammatory therapeutic radiopharmaceuticals
|
|
|
|
|
|
V10AX01
|
Phosphorus (32P) chromicphosphate colloid
|
|
|
|
|
|
V10AX02
|
Samarium (153Sm) hydroxyapatite colloid
|
|
|
|
|
|
V10AX03
|
Dysprosium (165Dy) colloid
|
|
|
|
|
|
V10AX04
|
Erbium (169Er) citrate colloid
|
|
|
|
|
|
V10AX05
|
Rhenium (186Re) sulfide colloid
|
|
|
|
|
|
V10AX06
|
Gold (198Au) colloidal
|
|
|
|
V10B
|
|
|
Pain palliation (bone seeking agents)
|
|
|
|
|
V10BX
|
|
Various pain palliation radiopharmaceuticals
|
|
|
|
|
|
V10BX01
|
Strontium (89Sr) chloride
|
|
|
|
|
|
V10BX02
|
Samarium (153Sm) lexidronam
|
|
|
|
|
|
V10BX03
|
Rhenium (186Re) etidronic acid
|
|
|
|
V10X
|
|
|
Other therapeutic radiopharmaceuticals
|
|
|
|
|
V10XA
|
|
Iodine (131I) compounds
|
|
|
|
|
|
V10XA01
|
Sodium iodide (131I)
|
|
|
|
|
|
V10XA02
|
Iobenguane (131I)
|
|
|
|
|
|
V10XA53
|
Tositumomab/iodine (131I) tositumomab
|
|
|
|
|
V10XX
|
|
Various therapeutic radiopharmaceuticals
|
|
|
|
|
|
V10XX01
|
Sodium phosphate (32P)
|
|
|
|
|
|
V10XX02
|
Ibritumomab tiuxetan (90Y)
|
|
|
V20
|
|
|
|
Surgical dressings
|
|
|
|
|
|
|
empty
|
כניסה 
עקבו אחרינו בפייסבוק